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The aim of this thesis is to investigate and better understand the mechanisms
of protein self-assembly. Specifically, I study three protein systems which form
morphologically and structurally distinct fibrillar protein aggregates. The first
of these studies is concerned with the self-assembly of amyloid fibrils formed
from bovine insulin. Amyloid fibrils are associated with human diseases such
as Alzheimers Disease and type-2 diabetes, and are also garnering interest in
biomaterial applications. Fragmentation-dominated models for the self-assembly
of amyloid fibrils have had important successes in explaining the kinetics of
amyloid fibril formation but predict fibril length distributions that do not
match experimental observations. Here I resolve this inconsistency using a
combination of experimental kinetic measurements and computer simulations.
I provide evidence for a structural transition demarcated by a critical fibril mass
concentration, or CFC, above which fragmentation of the fibrils is suppressed.
Our simulations predict the formation of distinct fibril length distributions above
and below the CFC, which I confirm by electron microscopy. These results
point to a new picture of amyloid fibril growth in which structural transitions
that occur during self-assembly have strong effects on the final population of
aggregate species with small, and potentially cytotoxic, oligomers dominating for
long periods of time at protein concentrations below the CFC. I further show that
the CFC can be modulated by environmental conditions, pointing to possible in
vivo strategies for controlling cytotoxicity. I probe the structural nature of the
transition by performing small angle neutron scattering.
Secondly, I study the formation of amyloid-like fibrils from the protein
ovalbumin. I undertake kinetic experiments of self-assembly and find two key
features emerge: the lack of a lag time and the existence of a slow growth regime
in the long-time limit. I observe, using TEM, that these fibrils are worm-like in
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nature and form closed-loops. I find the growth kinetics are intimately connected
to this particular morphology. I present a simple kinetic model which captures
the features of the kinetics found in experiments by incorporating end-to-end
association of fibrils. I comment on the ramifications this type of amyloid fibril
assembly may have on oligomeric toxicity.
Thirdly, the DNA-mimic protein ocr is highly charged (-56e at pH 8) and forms
non-amyloid fibrillar assemblies at very high ammonium sulphate concentrations
(3.2M). The fact that ocr forms translucent fibrillar gels at such high salt
concentrations is extremely unique. Typically under such high salt conditions,
non-specific amorphous aggregates are formed. In order to better understand
the mechanism of why ocr forms specific fibril aggregates, I used variants of the
wile-type protein in which extensive regions of surface have been removed or
modified. The structural characteristics of gels formed from the variants were
probed using microrheological techniques. I find that non-specific electrostatic
charge screening plays an important role in ocr aggregation. However, I also locate
a potentially important α-helical region which may play a part in establishing
specific interactions so that ocr may form ordered fibrillar assemblies.
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Lay Summary
Proteins are complex biological molecules which act as the primary work horse for
the cell and can be found in every tissue and organ within the body. They perform
many critical functions that maintain life such as replicating DNA, transporting
small molecules around the cell, or providing structural rigidity to cells and
tissues. Their ability to do their job properly is often intimately connected to their
three-dimensional shape, often referred to as the ‘native fold’. However, in many
circumstances, the native fold can become disrupted and misfolded or partially
unfolded. When ‘sticky’ regions on the protein become exposed, which otherwise
would be hidden when the protein is in its native fold this, quite often proteins
like to join together. This process is known as protein aggregation. There are
many structures that aggregates can form, from amorphous blobs, to structured
filaments or fibrils.
Scientists are interested in how and why protein aggregation occurs for many
reasons. One extremely important purpose for studying protein aggregation is
that such processes are involved in many human diseases. Well known examples of
diseases associated with protein aggregation are Alzheimer’s disease, Parkinson’s
disease, and Type-2 diabetes. Furthermore, protein-based pharmaceuticals can
be very susceptible to aggregation. If protein-based drugs aggregate, they are
rendered useless. It is therefore of great importance in the pharmaceutical
industry to understand, and in turn, prevent protein aggregation during the
production and storage of pharmaceuticals to ensure stable drugs with long shelf
lives. However, protein aggregation is not always entirely unwanted. Many
researchers are now becoming increasingly interested in using certain types of
protein aggregates as the basis for new and exciting materials.
In this thesis I investigate the basic mechanisms which drive the assembly of
proteins into fibrillar aggregates. I use three different types of proteins which
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all form structurally different filamentous aggregates. First, insulin forms a
particular type of aggregate known as an amyloid fibril. These aggregates are
closely associated with the diseases mentioned above. The important result from
this work is that I found conditions in which the potentially harmful aggregates
which may cause these diseases can either drastically accumulate or be effectively
minimized due to structural changes of the fibrillar aggregates. This insight may
have ramifications for understanding the progression of these diseases within the
body.
Second, I use another protein, ovalbumin, which forms flexible, worm-like,
fibrillar aggregates. I find that these aggregates can form circular fibrils or
loops. By using a simple mathematical model, I am able to show that interesting
features of how they grow can be successfully explained by their ability to form
these loops. The mechanism of end-joining could provide a different mechanism
from the one mentioned above on how to prevent the accumulation of harmful
aggregates associated with disease.
Finally, I study another protein, called ocr, that forms a highly unusual fibril
aggregate. Typically, proteins in very salty solutions aggregate, but they almost
always form amorphous, globular aggregates. Ocr is unique in that it forms fibrils
in the presence of high concentrations of salt. I used genetically modified versions
of the protein, and studied the structure of the subsequent aggregate gel that is
formed, to understand how and why this protein surprisingly forms this type of
aggregate under these conditions.
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1.1 Generic picture of amyloid fibril assembly. For structured
proteins or peptides, it is commonly accepted a destabilization
of the native structure must be achieved before amyloidogenic
aggregation can proceed. From a partially denatured monomer
unit, amyloid or amyloid-competent oligomers form until amyloid
‘seeds’ or nuclei are formed. From this point, amyloid filaments
may grow by addition to the ends of the growing filaments. These
filaments can then associate into protofibrils and eventually mature
amyloid fibrils. Image taken from [1]. . . . . . . . . . . . . . . . . 10
1.2 Generic structure of amyloid fibrils. Amyloid fibrils are
typified by the presence of cross β-sheet structure as revealed by
x-ray diffraction experiments. The schematic shows a meridional
x-ray diffraction pattern indicating a spacing of ∼ 10 Å. A
second equatorial pattern shows a spacing of 4.7 Å. These spacing
correspond to the inter-sheet and inter-strand spacing within an
amyloid fibril. Images adapted from [2]. . . . . . . . . . . . . . . 11
1.3 Schematic of kinetic models. In the classical nucleation picture
of amyloid fibril assembly, a native monomer unit becomes partially
destabilized due to environmental conditions. These destabilized
units can aggregate, eventually forming a critical nucleus of
some size nc that can then continue to grow into fibrils. Such
nucleated growth is typified by the lag time scaling with the protein
concentration as τlag ∼ c−(nc+1)/2. In a model where nucleation is
still present, but the kinetics are dominated by fibril fragmentation
as different scaling behavior exists quite distinct from the classical
model: τlag ∼ c−1/2. Since the scaling exponent in the classical
nucleation picture is always greater than one, the predominant
mechanisms which determine the kinetic features of fibril assembly
may be reliably distinguished. . . . . . . . . . . . . . . . . . . . . 22
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2.1 Schematic of the amino acid structure of bovine insulin.
Bovine insulin consists of 51 amino acids which are subdivided
into two units: the A and B chains. There are two inter-chain
disulphide bonds linking the A and B chains; there is also an
interchain disulphide bond within the A chain. Taken from [3] . . 27
2.2 Ovalbumin structure. Displayed is an ovalbumin monomer unit.
Ovalbumin contains substantial β-sheet (dark blue) and α-helix
(green) secondary structure. A member of the serpin family of
proteins, it is the most abundant protein in a hen egg white. Taken
from PDB 1OVA. . . . . . . . . . . . . . . . . . . . . . . . . . . 28
2.3 Ocr amino acid sequence Wild-type ocr is comprised of 116
amino acids. There is a large number of aspartates and glutamates
which contributes to the very high surface charge of ocr. . . . . . 29
2.4 The Ocr dimer dimics the charge and structure of bent
DNA’ An ocr dimer (blue) with bent double stranded DNA
(green) overlaid. Note the similarity in location of the charge
groups for ocr and DNA. DNA phosphate groups are yellow and
purple. The ocr carboxyl groups are red and black. The bend
angle is 33.6◦. (Source: [4]) . . . . . . . . . . . . . . . . . . . . . . 30
2.5 Origin of circular dichroism. A Projection of the left- and
right- circularly polarized light perpendicular to the direction of
propagation. Linearly polarized light can be thought of as a
superposition of left- and right- circularly polarized light that
have the same amplitude and phase. B However, if light passes
through an optically active medium which differentially absorbs
left- and right- circularly polarized light (e.g. chiral molecule), the
component which is absorbed more will experience a reduction
in amplitude; projecting these components orthogonally to the
propagation direction results in tracing out an ellipse. This
ellipticity is known as circular dichroism (CD). When there is
circular dichroism, there always exists a change in the phase
between the left- and right- circularly polarized components.
This results in a change in the polarization plane (the elliptical
axes) creating a ‘tipping’ of the ellipse by some angle. C
Circular dichroism experiments often report the amount of circular
dichroism in a sample by measuring the ellipticity, θ, which is the
tangent of the ratio of the minor and major axes of the ellipse
(usually measured in milli-degrees). . . . . . . . . . . . . . . . . 41
xiii
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2.6 Standard far-UV CD spectra for common protein sec-
ondary structure motifs. One can determine the presence and
the relative amount of a particular type of secondary structure due
to these motifs having distinct CD ‘finger prints’. Some examples
are α-helix (solid line), anti-parallel β-sheet (long dashed line),
type I β-turn (dotted line), extended 310-helix (cross dashed line),
irregular structure (short dashed line). Taken from [5] . . . . . . 42
2.7 Graphical origin of the Q-vector. An incoming particle with
wave vector ki (magnitude of 2π/λ) scatters by some angle θ
and the resulting wave vector is kf . If the scattering event is
elastic, there is no energy exchange between the particle that’s
been scattered and the scattering center (e.g. the nucleus). In
that case, the wavelength is unchanged and the magnitude of ki
and kf are the same; only the direction changes. This change in
direction is quantified by the scattering vector Q whose magnitude
is Q = 4π
λ
sin(θ/2). . . . . . . . . . . . . . . . . . . . . . . . . . . 45
2.8 Schematic of ISIS neutron source and the Sans2D detec-
tor. The ISIS neutron source creates high energy protons (800
MeV) via a linear and synchrotron accelerator. Neutron beams are
created by colliding these protons into tungsten plates (spallation).
There are two target stations at ISIS; Target Station 2 is optimized
to deliver longer wavelength and lower energy neutrons ideal for
soft matter and biological experiments. The Sans2d detector is
a time-of-flight, small angle neutron scattering instrument. It
contains two detectors allowing for a typical Q-range coverage of
0.002-3A−1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
2.9 Definition of θ and φ used in the fitting of cylinder model
to data. (Image taken from SasView Manual [6].) . . . . . . . . 50
3.1 Representative kinetic trace for insulin amyloid fibril
formation as monitored by ThT fluorescence. The plot
shows a kinetic trace that has been normalized to its maximum.
A linear function is fit through the region of maximum growth.
The growth rate is defined as the slope of the fit curve. The lag
time is determined by extrapolating the fit curve to the time-axis.
Inset shows well-to-well variation in the kinetics of insulin amyloid
fibril formation. Replicate experimental kinetics curves show the
variability typical of replicate experiments within a microwell plate,
for an insulin concentration of 1.5 mg/ml. . . . . . . . . . . . . . 56
xiv
LIST OF FIGURES
3.2 Lag time vs. insulin concentration for unagitated samples.
Each data point in the plot consists of 140-200 individual exper-
iments carried out in several microwell plates. The plates were
not agitated during the time course of fibril assembly. Lag times
are plotted as a function of insulin concentration on a log-log plot.
The data is fit with a generic power law function y = axb. The
scaling exponent γ, is -0.37 ± 0.02. Data points show mean ± s.d. 57
3.3 Maximum rate of fluorescence increase vs. insulin con-
centration for unagitated samples. The rate of maximum
fluorescence increase, kfluo, was determined as shown in Fig. 3.1.
Plot shows kfluo as a function of insulin concentration. From 0.1-
0.75 mg/ml there is a linear trend; between 0.75 and 1 mg/ml a
sharp increase in fluorescence is observed. Data points show mean
± s.d. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
3.4 Mean maximum fluorescence vs. insulin concentration for
unagitated samples. The maximum fluorescence values show
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points show mean ± s.d. . . . . . . . . . . . . . . . . . . . . . . . 59
3.5 Lag time vs. insulin concentration for agitated samples.
The plates were agitated in a double orbital motion at 600 rpm for
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normalized to their maxima and the normalized growth rate, kgr
were extracted the same manner as determining kfluo. There is a
linear increase in kgr between 0.1 and 0.4 mg/ml; for concentrations
greater than 0.4 mg/ml kgr reaches a plateau (red circles). For
comparison, the predicted kgr from a fragmentation dominated
model is shown (blue triangles). Data points show mean ± s.d. . 64
3.10 CD spectra of insulin amyloid fibrils formed at initial
protein concentrations above and below cT. Plotted are the
molar ellipticities at the minimum (218 nm) of the CD spectra
(inset) as a function of the insulin concentration. The inset shows
the CD spectra for insulin amyloid fibrils formed from 0.25 mg ml−1
(black), 0.5 mg ml−1 (red), 0.75 mg ml−1 (blue), 1 mg ml−1 (pink),
2 mg ml−1 (green), 4 mg ml−1 (orange). There is a striking cross-
over between regimes reflected in the CD signal above and below
1 mg ml−1 insulin coincident with where the kinetic transition
occurs. At low concentrations (<0.75 mg ml−1) I attribute the
gradual decrease in the CD spectra to changes in the filament
organization with increasing protein concentration (i.e. from single
filaments to double [7]). Above 1 mg ml−1 I ascribe the contrasting
increase in signal to a structural transition similar to that observed
for small aromatic molecules on changing from the solution to the
crystalline state [8] . . . . . . . . . . . . . . . . . . . . . . . . . . 65
3.11 2D MSD of insulin amyloid fibril solutions shows a
transition to a gel-state at 0.75 mg/ml. The mean square
displacement (MSD) of 1 µm beads are shown for a range
of insulin concentrations: buffer control (squares), 0.09 mg/ml
(circles), 0.18 mg/ml (triangles), 0.375 mg/ml (diamonds), 0.75
mg/ml (hexagons), 6 mg/ml (stars). For particles undergoing
Brownian motion, the MSD scales as 〈r2〉 ∼ tα, where α is the
scaling exponent. Black line indicates α=1. For concentrations
below 0.75 mg/ml the insulin amyloid fibril solutions exhibit the
characteristics of a viscous fluid. At 0.75 mg/ml, the MSD scaling
exponent drops from 1 to ∼0.2 indicating a transition to a highly
viscous fluid. Inset shows the MSD scaling exponents as a function
of insulin concentration. . . . . . . . . . . . . . . . . . . . . . . . 66
3.12 kgr as a function of insulin concentration: comparing
experiment and simulation. With the addition of the CFC
into the simulation, we find a close agreement betweens simulation
(black squares) and experiment (red circles). For comparison, the
prediction from the model is shown without a CFC (blue triangles). 68
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3.13 Fibril length distributions obtained by simulation Fibril
length distributions obtained by simulation (A) above cT (4
mg/ml) and (B) below cT (0.2 mg/ml). We express the fibril
length in terms of the composite parameter κ/kf . Our simulations
do not make absolute predictions of fibril length because the
choice of values of k+ and kf is not strongly constrained (§2.2.9),
whereas the shape of the length distribution (plotted as a function
of monomer units × kf/κ ) is independent of this choice. The
length distribution in (A) is best described by by a log-normal
distribution; (B) is well-fitted by an exponential distribution (black
fit lines). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
3.14 Representative TEM images of insulin amyloid fibrils
formed above and below the CFC. Images of insulin amyloid
fibrils formed from initial insulin concentrations of (A) 0.2 and
(B) 4 mg/ml. See Fig. 3.15 for corresponding length distributions.
Scale bar is 1 µm. . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
3.15 Fibril length distributions extracted from TEM (A) above
cT (4 mg/ml, N=159, bars) and (B) below cT (0.2 mg/ml, N=75,
bars). As predicted by the model, fibrils formed at protein
concentrations below the CFC are significantly shorter (mean
length of 231.5 ± 230.4 nm) and the distribution is exponential
(black curve). Length distributions above cT show a log-normal
distribution (black curve) with a mean fibril length of 2441.5 ±
1590.3 nm (mean± s.d.). Experimental and simulation data points
show mean ± s.d. . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
3.16 The trends in maximum ThT fluorescence as a function
of concentration and NaCl. Plotted are the mean maximum
ThT fluorescence values, as a function of insulin concentration,
for (A) 0.1 M, (B) 0.24 M, (C) 0.34 M, and (D) 0.49 M NaCl
concentrations. I find that the concentration at which the non-
linearity in the ThT fluorescence occurs at decreasing insulin
concentrations as the NaCl concentrations is increased. This
observation can be explained by positing that the CFC is shifting
to lower concentrations. . . . . . . . . . . . . . . . . . . . . . . . 72
3.17 Experimental kgr as a function of insulin concentration
with the addition of NaCl. Growth rates obtained from
normalized traces plotted as a function of insulin concentration
for NaCl concentrations of 0M (black squares), 0.1M (red circles),
0.24M (blue triangles), 0.34M (dark cyan diamonds), and 0.49M
(pink stars). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
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3.18 Simulated kgr obtained by varying the elongation rate
and the CFC. Parameters used in the simulations were CFC
= 0.4 mg/ml, k+=5x10
4M−1s−1 (squares); CFC= 0.4 mg/ml,
k+=1x10
6M−1s−1 (circles); CFC = 0.2 mg/ml, k+=1x10
6M−1s−1
(triangles); CFC = 0.1 mg/ml k+=1x10
6M−1s−1 (diamonds); and
CFC = 0.05 mg/ml, k+=1x10
6M−1s−1 (stars). For all simulations
kf was 1x10
−8s−1. . . . . . . . . . . . . . . . . . . . . . . . . . . 74
3.19 Lag times as a function of insulin concentration in the
presence of NaCl. The data are fit same generic power law
function as above. The resulting scaling exponents are −0.27 ±
0.01 (0.1M NaCl, circles), −0.56 ± 0.05 (0.24M NaCl, triangles),
−0.65± 0.04 (0.34M NaCl, diamonds), −0.75± 0.06 (0.49M NaCl,
stars). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
3.20 Lag times as a function of insulin concentration obtained
by varying the elongation rate and the CFC. Parameters
used in the simulations were k+=1x10
6M−1s−1 and kf =1x10
−8s−1.
The scaling exponents are −0.43(circles) −0.55 (triangles), −0.59
(diamonds), and −0.65 (stars) when the CFC is 0.4 mg/ml, 0.2
mg/ml, 0.1 mg/ml and 0.05 mg/ml, respectively. . . . . . . . . . . 76
3.21 The influence of environment on the growth kinetics. A
series of 1.5 mg/ml insulin samples were incubated simultaneously.
At specific time points during the kinetics of self-assembly (every
30 minutes), NaCl was added to three samples. The mean value of
kgr from the resulting kinetic traces of each group of samples are
plotted against the time at which the NaCl was added (squares).
To illustrate where on the kinetic profile the NaCl was added, the
kinetic trace for the control is also shown (triangles). The grey
box corresponds to the mean kgr ± s.d. for this salt-free control.
In the absence of any structural transition, we would expect to
observe the behavior shown by the dashed line, with enhanced
growth rates during the early stages of fibril assembly, returning
to control values if salt is added after the point at which kgr is
measured (∼160 min). With the existence of a CFC, we would
expect instead the trend in kgr as shown by the solid line; the
decrease in kgr now occurs the moment the CFC is reached. Indeed,
we observe that kgr decreases to the control value when salt is
added at any time after 120 minutes, consistent with the sample
having reached the CFC, which for 1.5 mg/ml insulin under these
conditions we estimate to occur at 110 minutes. . . . . . . . . . . 77
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3.22 Oligomer population as a function of time. The number
of short fibrils, of ≤ 1000 monomer units, plotted as a function
of time (red squares); kinetic traces of the total fibril mass (scaled
arbitrarily) are also show (black lines). (A) At cp= 0.2 mg/ml, the
protein concentration is below cT and large number of short fibrillar
species persist for long periods of time. (B) At cp=0.55 mg/ml,
a maximum in short species occurs at a time of approximately
50% assembly completion. Once the CFC is reached and the
structural transition takes place, this population diminishes due to
the suppression of fragmentation. The simulations are stochastic
and the data points are the average oligomer number of 150 runs;
the error bars are the standard deviation of the mean. . . . . . . 78
3.23 A measure of cytotoxicity as a function of time during
Aβ(1-40) fibril formation. (A)Taylor et al. quantified cytotox-
icity by measuring SYTOX green uptake by human epithelial cells
(SH-EP1). SYTOX green is only taken into the cell when the cell
membrane becomes permeable. Upon uptake, SYTOX green binds
to nucleic acids and has a marked increase in fluorescence intensity.
(A) shows the level of SYTOX green fluorescence as a function of
Aβ(1-40) fibrillation time. (B) is a plot Aβ(1-40) fibril formation
kinetics as monitored by turbidity at 405 nm. One observes that
a peak in cytoxicity in (A) occurs at approximately the point of
maximum aggregation in (B). Taken from [9]. . . . . . . . . . . . 81
3.24 Schematic of amyloid fibril assembly with the presence of
a CFC. Amyloid fibrils grow by monomer addition to the ends
of the fibrils. Fibril fragmentation multiplies the number of free
ends by which monomer may attach. For concentration below
the the critical threshold concentration, cT , fragmentation is never
arrested. The result are short fibrils at long times. In contrast,
when the concentration is above cT , fibril-fibril association arrests
fragmentation resulting in a broader distribution of long fibrils. . 82
4.1 Dimensions of the insulin monomer. Shown is a cartoon
of the insulin monomer taken from PDB 1GUJ. The dimensions
used for the theoretical Rg are r=11 Åand L=30 Å. The helices are
green, coil are red, turns are blue. Surrounding the cartoon is the
surface representation of the protein where yellow is the A-chain
and white is the B-chain. . . . . . . . . . . . . . . . . . . . . . . 86
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4.2 Scattering function for a cylinder with a dimensions
L=30År=11Å In order to obtain a theoretical scattering curve
we assume the shape of the monomeric state of insulin to be ap-
proximated by a cylinder. We use the crystal structure dimensions
of an insulin monomer (PDB 1GUJ) as inputs for the simulation.
The results are shown in the figure above for the Q-range explored
in experiment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
4.3 Scattering function of 4 mg/ml insulin at t = 0. Plotted
is the scattering curve for 4 mg/ml insulin at at the beginning of
the kinetic run. We find that this scattering curve is well-fitted to
a model where the scatterer is cylindrical in shape. The red-line is
the line of best fit which yields Rg=11.67±0.98 Å. . . . . . . . . 88
4.4 Fit to the cylinder model at t=270 min. Plotted is the
scattering data at 270 min fit with the cylinder model. Clearly,
the fit is poor, especially at high Q-values. This lack of fitting to
the cylinder model persists for times greater than 270 min. . . . . 89
4.5 Time-resolved scattering curves for 4 mg/ml insulin.
Plotted are the scattering curves for 4 mg/ml insulin over a time
range 0 to 345 minutes. For t<150 minutes the scattering curves
remain constant. For t>200 minutes an increase in the scattering
intensity is observed in the low-Q range of our experiments
corresponding to growth of larger aggregates. . . . . . . . . . . . 90
4.6 The length, radius, and Rg as a function of time for times
0 ≤ t ≤ 255 mins. Plotted are the lengths (black squares) and
radii (red circles) obtained from fitting the data up to 255 min by
a cylindrical model. The fitted lengths are constant until t ≥ 180
mins, after which there is an exponential increase. The radii over
the same time remain constant. The inset shows Rg for a cylinder
as a function of time obtained from the fitted values of L and r. 91
4.7 P (r) distributions for several time points in the kinetics.
Plotted are real-space distributions P (r) for (A) 0 mins, (B) 60
mins, (C) 180 mins, (D) 225 mins, (E) 270 mins, and (F) 345
mins. Note the change in x-axis between 60 and 180 min. At
t=0, the solution is dominated by a population of monomer-sized
scatterers. Over time, larger-sized aggregates form until a critical
time at t=270 mins (which corresponds to a simple cylinder model
no longer fitting the data) when the monomer peak is dominated
by larger aggregates. By the final time point at 345 mins a large
distribution of large aggregates are present and the monomer peak
is obscured completely. . . . . . . . . . . . . . . . . . . . . . . . 92
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4.8 Examples of the data fit to cylinder or cylinder+cylinder
models. (A) t=0 and (B) t=225 mins scattering curves fit to a
single cylinder model. (C) t=270 and (D) t=345 mins scattering
intensities are fit to a linear combination of two cylinder models. 93
4.9 Time-resolved scattering curves for 0.5 mg/ml insulin.
Plotted are the scattering for 0.5 mg/ml insulin at t=15 minutes
and t=15 hours, 10 minutes. The signal-to-noise ratio is much
less favourable due to the sample being much more dilute. We
still find a scattering curve that is discernible over the background.
However, in the time-scale of these experiments we did not observe
any evolution in the scattering function. . . . . . . . . . . . . . . 94
4.10 Scattering intensity for the end-point of 0.5 mg/ml fibril
kinetics. Plotted is the scattering intensity for 0.5 mg/ml insulin
sample that had been incubated in a 96-well plate at 60◦C for
24 hours. The data is fit to a power-law with an exponent of
-1.66±0.04. Fit gives an adjusted R2=0.96. . . . . . . . . . . . . 95
4.11 Scattering intensity for the end-point of 0.5 mg/ml, 0.1 M
NaCl fibril kinetics. Plotted is the scattering intensity for 0.5
mg/ml insulin sample with the addition of 0.1 M NaCl that had
been incubated in a 96-well plate at 60◦C for 24 hours. The data
is fit to a power-law with an exponent of -2.19 ± 0.07. Fit gives
an adjusted R2=0.98. . . . . . . . . . . . . . . . . . . . . . . . . 96
5.1 Representative kinetic traces of ovalbumin amyloid fibril
formation. Plotted are representative kinetic traces, monitored
using ThT fluorescence for Grade 5 ovalbumin: 0.1 mg/ml (black),
0.4 mg/ml (red), 0.8 mg/ml (blue ), 1 mg/ml (green diamonds), 2
mg/ml (magenta), 4 mg/ml (purple), 12 mg/ml (orange). . . . . 100
5.2 ‘Flick time’ as a function of concentration for two grades
of ovalbumin Plotted are the flick times for Grade 5 ovalbumin
(black) and Grade 2 ovalbumin (red). In each case, the flick time
decreases with concentration. . . . . . . . . . . . . . . . . . . . . 101
5.3 Temperature dependence on the ‘flick time’ (A) The ‘flick
time’ is plotted as a function of temperature. We see that with
increasing temperature, the ‘flick time’ decreases and may be
eliminated at temperatures > 70◦C. (B) The fluorescence value
at the minimum is plotted as a function of temperature. I find the
fluorescence value is roughly equivalent for each temperature. . . 102
5.4 Fluorescence at t=0 is not constant with increasing
concentration. Plot of the fluorescence value at t=0 for the
concentrations investigated (Grade 5). This initial fluorescence
value scales with the initial ovalbumin concentration. I attribute
this to the fibril growth process being effectively seeded. . . . . . 103
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5.5 An illustrated example of the different phases of growth
observed in ovalbumin amyloid fibril formation. This plot
shows the aggregate growth, as monitored by ThT fluorescence, of
a 4 mg/ml ovalbumin sample. We first observe an initial decrease
in the fluorescence which results in a minimum value. After this
minimum is reached the kinetics are characterized by exponential
growth. The minimum in fluorescence at the early times of the
kinetics is defined as the ‘flick time’(inset). The exponential growth
rate is called k1. Instead of the growth kinetics reaching a constant
plateau, I observe a slow growth regime which is parameterized by
the growth rate k2. . . . . . . . . . . . . . . . . . . . . . . . . . . 104
5.6 Exponential growth rates for two grades of ovalbumin. The
growth rates during the exponential are plotted for Grade 5 (black
squares) and Grade 2 (red triangles) as a function of concentration.
The rates for the less pure Grade 2 ovalbumin are less than the
Grade 5 possibly due to inhibiting effects of additional salt and/or
proteins. Furthermore, the actual percentage of ovalbumin present
in Grade 2 is roughly 70% which will render the kinetics to be
slower. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
5.7 The rates of growth in the slow growth regime for two
grades of ovalbumin The growth rate in the slow growth regime
of the kinetics is shown for Grade 5 ovalbumin (black squares) and
Grade 2 (red triangles) as a function of concentration. The rates
for the less pure Grade 2 ovalbumin are less than the Grade 5. . 106
5.8 Bradford assays show growth kinetics far from completion
in the time-scale of our experiments. We performed a
Bradford Assay, using a BSA calibration standard, to determine
the percentage of fibrillar material produced during the time course
of our experiments. We find, even for the highest concentrations
studied, after 24 hours, the fibril formation process is far from
complete. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
5.9 Representative TEM image of ovalbumin fibrils. This
image is an example of a typical TEM image of fibrils formed from
6.4 mg/ml ovalbumin. They exhibit a worm-like, highly flexible
morphology. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
5.10 Ovalbumin fibrils form a population of closed loop mor-
phologies. This is a more detailed image showing a population of
closed-loop fibrils, formed from 6.4 mg/ml ovalbumin, interspersed
with other worm-like fibril structures. Boxed in fibrils highlight the
closed-loop morphologies. Inset shows detail of a ovalbumin fibril
loop. Scale bar is 0.2µm. . . . . . . . . . . . . . . . . . . . . . . 109
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5.11 The process of determining the contour length and end-
to-end distance from TEM images TEM images were
analyzed using ImageJ software. The distance measurements were
calibrated using the scale bar associated to the image. (A) shows
an image of a fibril to be measured. (B)The contour length was
found using the ‘segmented line tool’ in ImageJ; (C) the end-to-
end distance is simply found using the ‘line’ tool. Fibrils were only
measured where the ends were clearly discernible in the image. . 109
5.12 Experimentally determined length distribution for ovalbu-
min fibrils. The contour lengths of ovalbumin fibrils were found
as in Fig. 5.11. The plot is a histogram of the contour lengths with
N=110. The mean fibril length is 239.8 ± 183.6 nm. We find the
distribution is best fit to a log-normal distribution (black curve).
This result is consistent with the observation that the mean length
is short due to the fibril assembly process being far from complete. 110
5.13 Calculating the persistence length of ovalbumin fibrils.
Fibril contour lengths (L) and end-to-end distances (R) were found
as is shown in Fig. 5.11. From this procedure R2 is plotted against
L for each fibril (N=110). The data is fit using Equation 5.1. A
value for the persistence length, P, is found to be 26 nm. . . . . . 111
5.14 A simple downhill polymerization model does not capture
the experimental kinetics. Plotted are solutions to Equation
Fig. 5.2 for several parameters of k+: 1x10
−4s−1(blue triangles),
1x10−5s−1 (red circles), 1x10−6s−1 (black squares), 5x10−7s−1
(pink diamonds). The other parameters were held constant:
M0=1x10
−4 mg/ml, mtot=1 mg/ml, and E
∗=100. For larger values
of k+, fibrils are formed extremely rapidly and the polymerization
reaction quickly comes to completion. Even for small values of
k+, the amount of material converted to fibrils approaches 100%
in the time window of a typical experiment. In experiments we
find the percentage of fibrillar mass is far from 100% (Fig. 5.8)
during the time scale of the experiments. This simple model does
not match these observations. Moreover, there is an absence of the
slow growth phase in this model. . . . . . . . . . . . . . . . . . . 113
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5.15 A model with end-joining reproduces the observed ki-
netics. Plotted are solutions to the set of equations Fig. 5.4
and Fig. 5.6 for several different values of the joining rate kj:
(A) 1x10−2s−1, (B) 1x10−3s−1, (C) 1x10−4s−1, (D) 1x10−5s−1.
The other paremeter values were held constant: k+=1x10
−5s−1,
M0=1x10
−5 mg/ml, mtot=1 mg/ml, and E
∗ = 100. The resulting
solutions show an initial exponential growth phase followed by a
slow growth phase at later times. The slow growth phase exists
due to the elimination of available growing ends due to joining;
because of this the polymerization reaction can not come to a
rapid completion. For larger values of kj the amount of material
converted to fibril is very small (∼ 1 %) before the slow growth
regime is reached. In our experiment we see fibril mass percentages
similar to the parameter values in C. Note in the limit that kj → 0
the solution becomes a simple downhill polymerization. . . . . . 115
5.16 Gels do not form from ovalbumin amyloid fibril samples
as shown by bead tracking experiments 1 µm beads were
optically tracked while diffusing in amyloid fibril solutions made
from ovalbumin. A range of concentrations were explored: buffer
control/no fibrils (black squares), 0.375 mg/ml (red circles), 0.75
mg/ml (blue triangles), 1.5 mg/ml (yellow diamonds), 3 mg/ml
(magenta stars), 6 mg/ml (purple asterisks), 12 mg/ml (grey
crosses). With increasing concentration the solutions become
increasingly viscous, but no viscoelastic plateau is observed. The
hypotenuse of the black triangle has a slope of 1, and is provided
for comparison. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
6.1 AFM images of ocr fibrils AFM image of 36 µM ocr in 20 mM
Tris-HCl pH 8 with 3.2M ammonium sulphate. Typical dimensions
of fibrils from AFM measurements show heights ∼ 10 nm with
lengths up to 1 µm. Taken from [4]. . . . . . . . . . . . . . . . . 120
6.2 Diagram of ’ocr-Mutant7’ Regions of genetic modifications of
the ocr dimer are highlighted. Amino acids substitutions are:
D25C, D26N, D29N, D31N, D32N, D35N (magenta); D92N, E95Q,
D96N, E98Q, D99N (blue). . . . . . . . . . . . . . . . . . . . . . 122
6.3 Diagram of ‘ocr-Mutant11’ Regions of genetic modifications
of the ocr dimer are highlighted. Amino acids substitutions are:
D25C, D26N, D29N, D31N, D32N, D35N (magenta); E59Q, D62N,
E64Q, E66Q, D67N (red). The bottom image of the ocr dimer is
rotated by 90◦ relative to the top view. . . . . . . . . . . . . . . . 123
xxiv
LIST OF FIGURES
6.4 Diagram of ocr-POcr Mutant Regions of genetic modifications
of the ocr dimer are highlighted. Amino acids substitutions are:
D76N, E87Q, D92N, E95Q, D96N, E98Q, D99N, E103Q, E106Q,
E107Q, E109Q, E110Q, E112Q, E113Q, E114Q, E115Q, E116Q. . 124
6.5 Mean squared Displacements for wild-type ocr. Plot of the
MSDs for a range of ammonium sulphate concentrations (M): 0
(black squares), 0.8 (red circles), 1.2 (blue triangles), 1.6 (pink
diamonds), 2 (green hexagons), 2.4 (navy stars), 2.8 (purple +),
3.3 (orange *). Triangle is a guide for the eye; the hypotenuse
shows a slope of 1 which is equivalent to a liquid with the viscosity
of water. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
6.6 Mean squared Displacements for Mut7 ocr. Plot of the
MSDs for a range of ammonium sulphate concentrations (M): 0
(black squares), 0.4 (red circles), 0.8 (blue triangles), 1.2 (pink
diamonds), 1.6 (green hexagons), 2 (navy stars), 2.4 (purple +),
2.8 (orange *), 3.3 (yellow spheres). Triangle is a guide for the eye;
the hypotenuse shows a slope of 1. . . . . . . . . . . . . . . . . . . 126
6.7 Mean squared Displacements for Mut11 ocr. Plot of the
MSDs for a range of ammonium sulphate concentrations (M): 0
(black squares), 0.4 (red circles), 0.8 (blue triangles), 1.2 (pink
diamonds), 1.6 (green hexagons), 2 (navy stars), 2.4 (purple +),
2.8 (orange *), 3.3 (yellow spheres). Triangle is a guide for the eye;
the hypotenuse shows a slope of 1. . . . . . . . . . . . . . . . . . . 127
6.8 Mean squared Displacements for pOcr ocr. Plot of the MSDs
for a range of ammonium sulphate concentrations (M): 0 (black
squares), 0.4 (red circles), 0.8 (blue triangles), 1.2 (pink diamonds),
1.6 (green hexagons), 2 (navy stars), 2.4 (purple +), 2.8 (orange
*). Triangle is a guide for the eye; the hypotenuse shows a slope
of 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
6.9 Viscosities of ocr and its mutant variants as a function
of ammonium sulphate concentration. Plotted are the
viscosities determined from the mean squared displacements and
applying the Stokes-Einstein equation: (A) wt-ocr, (B) mut7, and
(C) mut11, and (D) pOcr. pOcr behaves distinctly from wt-
ocr and the Mut7 and Mut11: there is a transition to a gel-like
state at 0.8M ammonium sulphate. Moreover the gel formed is
apparently weaker than the other samples tested. Mut7 and Mut11
exhibit very similar viscosities as a function of ammonium sulphate
concentration. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
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6.10 Mean squared displacements for ocr99. Plot of the MSDs
for a range of ammonium sulphate concentrations (M): 0.8 (black
squares), 2 (red circles), 2.4 (blue triangles), 2.8 (pink diamonds),
3.3 (orange stars). Triangle is a guide for the eye; the hypotenuse
shows a slope of 1. . . . . . . . . . . . . . . . . . . . . . . . . . . 130
6.11 The ammonium sulphate concentration at the gel-point
scales with surface charge. Plotted are the ammonium
sulphate concentrations at which a gel is formed as a function of
surface charge. One finds that the gel point ammonium sulphate
concentration scales with surface charge. . . . . . . . . . . . . . . 131
A.1 BMG Omega Mean Lag Time By Row Displayed are the
mean lag times as a function of row for a 1 mg/ml insulin sample. 140
A.2 BMG Omega Mean Lag Time By Column Displayed are
the mean lag times as a function of column for a 1 mg/ml insulin
sample. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
A.3 Spectramax M5e Mean Lag Time By Row Displayed are the
mean lag times as a function of row for a 1 mg/ml insulin sample. 142
A.4 Spectramax M5e Mean Lag Time By Column Displayed are
the mean lag times as a function of column for a 1 mg/ml insulin
sample. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
A.5 BiotekH4 Mean ThT Fluorescence By Row Displayed is
the mean maximum ThT fluorescence of 1 mg/ml ovalbumin as
a function of row. . . . . . . . . . . . . . . . . . . . . . . . . . . 144
A.6 BiotekH4 Mean ThT Fluorescence By Row Displayed is
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B.3 Lag Time Distributions for Insulin Amyloid Fibrils Shown
are lag time distributions for 0.1 mg/ml (red), 0.4 mg/ml (green),
1.5 mg/ml (blue), and 4 mg/ml (magenta) insulin concentrations.
Note that the distributions, especially for higher concentrations are
sharply peaked indicating very reproducible kinetics. This should
be contrasted against what has been previously observed in insulin
fibril kinetics where the variability was significantly larger [10].
Such reproducibility in our experiments has allowed for kinetic
features to be observed which otherwise would be obscured by





Proteins are ubiquitous biological macromolecules in living systems; they can
be found in every cell and every component of the cell. All proteins, at their
most basic level, are biopolymer chains comprised from a set of 20 amino acids.
These subunits are covalently linked together by the characteristic peptide bond.
From this starting point, a startling diversity in protein sizes, structures, and
functions emerges. Proteins play a role in various biochemical mechanisms, from
transmembrane ion transport, carbohydrate metabolism, controlling cell cycle
and differentiation, to a myriad of other functions [3].
Such diversity and the specificity of their function is often directly linked
to their three dimensional native structure. How a polypeptide chain self-
assembles from an unstructured polymer to a biologically viable three dimensional
protein is one of the fundamental questions of life. Anfinsen’s pioneering
work [11, 12] showed that proteins self-assemble almost spontaneously, without
any external input. In a seminal experiment he showed that urea unfolded
ribonuclease can be restored to its native conformation by returning the protein
to physiological conditions. In Anfinsen’s own words this reversibility shows
“that the information...for the assumption of the native secondary and tertiary
structures, is contained in the amino acid sequence itself”[11]. This is the crux of
what has become known as ‘Anfinsen’s Dogma’: under physiological conditions a
protein will adopt a configuration of the amino acid sequence that is a minimum
of its free energy landscape. While this may explain why proteins fold it does not
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explain how that fold is achieved. An immediate problem arises: the probability
of finding the native fold by randomly searching the configuration space of even
a moderately sized polypeptide chain (∼ 100 amino acids in length) results in
folding times longer than the age of the universe [13, 14]. The folding time of most
proteins is on the order of milliseconds (some even fold on the microsecond time
scale [15]). Clearly, proteins can not randomly search the configuration space
to find their native state; some more efficient mechanism must govern protein
folding. One solution to this problem, argued by Levinthal, was that there are
specific ‘folding pathways’ which are guided by local interactions between specific
amino acid groups creating stable, native-like structures. These interactions act
effectively as nucleation steps in the folding process [16].
With the advent of techniques which allow for greater molecular resolution
(i.e. NMR) and computational power, the kinetics of folding has shifted to a
‘new’ view of protein folding. Protein folding does not seem to require specific,
step-wise pathways to achieve the native fold; rather it is a stochastic process
which relies on the inherent fluctuations in the conformation of the unfolded
state. What has emerged is a picture of trial-and-error: stochastic fluctuations
of residues in a polypeptide chain can make native-like contacts, funneling the
chain down an energy landscape to its native state [17]. Indeed, if the energy
landscape is of the right shape, only a small number of contacts need to be made
in order for the chain to adopt the correct native state [18].
1.2 Protein Aggregation
There are inevitably situations, both in vivo and in vitro, in which the
native and biologically functional conformational state of a protein is not
achieved or becomes perturbed. When a protein becomes misfolded or partially
unfolded, multiple protein units can self-associate into larger, often insoluble
and irreversible, complexes via non-native interactions. This process is known
as protein aggregation. Often in protein aggregation, the non-native contacts
established between protein units are driven by inter-protein hydrophobic
interactions between exposed hydrophobic regions on misfolded proteins [19].
These non-native states can arise due to thermal or oxidative stresses [20, 21],
mutations of amino acid sequences which may lead to accumulation of kinetically
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trapped, partially unfolded intermediates or to misfolded states intrinsically
prone to aggregation[20], the presence of hydrophobic surfaces and alterations
of solution conditions such as pH (the optimal pH for stability of the native
structure is 7.2-7.4) and the presence of salts and other co-solutes [22].
1.2.1 Multiple pathways of protein aggregation leads to a
diversity of aggregate morphologies.
There are a variety of pathways in which proteins may aggregate with varying
morphological and structural end products. These pathways may be dependent
upon the type of protein, the initial conformational state of the protein, or the
environmental conditions. Broadly speaking, protein aggregates can broken down
into two classes: ordered and disordered.
Ordered protein aggregates are typified by the presence of long-range struc-
tural organization within the aggregate complex. The specificity of the inter-
actions which give rise to this long-range order can induce a directionality in
the assembly of the aggregate resulting in filamentous or fibrillar structures.
The most well known example of this class of aggregate are the amyloid fibrils.
Generically, amyloid fibrils are filamentous aggregates with large proportions of β-
sheet comprising the structure of the fibrils. This preponderance of β-sheet within
the fibril arises regardless of the initial native conformation of the constituent
protein. Amyloid fibrils, their structure and formation will be discussed in
further detail below. There are many ordered protein fibril aggregate assemblies
which do not bear the characteristics of amyloid fibrils–for instance the fibrillar
polymerization of haemoglobin in erythrocytes affected by sickle cell disease [23].
Disordered, amorphous aggregates are characterized by the non-specific
agglomeration of protein into complexes without any discernible repetitive or
long-range structural characteristics. An archetypal example of this is the
heat denaturation of hen egg white. Another example are protein precipitates
formed during an ammonium sulphate ‘salting out’ step in a protein purification
procedure. In that case, the addition of salt ions to a protein solution causes
a dehydration of the solvation shell which surrounds the protein. This loss
of the interaction of water molecules from the charged protein surface allows
for protein-protein hydrophobic interactions to become important. These non-
specific hydrophobic interactions induce proteins to aggregate into clusters that
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eventually become larger enough to be seen by eye and may precipitate out of
solution in amorphous flocs. It should be noted that certain salt anions and
cations are more efficient at removing the hydration from the protein surface and
thus are better at precipitating proteins from solution. This hierarchy of cations
and anions is known as the Hofmeister series.
Straddling these two extremes are the spherical or particulate protein
aggregates which appear ‘regular’ in structure at large length scales (i.e. larger
than protein molecules) but are disordered and fractal-like at shorter length
scales. Many proteins have been observed to form these types of structures such
as β-lactoglobulin, bovine serum albumin, hen egg white lysozyme, and casein
[24, 25, 22]. Unlike amyloid fibrils, they lack a common structural motif and often
contain structure similar to the native conformation of the constituent protein. It
has been observed that for many proteins under partially denaturing conditions,
these particulate protein aggregates often form near their isoelectric point (pI)
or under conditions of large salt-screening [22]. Intriguingly, Krebs et al. found
that the same proteins will form amyloid fibrils when the pH of the solution was
changed so that the protein possessed a high positive net charge. The picture that
emerges is that, under partially denaturing conditions, solution conditions, and in
turn the surface charge, will determine to a large extent the aggregate morphology.
The lack of electrostatic repulsion at the pI or high ionic strength allows for
rapid and non-specific aggregation; this lack of specificity results in an absence of
directionality in the aggregate formation resulting in spherical aggregate particles.
In contrast, highly charged partially unfolded aggregates will associate slowly due
to electostatic repulsion. This allows time for specific structural re-organization
into β-sheets. This structural specificity imparts the uni-directional nature of
the aggregation process which results in linear aggregates. It is clear that the
conditions in which aggregates form is critical in determining the pathway of
formation and subsequent morphology.
If protein concentrations are sufficiently high, a protein aggregate gel may be
formed whose structure is comprised of the various aggregates discussed above.
The underlying aggregate morphology of a protein gel will, to a large extent,
determine its rheological and optical properties. It was observed that transparent
protein gels were composed of a network of fine-stranded aggregates with a
filament diameter on the order of the native protein diameter [26, 27, 28]. Turbid
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and opaque protein gels were found to form from colloidal protein aggregates or
coarsened fibrillar aggregates with diameters > 0.5µm [26, 27, 28]. In light of the
previous discussion, electrostatic charge is crucial in determining the properties
of these gels. For pH values greater than or less than the pI, fine-stranded gels are
formed, but often with distinct rheological properties. When the pH ∼ pI, turbid,
particulate gels are formed. Such control over structural and optical properties
are important in the food sciences where mouth-feel, texture, and appearance will
be markedly different for the same protein gel made under different conditions
(e.g. whey protein isolate gels) [29, 30]. It is clear that the structure of a protein
gel is inherently linked with the underlying protein aggregate morphology.
1.2.2 Aggregation in vivo
Evolution has equipped cells with biological ‘machinery’ to guide the protein
assembly process and to sequester and destroy proteins that are not correctly
folded. One important class of molecular objects that aid in this process are the
so-called chaperones proteins. Chaperones can play various roles, from interacting
with newly synthesized polypeptide chains to aiding in the final steps of protein
folding. Chaperones do not act as catalysts, but instead ensure efficient and
faithful assembly of polypeptide chains into properly folded proteins. Well studied
examples of these are the family of heat shock proteins (HSP), in particular
the GroEL chaperone. GroEL can sequester partially unfolded regions of a
polypeptide chain from the surrounding environment to ensure the adoption of
proper native structure [31].
There exists other ‘quality-control’ mechanisms within the cell, particularly
in the endoplasmic reticulum (ER) where many proteins are translocated to
fold properly, before secretion. In addition to the presence of a wide range of
chaperones, folding catalysts are present to ensure efficient and expedient folding.
Such quality-control is achieved via specific glycosylation and de-glycosylation of
proteins, allowing the cell to distinguish between folded and misfolded proteins
[32]. If a protein is recognized through this process as being misfolded it is
ubiquitinated and trafficked to the proteasome to be safely degraded.
Since proteins are the molecules that drive most processes in life, misfolded
proteins can obviously result in biological malfunction and therefore disease.
One way in which misfolded proteins result in disease is when there are genetic
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errors which encode for certain proteins. For instance, many misfolded protein
pathologies are characterized by an absence of a particular protein. This is due to
the efficient and effective mechanisms of protein folding quality control: as mutant
protein generated from genetic defects emerges from the ribosome and into the
ER, it will often fold improperly. The quality control mechanism of the cell
takes over and it is safely eliminated. Many protein misfolding diseases originate
in this way: cystic fibrosis (CFTR protein), Marfan syndrome (fibrillin), Fabry
disease (α-galactosidase) and Gauchers disease (misfolded β-glucocerebrosidase).
Additionally some cancers may be linked to protein misfolding. An important
example of this is p53-a tumor suppression protein [33].
The cell’s ability to recognize, traffic, and metabolize protein aggregates may
become defective, impaired, or is overwhelmed. When this occurs a wide variety
of diseases are attributed to the presence or accumulation of misfolded protein
aggregates. A well known class of protein aggregates diseases are the amyloidoses
which will be discussed in further detail below. Instances of non-amyloid protein
aggregate pathologies are sickle cell disease, ALS, Alexander disease, and variants
of cystic fibrosis.
1.2.3 Aggregation in vitro
It is of increasing importance to have a fundamental understanding of protein
aggregation not only for understanding human diseases but also for improving the
production, purification, and storage of proteins for pharmaceutical therapeutics
as well as improving the texture and taste of food.
The explosion of recombinant DNA techniques several decades ago coupled
with advances in analytical protein separation technologies have caused a great
deal of interest in producing high-grade protein-based pharmaceuticals for a
wide-range of clinical and therapeutic applications. However, the risk of
aggregation is present at almost every stage of drug development and production
[34, 35, 36, 37, 38]. During cell culturing, high levels of expression may cause
intracellular aggregates to accumulate. Eventual secretion of the protein into cell
culture medium may introduce the protein to conditions which render it unstable.
Purification steps such as Protein A chromatography can expose proteins to a
regime of unfavorable pH or ionic conditions which could lead to destabilization
and aggregation. Storage conditions, be that temperature, freeze-thaw cycles or
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the type of container used for storage can have marked influence on the level and
amount of aggregation present in a protein pharmaceutical product. It is evident
that a fundamental understanding of all the various processes and pathways of
protein aggregation is an important task to ensure the continued improvement of
the stability and quality of protein-based pharmaceutical products.
Food scientists have been studying protein aggregates for many decades
in order to improve the texture and flavor of food. The presence of protein
aggregates, and protein aggregate gels in particular, are ubiquitous in food
science-from cooked eggs to cheese. The textural mouth-feel of these food
products is intrinsically linked with the molecular structure of the protein gels
(e.g. fine-stranded vs. particulate gels) and their network connectivity (e.g.
the interactions which govern the cross-linking or association of the constituent
aggregates). As has been discussed, whey protein aggregate gels can exhibit
markedly different rheological and optical properties based upon the conditions
in which they are formed which can be very important in producing synthetic
food formulations.
1.3 Amyloid Fibrils
As has been mentioned, a large family of diverse human diseases have been
associated with filamentous insoluble protein aggregates known as amyloid fibrils.
Each disease is related to a particular protein or peptide that undergoes a
transition from a native conformation to a highly ordered fibrillar aggregate.
These aggregates can then accumulate extracellularly into large plaques, possibly
incorporating many other molecular compounds such as sugars or other proteins.
Indeed, the term ’amyloid’ first derived from the mistaken identification of these
plaques as starchy inclusions in ex vivo tissue samples.
Some of the most well-known amyloid-related diseases are neurodegenerative
disorders such as Alzheimer’s disease (aggregation of the peptide fragments amy-
loid β(1-40) or (1-42)), Parkinsons’s disease (α-synuclein), Huntington’s disease
(Huntingtin), and prion-related spongiform encephalopathies like Creutzfeld-
Jakob disease. A number of amyloid fibril related illnesses occur in tissues
other than the brain such as Type 2 diabetes (islet amyloid polypeptide),
cataract (γ-crystallin), and amyloidosis associated with localized injections, e.g.
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Disease Associated Protein or Pep-
tide
Alzheimer’s disease Amyloid β peptide (1-40) &
(1-42)
Parkinson’s disease α-synuclein
Spongiform encephalopathies Prion proteins
Hungtington’s disease Huntingtin with poly-
glutamine expansion
Spinal and bulbar muscular atrophy Androgen receptor with
poly-glutamine expansion
Amyotrophic lateral sclerosis Superoxide dismutase 1
Spinocerebellar ataxias Ataxins with poly-
glutamine expansion
Dementia with Lewy Bodies α-synuclein
AL Amyloidosis Immuglobulin light
chains/fragments
AA Amyloidosis Serum amyloid A protein
fragments
Hemodialysis-related amyloidosis β2-microglobulin
ApoA(I,II,IV) amyloidoses N-terminal fragments of
apoliproprotein A(I,II,IV),
respectively
Type 2 diabetes Islet amyloid polypeptide
Aortic medial amyloidosis Medin
Cataract γ-Crystallin
Injection-localized amyloidosis Insulin
Table 1.1: List of amyloid-related diseases and their associated proteins or
peptides
subcutaneous insulin pumps. For a further list of amyloid-related pathologies and
their associated proteins and polypeptides see Table 1.1. For a more complete
list see [19].
Interestingly, the proteins and peptides associated with these diseases do not
share primary amino acid sequences or structural homologies; there is seemingly
no apparent universal structural attribute which links these proteins and peptides
other than the fact they, under the correct conditions, will undergo the transition
to an amyloid fibril state. Indeed, as will be discussed, the key consideration as to
whether a protein or peptide is driven to the amyloid state is the conditions under
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which fibrils are formed. Both thermodynamic and kinetic factors will determine
if a peptide or protein will undergo the amyloid transition.
1.3.1 Structural Schematic of Fibril Formation
The formation of amyloid fibrils can be encapsulated by a generic schematic
of the structural species extant along the pathway of assembly. For a typical
globular protein, a necessary condition for driving a protein to an amyloid state
is to destabilize or partially denature the native conformation. This can be
achieved, in vitro by alterations in the solution conditions such as temperature
or pH, or by additives such as denaturing salts or proteolytic compounds. This
destabilization of the native conformation may expose the hydrophobic peptide
main chain and residues and seems an important step to inducing amyloid fibril
formation [39]. The next step in amyloid fibril formation is the appearance of
small, soluble oligomeric species which may appear as amorphous aggregates,
micellar structures, or even pore-like rings ([40, 41, 42, 43, 44]). These oligomeric
units then go on to assemble into more distinct, filamentous aggregates which are
typically on the order of hundreds of nanometers in length and have relatively
short persistence lengths ([44]). These ‘protofilaments’ can then further associate
into ‘mature’ amyloid fibrils which can span many microns in length. See Fig.
1.1 for a pictorial schematic of this process.
1.3.2 Structure & Morphology
Amyloid fibrils, regardless of the initial structural configuration of the native
protein or peptide, share many characteristics. Generically, one can utilize
three attributes to ‘define’ any amyloid fibril from other filamentous protein
assemblies. Firstly, the archetypal feature of amyloid fibrils is the presence of
a cross β-sheet structure as seen from X-ray diffraction [45]. This distinctive
pattern is indicative of the protein or polypeptide organized in β-sheets arranged
parallel to the fibril axis and their constituent β-strands perpendicular to the
fibril axis with spacings of approximately 4 Åand 10 Å, respectively (see Fig.
1.2). Secondly, amyloid fibrils show distinctive optical activity in the presence of
histological dyes. Congo red displays ‘apple-red’ birefringence in the presence of
amyloid fibrils. Another dye, Thioflavin T, is a benzothiazole salt which displays
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Figure 1.1: Generic picture of amyloid fibril assembly. For structured
proteins or peptides, it is commonly accepted a destabilization of the native
structure must be achieved before amyloidogenic aggregation can proceed. From a
partially denatured monomer unit, amyloid or amyloid-competent oligomers form
until amyloid ‘seeds’ or nuclei are formed. From this point, amyloid filaments may
grow by addition to the ends of the growing filaments. These filaments can then
associate into protofibrils and eventually mature amyloid fibrils. Image taken
from [1].
characteristic fluorescence enhancement when bound to the structure of amyloid
fibrils ([46, 47, 48]). Thirdly, amyloid fibrils, as seen by atomic force microscopy
(AFM) or transmission electron microscopy (TEM), exhibit typically filamentous
morphologies with typical diameters of 2 to 20 nm and lengths up to several
microns ([49]).
Advances have been made to elucidate the organization of amyloid fibrils
at a molecular level using high resolution techniques such as solid-state NMR
spectroscopy, X-ray crystallography, and cryoelectron microscopy. The picture
that emerges is that peptide backbone, mainly via hydrogen bonding, determine
the overall structural framework at the core of amyloid fibrils. Indeed, the
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ubiquity of cross-β sheet structure in amyloid fibrils is highly indicative that
the peptide backbone is the major player in determining the generic structure of
amyloid fibrils.
Figure 1.2: Generic structure of amyloid fibrils. Amyloid fibrils are
typified by the presence of cross β-sheet structure as revealed by x-ray diffraction
experiments. The schematic shows a meridional x-ray diffraction pattern
indicating a spacing of ∼ 10 Å. A second equatorial pattern shows a spacing
of 4.7 Å. These spacing correspond to the inter-sheet and inter-strand spacing
within an amyloid fibril. Images adapted from [2].
At the next hierarchical level of structure, these techniques have shown there
exists a degree of polymorphism between fibrils created from different peptides
or proteins in terms of how the β-strands are oriented, the number of β-sheets
in a protofibril, how many protofibrils constitute a mature amyloid fibril [44, 50,
2, 51]. These differences may be attributed to how the side chains within the
fibril interact with one another sterically and electrostatically and also with the
surrounding solvent.
This molecular-level polymorphism, driven by side-chain interactions can
generate heterogeneous morphologies of mature fibrils, even those formed from
the same peptide or protein ([2, 51, 52]). One may find, under the correct
conditions, long, straight fibrils ([53, 54]), wide tapes ([55]), twisted ribbons
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([53, 56]), or closed loops ([56, 57]). Such differences in morphology may be
linked back to differences in the molecular structure of these fibrils caused by
different conditions in which the fibrils form ([58]). Moreover, it has been shown
that in many cases, fibrils formed from seeds inherit the structural characteristics
of the parent seeds. It is interesting to consider that, regardless of the amino
acid sequence of a peptide or protein, there is a spectrum of structures available
in the free energy landscape and the existence of one morphology over another
is controlled thermodynamically and kinetically, based upon the conditions of
formation.
Many researchers have made an effort to identify possible indicators in
the amino acid sequence of peptides and proteins that may point toward a
propensity to form amyloid fibrils and several criteria have been identified. First,
hydrophobicity seems to be an important factor. Studies have shown making
amino acid substitutions with higher (or lower) hydrophobicity can increase
(or decrease) the propensity of fibril formation ([59, 60]). Indeed, it has been
demonstrated that in natural protein sequences, there is an absence of clusters
of hydrophobic residues within a sequence [61, 62]. It seems evolution has
selected amino acids sequences to avoid three or more consecutive hydrophobic
residues. Second, proteins or peptides with high electrical charges will not easily
self-associate due to electrostatic repulsion, thus decreasing the propensity to
aggregate([63]. Thirdly, it has been shown that sequences that promote the
formation of β-sheets over α-helices are lower than expected, indicating evolution
has selected against sequences that form β-sheets ([64]).
1.3.3 Universality of the amyloid fibril structure
Despite these insights into how amino acid residues can influence not only the
propensity to form amyloid fibrils but also their morphology, what has clearly
emerged is that the critical interactions that drive the assembly of peptides and
proteins into the amyloid state occurs via the peptide backbone. The observation
that there is no characteristic amino acid sequence or structural homology which is
universally indicative of amyloid forming proteins and peptides can be understood
through the fact that amyloid assembly is most critically dependent on the
backbone association into β-sheet architecture. It is conceivable that amyloid
fibril structure represents a global minimum in the free energy landscape of
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peptides and proteins ([65]). Therefore, any peptide or protein theoretically can
be driven to the amyloid state. As has been noted, what ultimately determines if
and when this occurs is based on thermodynamic considerations and the kinetic
availability of the amyloid state which is contingent on the solution conditions
during formation.
1.3.4 Functional Amyloid Used by Living Organisms
It has been found that some living systems have utilized amyloid fibrils in a
functional and beneficial way. Several species of bacteria have developed highly
regulated biomolecular processes to assemble functional amyloid to aid in biofilm
formation and spore dispersal [66, 67, 68]. There have even been examples found
in mammalian systems which have developed highly specific and regulated use
of amyloid-like structures. A domain of the membrane protein Pmel17 forms an
amyloid like structure within the compartmentalized melanosome to template the
formation of melanin granules [69].
1.3.5 Amyloid Fibrils as Biomaterial
Amyloid fibrils possess several characteristics which make them attractive as a
class of biomaterials. Firstly, amyloid fibrils self-assemble. Self-assembly is the
process by which molecular objects, via cooperative molecular recognition, form
regularized supramolecular structures without external input. Self-assembly is
ubiquitous in biology – from micellization to protein folding. This phenomenon is
an indispensable tool in any bottom-up approach to constructing nanomaterials.
Secondly, they possess structural properties unique to many biological
materials. A range of experimental techniques have demonstrated amyloid fibrils
possess a Youngs Modulus around the GPa scale and a strength comparable to
steel [70]. The structural properties of any material gives indirect indications
on the underlying intermolecular forces which collectively give rise to the bulk
attributes of a material. The distinguishing feature of amyloid and amyloid-
like fibrils, according to high resolution data gathered from x-ray diffraction and
NMR experiments, is the presence of extensive cross β-sheet structure within the
core of the fibril. This extensive β-sheet structure forms an expansive hydrogen-
bonding network involving the polypeptide backbone which spans the length of
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the fibril. It is this cooperative intermolecular hydrogen bonding network which
confers the stability and unique material properties to amyloid fibrils [71]. While
a complete structure of an amyloid or amyloid-like fibril has yet to be determined
this common structural motif is always present, regardless of the initial protein or
polypeptide conformation. Indeed, amyloid and amyloid-like fibrils are known to
form from large globular proteins with diverse secondary and tertiary structure
down to short dipeptides and protein fragments. Ultimately, amyloid fibrils,
regardless of the initial structure, generally exhibit typical dimensions of 5-20
nm in diameter and extend to microns in length. Furthermore, the fact that
amyloid fibrils exhibit similar mechanical properties to silk, which is known to be
one of the strongest and most rigid proteinacious materials in nature, should not
be surprising; silk and amyloid fibrils both possess the common characteristic of
expansive hydrogen-bonded β-sheet networks.
Thirdly, since amyloid fibrils can be constructed from a diverse range
of proteins and polypeptides, the conditions by which fibrils form are also
expansive. The one apparent key environmental characteristic to form amyloid
fibrils is the existence of partially denaturing conditions which destabilizes the
initial conformation. This flexibility in experimental conditions lifts potential
restrictions in applying the assembly of amyloid fibrils to nanobiotechnological
applications.
Since amyloid fibrils are constructed from amino acid units the power and
relative ease of genetic modification and manipulation of bacterial expression
systems is at the disposal of anyone designing novel amyloid biomaterials [72].
These well understood techniques permit the introduction of point mutations in
the amino acid sequence which opens the possibility to chemically functionalize
the surface of a fibril or changing its electrostatic characteristics [73, 74, 75].
Furthermore, given the enormous combinatoric sequence space available for
creating de novo peptide and protein sequences, it should be possible to design
amyloidogenic materials with unique environmental responsiveness. There has
already been some success in utilizing amyloid fibrils in biomaterial applications
from templating nanowires [76, 77, 78], hydrogels for tissue engineering [79, 80,
81, 81, 82, 66] and drug delivery systems [81, 83, 84, 85], to light harvesting
materials [86, 87, 88]. The potential ease of modification, hybridization and
functionalization vastly enlarges the material applications, capabilities, and
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potential usefulness of amyloid as a biomaterial.
1.4 Kinetic Models of Amyloid Fibril Formation
It is clear a full understanding of the complete process of amyloid fibril formation
requires a detailed understanding of the species extant at each phase of assembly.
In particular, an elucidation of the molecular contacts each species makes to move
onto the next step of fibril assembly and the thermodynamic and kinetics of each
of these transitions is of great importance. However, at a more coarse-grained
level of detail, the kinetics of amyloid fibril assembly can be simply characterized
by a few generic features: a lag phase in which no fibrils have been formed (within
the limits of experimental detection), this is followed by a rapid proliferation and
elongation of fibrils after the quiescent lag phase and a final steady-state phase
where growth has come to completion [39, 89, 90, 91, 92]. Additionally, the lag
phase can be eliminated by the addition of pre-formed fibrillar seeds and there is
a critical initial concentration below which fibrils will not form [49].
There are many ways in which the kinetics of amyloid assembly can be
monitored. ThT fluorescence is a powerful and common method to measure
the assembly process since ThT preferentially binds to the characteristic cross
β-sheet structure of amyloid fibrils [39, 93]. Although the exact mechanism
of ThT binding to amyloid fibrils is not completely understood [46, 47, 48] it
has been established that it has a negligible effect on the self-assembly process
[39]. One must take care, however, when utilizing ThT as a reporter of the
kinetics due to potential non-linear scaling with concentration [10]. Additionally,
ANS fluorescence has shown that fibril formation is indeed preceded by partial
unfolding and the exposure of the interior hydrophobic core for structured and
globular proteins [39]. Dynamic light scattering (DLS) has proven useful not
only for monitoring the kinetics of fibril growth but also as a means to extract
the size (hydrodynamic radii) of molecular species during the time course of
the experiment [94, 95, 96, 97, 98]. DLS, while useful to study early events and
species in the fibril formation process, it is unable to provide detailed information
regarding aggregate sizes once large species are present which overwhelm the
scattering signal. Another useful means of characterizing the oligomeric content
during the time course of assembly is by mass spectrometry [99, 100]. Mass
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spectrometry data suffers from the drawback that the monomer or oligomeric
species being studied are removed from the solution environment and subject to
harsh gas-phase conditions which can influence their structure. Circular dichroism
(CD) and Fourier Transform Infrared Spectroscopy (FTIR) provide a means to
monitor the changes to secondary structure of molecular constituents during
aggregation [101, 102, 98, 54, 103]. Atomic force microscopy (AFM) is a powerful
tool to gain insight into the oligomeric species present and their evolution during
self-assembly [104, 105, 106, 52, 107]. Along with AFM, electron microscopy (EM)
techniques have also shed light on protofibril structure and a means to visualize
the wide array of fibril morphologies [2, 51, 90, 108, 109]. Other techniques
such as static light scattering, small angle X-ray scattering [110, 90], neutron
scattering [111, 112], and solid state NMR [113, 114] can be useful in elucidating
the kinetics, with molecular resolution, of fibril formation. No single technique is
sufficient to elucidate the processes and mechanisms of self-assembly; a program of
study which includes some of these can provide complimentary and corroborating
information which ultimately can allow one to begin to understand the system
being studied.
1.4.1 Classical Nucleation Model
The features of amyloid fibril assembly, as listed above, bear the hallmarks of
a nucleation-dependent growth mechanism: the lag phase is the time it takes to
form a critical nucleus, from which rapid growth by addition can then follow. The
final equilibrium is reached once the concentration of protein drops to the critical
concentration. Indeed, there are many protein aggregation processes which are
governed by nucleation-dependent kinetics. In this section, I will review the
standard classical nucleation models for protein aggregation, and in particular
apply these ideas to understand the observed kinetics of amyloid fibril formation.
1.4.1.1 Homogeneous Nucleation
One can define in a formal way, the formation of linear aggregates by end-to-end
association,
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X +Xi ⇀↽ Xi+1 (1.1)
where X is a monomer unit and Xi is an aggregate composed of i-monomer
units. This reaction is of course characterized by the polymerization and de-
polymerization rate constants, k+i , k
−
i , respectively, for all species i. In many
cases, the initial step(s) in this reaction have rates much smaller compared to later
ones even if the conditions for nucleated polymerization are favourable. This is
due to the fact that in order for polymerization to proceed, a thermodynamically
unfavourable nucleus must be formed. To make this more concrete, one can
simplify this formal scheme by considering that the initial steps of this reaction
take place close to thermodynamic equilibrium and that these initial steps, up
until a certain critical size of aggregate, n∗, is thermodynamically unfavourable,
X +Xi ←− Xi+1, i < n∗ (1.2)
X +Xi −→ Xi+1, i > n∗ (1.3)
The probability of finding a particular species Xi, at equilibrium, is of course
related to the Gibbs free energy,
[Xi] = [X0] exp(−∆G(i)/RT ) (1.4)
where X0 is some standard state concentration, often taken as the initial
concentration. With this in mind, one can write down, at equilibrium,
k+i c[Xi] = k
−
i+1[Xi+1] (1.5)
which can be re-written as a ration of the relative concentration of species i




i+1. This ratio can be cast in terms of the ratio of
Gibbs free energies such that,
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Therefore, one can understand the transition in the rate constants in
Equations 1.2 & 1.3 as the change in the slope of the free energy barrier. For
a sufficiently steep barrier, there exists essentially one state, populated by a
very small number of species n∗ such that it becomes the rate-limiting step in
the reaction. This species n∗ is defined as the critical nucleus; the kinetics of
aggregation are therefore determined by the population and the growth rate of
the nuclei [115]. The waiting time for nucleation formation can be bypassed by
‘seeding’ the system with pre-formed nuclei. By doing so, the growth kinetics
may bypass the lag phase and growth may immediately occur. Such a kinetic
scenario is referred to as a downhill polymerization process when the forward
rate of elongation is essentially irreversible and has a first-order dependence on
concentration [115].
In this simple scheme what do the kinetics look like? One can write down
equations for the polymerization rates involving growth rates of nucleus, the rate
of monomer addition to polymers, etc. which can be solved by a number of
methods [116, 117]. What emerges from this formalism are some key features.
Firstly, in this simple linear aggregation picture with a homogeneous nucleation
step, the early rate of growth is proportional to t2 and results in a weak delay to
the start of polymerization. Secondly, the characteristic time of the aggregation
reaction has a very specific scaling relation with the initial protein concentration.
Oosawa showed that the characteristic time, or the lag time, τ scales with an
exponent γ as τ ∼ c−γ = c−(n∗+1)/2. The important point is that the exponent γ
is always greater than unity. It is therefore very instructive to study aggregation
kinetics as a function of initial protein concentration. As an application of this
theory, Oosawa demonstrated this homogeneous nucleation scheme describes well
the polymerization of F-actin [116]. It should be noted that the polymerization
of F-actin into linear aggregates is an example of ‘native’ self-assembly.
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1.4.1.2 Secondary Pathways of Aggregation
While the previous theory describes actin polymerization well, there are cases of
protein aggregation which show much more pronounced lag times and exponential
growth after the lag phase. One example of a protein aggregating system with
pronounced lag times followed by exponential growth is the polymerization of
sickle cell haemoglobin [118]. There are several ways of achieving this type of
behavior: fragmentation, heterogeneous nucleation, or branching. Fragmentation
is merely the breaking up of aggregates into smaller pieces; this allows for
new ends to be created resulting in an autocatalytic and exponential increase
in the growth of aggregates. Heterogeneous nucleation is the nucleation of
a new aggregate on the surface of an already formed aggregate. Branching
and heterogeneous nucleation on the face of it seem identical–however they are
thermodynamically distinct. There is no free energy barrier governing the rate of
branching; heterogeneous nucleation is dependent on a free energy barrier (which
is often lower than the primary nucleation barrier) that must be traversed before
additional growth may occur.
These features may be incorporated into a similar formalism as discussed
above, kinetic equations written down and solved [115]. Several salient features
again emerge. Firstly, the initial growth rate is exponential. Secondly, the lag
time, which is governed by the primary nucleation process, will still have the same
concentration scaling as described above. Thirdly, if one observes a pronounced
lag time in the kinetics of aggregation it does not necessarily imply the presence
of a nucleation-dependent aggregation process. The pronounced lag time present
in secondary processes is a result of the exponential character of the solution
to the kinetic equations and not nucleation. As has been stated, in order to
understand the origin and details of the kinetics of an aggregation process, one
must study the concentration dependence of the various kinetic parameters one
uses to describe the system. This type of formalism with a secondary pathway
was extremely successful in explaining the kinetics of sickle cell haemoglobin via
a heterogeneous nucleation mechanism [23, 118].
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1.4.2 Fragmentation driven self-assembly of amyloid fib-
rils
In the preceding sections, the kinetic features of aggregation and assembly have
been predominately dictated by primary nucleation events. For instance, the
scaling behavior of the lag time is determined by the details of rate of primary
nucleation and the size of the nucleating species. A new analytical model has been
developed which combines primary and secondary nucleation events, coupled to
linear growth, that interestingly demonstrates that the kinetics of growth can be
dominated by the secondary rather than primary processes [119, 120, 121, 122].
In their approach they write down a Master equation detailing the coarse-grained
details of the microscopic processes that contribute to fibril assembly,
∂f(t, j)
∂t
= 2m(t)k+f(t, j − 1)




f(t, i) + knm(t)
ncδj,nc
where m(t) is the concentration of monomers, f(t,j) is the concentration
of fibrils of length j, k+ the elongation rate by monomer addition, k− the
fragmentation rate, nc is the critical nucleus of size n, and kn is the nucleation
rate. The first term represents the increase in the number of fibrils of length j by
the addition of a monomer to either end of a fibril, the second term is the decrease
of the number of fibrils of length j growing to j+1, the third term describes the
breaking of a fibril at any one of the j-1 possible sites along the its length. The
summation term accounts for the fact that there are two sites in any fibril which,
after fragmentation, will result in a fibril of length j and the final term is the rate
of nucleation of nuclei of size n.
From these non-linear and infinitely coupled kinetic equations, they are
able to write down the principal moments of f(t, j) in closed form to a very
good approximation. What emerges is a relatively straight-forward picture:
the maximal rate of fibril assembly depends only on one kinetic parameter,
κ =
√
2mtotk+k− (this is the rate of multiplication of the fibril population and
mtot is the total protein concentration). No other kinetic parameters like kn are
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important to describe the details of the assembly kinetics. Moreover, they can
write down an expression for the lag time as a function of this parameter κ,
τlag = [log(1/C+)− e+ 1]κ−1 (1.8)
where the C+ term contains details about rate of nucleation. Interestingly, the
lag time is not dominated by the formation of critical nuclei–this only appears as
a small logarithmic term in the above equation. The important conclusion to be
drawn is that when the ratio k−/mtotknn
c  1, the secondary process active in
the kinetics, in this case fragmentation, will determine the details of the kinetics,
such as the lag time.
Since the kinetics are essentially governed by this single parameter κ one can
obtain a scaling law for the lag time with concentration similar to that found
in the classical nucleation picture. As we have seen τlag ∼ κ−1 ≈ m−γtot , where
γ in this instance is 0.5. This is in contrast to the result found in the classical
nucleation model, where γ is always greater than unity. Therefore, by looking at
the concentration dependence of the lag time, one can determine if the kinetics
are dominated by a secondary process such as fragmentation.
1.4.3 Further details on the lag time of amyloid fibril
assembly
We have seen the lag time is an important kinetic parameter for the formation of
amyloid fibrils-one can determine possibly the size of the critical nucleus or the
kinds of processes active in fibril assembly based upon the way the lag time scales
with concentration. Furthermore, recent discoveries have shown that the most
toxic species in amyloid fibril formation are not the fibrils themselves but the
prefibrillar aggregates [40] often present in the early times of assembly. Hence, a
complete picture of the lag phase of amyloid fibril assembly is an important task
to resolve.
Fändrich has shown, by studying the lag times and growth constants of a
variety of amyloidogenic protein systems, there exists a universal underlying
mechanism in their nucleation behavior [92]. The lag time is also an indicator
for the propensity of an amyloidogenic protein system to form fibrils. The lag
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Figure 1.3: Schematic of kinetic models. In the classical nucleation picture of
amyloid fibril assembly, a native monomer unit becomes partially destabilized due
to environmental conditions. These destabilized units can aggregate, eventually
forming a critical nucleus of some size nc that can then continue to grow into
fibrils. Such nucleated growth is typified by the lag time scaling with the protein
concentration as τlag ∼ c−(nc+1)/2. In a model where nucleation is still present, but
the kinetics are dominated by fibril fragmentation as different scaling behavior
exists quite distinct from the classical model: τlag ∼ c−1/2. Since the scaling
exponent in the classical nucleation picture is always greater than one, the
predominant mechanisms which determine the kinetic features of fibril assembly
may be reliably distinguished.
time is extremely sensitive to solution environment such as pH, salt content,
temperature, agitation and protein concentration[39, 123, 124]. By studying
the lag time, information can be gained about the factors that influence fibril
formation.
An open question concerning the lag phase is whether it is a deterministic
or stochastic process. Hofricther observed that the onset time of sickle cell
haemoglobin polymerization fluctuated and a distribution of lag times was
generated. This distribution was described by the nucleation event, i.e. crossing
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the free energy barrier, being a random walk. He then used this distribution of lag
times to deduce the rate of nucleation [23]. Szabo went on to a provide a detailed
mathematical description of the lag time distribution to determine accurately the
nucleation rates of sickle cell haemoglobin polymerization [125].
Hortchansky et al. observed variability in the lag time of Aβ(1-40) fibril
formation, as a function of concentration, from identical samples (splitting of
a stock solution into individual aliquots) and that the lag time variation is
inversely correlated to the concentration. [123]. They obtained a Gaussian lag
time distribution, which they claim is evidence for stochastic nucleation. Their
distributions are constructed of approximately 20 replicates per concentration
so their statistical analysis is not completely conclusive. They also posit that
this macroscopic heterogeneity evidenced by the distribution of lag times may be
connected to the heterogeneity known to exist at the microscopic level. Therefore
the stochasticity of the nucleation event may point to the appearance of varied
morphologies of oligomers, protofibrils, and mature fibrils.
Foderá et al. also observe similar variation in the lag time, in this case during
the fibrillation of human insulin [10]. They undertake a statistical study of these
lag time variations and find that the spread of the distribution is dependent on
the concentration. As in [123] the spread is much greater at lower concentrations.
They make the analogy between insulin and sickle haemoglobin polymerization:
the stochastic initiation of a single nucleation event followed by secondary,
heterogeneous growth of insulin fibrils. Indeed, it has been shown that insulin
exhibits heterogeneous nucleation akin to sickle haemoglobin polymerization [93].
Their statistics are only based on an approximate sample size of 50 kinetic traces.
As in [123] the statistics, albeit pointing toward stochasticity, are somewhat
inconclusive. The precise description of this lag time distribution has yet to
be described.
Recently, however Hellstrand et al. have claimed that the stochasticity
observed in these and many other experiments are an artifact of imprecise
experimental protocols and a wide variation in experimental conditions [126].
They look at the Aβ(1-42) aggregation monitored by ThT fluorescence assays and
enzyme-linked immunosorbent assays (ELISA). By having a strict protocol for
production and filtration of the peptide and the use of PEG-coated, non-binding
assay plate, they are able to produce Aβ kinetics with great reproducibility.
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Previous lag time variation was on the order of hours. They obtain variations
on the order of minutes. They also have improved statistics by looking at 672
kinetic traces over varying concentrations. They conclude that in fact there is no
stochasticity in the nucleation event; this was merely a by-product of experimental
imprecision. They fit the lag time versus concentration by a power law with an
exponent of -1.5. They find that, akin to Flyvbjerg [117], the critical nucleus is of
size 2. This conclusion is drawn from the assumption that there are no secondary
pathways.
Taken together, one must conclude that the attribution of variability in the
lag time, almost certainly is not due to nucleation, as has been common in the
literature, but to imprecise experimental protocols and techniques. For amyloid
assembly that is dominated by fragmentation, the explanation that the variability
is due to nucleation are incompatible with one another. Experimental volumes in
almost all studies exploring the kinetics of fibril assembly ensure that nucleation
events occurs rapidly and the subsequent features of the kinetics are dictated
by the elongation and fragmentary processes of assembly. Such variation in lag
times can only be understood in terms of nucleation in the limit of small system
volumes (c.f. [127]). Therefore, the standard line in the literature concerning
nucleation and the lag time must be re-evaluated for protein systems in which it
can be shown that the kinetics are best described by a fragmentation-type model.
However, since the stochastic nature of nucleation determines amyloid growth
lag times in the small volume limit it may be possible to begin to understand
why, for instance, there may be variation in the onset of amyloidogenic diseases
in genetically identical individuals. An understanding of these variations can
help aid in the potential development of inhibitory treatments targeting the early
stage pre-fibrillar aggregates present in the lag time.
1.5 Outline Of Thesis
This thesis will study the formation of three different protein systems that form
fibrillar aggregates. First, in Chapter 3 I study mechanism of insulin amyloid
fibril formation and find a structural transition which has many interesting
ramifications concerning the growth kinetics, fibril structure, rheology, and the
presence of potentially harmful cytotoxic aggregate species. This transition will
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be further studied using small angle neutron scattering in Chapter 4. Second, I
explore the mechanism of ovalbumin fibril formation in Chapter 5. I find that
the ovalbumin growth kinetics contains several interesting features, some of which
may be understood in terms of the morphological characteristics of the fibrillar
aggregates. Finally, in Chapter 6 I investigate the curious case of ocr gelation.
Under the conditions in which ocr forms fibrillar aggregates, most proteins would
form amorphous aggregates and precipitate from solution. However, this protein
forms a translucent fine-stranded gel at very high salt concentration. I study the
structure of gels formed from mutant variants of ocr to better understand the




2.1 Protein Systems Studied
2.1.1 Insulin
Insulin is a 51 amino acid (Mw=5808 and 5733 Da for human and bovine
insulin, respectively) peptide hormone created in β-cells within the pancreas that
is involved in the regulation of fat and carbohydrate metabolism. Insulin is
comprised of two chains: the A and B chains which are linked by two disulphide
bonds. There is a further third internal disulphide bond within the A chain
(see Fig. 2.1). The secondary structure of insulin consists primarily of α-helices
while the disulphide bonds stabilize the tertiary structure. The monomeric unit
of insulin acts as the biologically active form [128]. The monomer contains two
non-polar surfaces; one is mainly comprised of aromatic residues while the other
is more extensive and flexible [129]. These surfaces are reactive and act as the
sites for receptor interactions [130]. However, over a large pH range (2-8) insulin
exists in a dimer state, burying the aromatic non-polar surface. Dimeric insulin
undergoes further assembly into a hexameric unit that is coordinated by the
presence of 2 to 4 Zn2+ ions [129]. Low pH, elevated temperatures, and agitation
can induce insulin to be in the reactive monomeric state [131].
This monomeric state appears to be an important ingredient in driving insulin
to form amyloid fibrils [39, 132, 101]. Indeed, insulin has a long history as a test
system to study the formation of amyloid fibrils going back to the 1940s and
1950s and the work of D.F. Waugh [133, 134]. Generally, insulin forms amyloid
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Figure 2.1: Schematic of the amino acid structure of bovine insulin.
Bovine insulin consists of 51 amino acids which are subdivided into two units:
the A and B chains. There are two inter-chain disulphide bonds linking the A
and B chains; there is also an interchain disulphide bond within the A chain.
Taken from [3]
fibrils at low pH (pH < 2) and high temperatures (>37◦C). The rate at which
insulin forms amyloid fibrils is contingent upon many parameters from the kind of
acid used, amount and kind of salt present, temperature, degree of agitation, and
the presence of surfaces [39, 135]. Insulin has been a well-studied amyloidogenic
system due to its relatively inexpensive cost and ease in which it will form amyloid
fibrils [90, 54, 10, 136, 137, 138, 105, 2, 139, 104, 140, 110].
In this thesis, bovine insulin was used to study the kinetics of amyloid fibril
formation in a variety of conditions and concentrations. Insulin is not only
an attractive test system for the reasons mentioned above, but also has direct
consequences for the pharmaceutical industry. For example, the accumulation
of insulin amyloid deposits in subcutaneous insulin injection systems for Type-1
diabetes patients is an ongoing issue [141] as well as prolonging the shelf-life of
pharmaceutical suspensions of insulin. Therefore studying insulin amyloid fibril
formation can have a broader impact than just being a ‘cheap standard protein’
for studying amyloid fibril formation.
2.1.2 Ovalbumin
Ovalbumin is the primary protein constituent in hen egg white. Its ubiquity and
thorough structural characterization has made it a useful test protein system.
Interestingly, its function is still not understood [142]. Ovalbumin consists of
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386 amino acids (Mw ∼ 48 kDa) that, under native conditions, is comprised of
α-helix, β-sheet, and random coil in a compact globular configuration containing
one intra-protein disulphide bond (see Fig. 2.2).
Several papers have shown that ovalbumin will form amyloid fibrils by
reducing the internal disulphide bond and/or incubating ovalbumin in denaturing
conditions [143, 144, 145]. I sought to study the formation of amyloid fibrils from
ovalbumin due to its unusual kinetic behavior as well as its copious availability.
In this thesis, ovalbumin was induced to form amyloid fibrils by the adding a
reducing agent and heating (§2.2.1.3).
Figure 2.2: Ovalbumin structure. Displayed is an ovalbumin monomer unit.
Ovalbumin contains substantial β-sheet (dark blue) and α-helix (green) secondary
structure. A member of the serpin family of proteins, it is the most abundant
protein in a hen egg white. Taken from PDB 1OVA.
2.1.3 ocr
Many microbial organisms have developed defense mechanisms to protect them-
selves from viral infections. During a viral infection, the virus will attach itself
to the host microbe and inject its DNA. However, the microbe has a means to
distinguish its own DNA from the foreign viral DNA. An enzyme known as a
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methyltransferase (MTase), which methylates unique sequences within the host
genome combined with an enzyme called a restriction endonuclease (REase), can
distinguish the methylated host DNA from the unmethylated DNA of the virus.
The REase will then destroy the viral DNA thus preventing infection. This
process is called the restriction modification system (R/M). An additional enzyme
is present that determines the specificity of the R/M process. This is known as a
type I restriction/modification complex. Viruses known as bacteriophages have
evolved unique methods of circumventing this R/M system such as methylating
their own DNA. However, bacteriophage T7 has evolved a unique strategy: a
DNA mimic protein [146].
2.1.3.1 What is Ocr?
When bacteriophage T7 first infects Eschericia coli, the first protein that is
expressed is ocr (Overcome Classical Restriction). Ocr is a protein consisting
of 116 amino acids in monomer form with a molecular weight of 13678 Daltons
(see Fig. 2.3 for the amino acid sequence of wild-type ocr). Importantly, ocr has
a very high number of aspartic and glutamic acids arranged on its surface giving
it a very high negative charge. At pH 8.0, for instance, the ocr dimer (ocr in
solution is dimeric) has a charge of -56e. Ocr contains all the natural amino acids
apart from cysteine. The exclusion of cysteine precludes the formation of inter-
or intra-protein disulphide bridges. The tertiary structure is comprised of four
α-helices per monomer. There are no β-sheets present in ocr.
1        M  A  M  S  N  M  T  Y  N  N  V  F  D  H  A  Y  E  M  L  K
2 1      E  N  I  R  Y  D  D  I  R  D  T  D  D  L  H  D  A  I  H  M  
4 1      A  A  D  N  A  V  P  H  Y  Y  A  D  I  F  S  V  M  A  S  E
6 1      G  I  D  L  E  F  E  D  S  G  L  M  P  D  T  K  D  V  I  R
8 1      I  L  Q  A  I  Y  E  Q  L  T  I  D  L  W  E  D  A  E  D  
1 0 1    L  L  N  E  Y  L  E  E  V  E  E  Y  E  E  D  E  E
Figure 2.3: Ocr amino acid sequence Wild-type ocr is comprised of 116 amino
acids. There is a large number of aspartates and glutamates which contributes
to the very high surface charge of ocr.
Ocr is expressed first since it is an inhibitor of E. coli’s R/M system. Once
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expressed, it will bind to an REase (for E. coli the type I enzymes are called
EcoKI and EcoBI), preventing the enzyme from recognizing and destroying the
viral DNA. The viral DNA is able to freely transcribe and the virus replicates.
Ocr’s inhibition of the R/M system is achieved by mimicking the structural
and electrostatic properties of DNA. The carboxyl groups of ocr simulate the
distribution of phosphate groups of B-DNA [147]. Furthermore, when EcoKI
binds to DNA it causes a bend to accommodate the target recognition domains.
Figure 2.4: The Ocr dimer dimics the charge and structure of bent DNA’
An ocr dimer (blue) with bent double stranded DNA (green) overlaid. Note the
similarity in location of the charge groups for ocr and DNA. DNA phosphate
groups are yellow and purple. The ocr carboxyl groups are red and black. The
bend angle is 33.6◦. (Source: [4])
Ocr exists naturally as a dimer; dimeric ocr has a natural bend very similar
to a bent DNA molecule bound to EcoKI [148]. Fig. 2.4 shows a dimer of ocr
with bent double stranded DNA laid over top. One can see that the arrangement
of charge groups on ocr closely resembles that of the DNA. In fact, ocr binding
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affinity to type I enzymes EckoKI and EcoBI is 50 times greater than that of
DNA. Ocr is therefore very effective in competing with DNA in binding to type
I enzymes; so much so that ocr can even cause bound enzymes to disassociate
from DNA [147]. Indeed, ocr is so effective because it will bind virtually all
R/M enzymes regardless of sequence specificity by virtue of its shape and charge
characteristics [148, 149].
2.2 Experimental Methods
2.2.1 Thioflavin T & Amyloid Fibrils
Thioflavin T (ThT) is a dye which preferentially binds to the structure of
amyloid fibrils. Free ThT in solution weakly fluoresces with λex = 350nm and
λem = 440nm. It was observed in the late 1950s that ThT exhibits characteristic
fluorescence enhancement when bound to amyloid fibrils at λem = 482nm when
excited at λex = 450nm [150]. Unlike other amyloid specific dyes, such as Congo
Red, it has been shown that ThT does not interfere with the assembly process or
significantly perturb the structure of the fibrils [151, 48]. Because of this, ThT is
particularly useful in monitoring the kinetics of amyloid formation and growth.
Despite the utility of ThT, the details of the binding mode to amyloid fibrils
are still not well understood. Krebs et al. demonstrated that the orientation of
binding as well as the steric interaction between ThT and the side chains of the
fibrils contributes strongly to the fluorescence enhancement observed [46]. They
propose ThT binds to ‘channels’ that run along the β-sheet structure of amyloid
fibrils. Similarly, Groenning et al. have shown that the characteristic ThT
fluorescence is induced by ThT binding within cavities which can accommodate
one or more ThT molecules. They posit that the presence of multiple ThT
molecules within a cavity can induce excimer formation which may explain the
enhancement of fluorescence often observed [47].
2.2.1.1 Thioflavin T Fluorescence Assays: Experimental Procedures
Thioflavin T fluorescence assays which monitor the kinetics of amyloid fibril
growth were extensively performed in this thesis. The kinetics of amyloid fibril
formation from bovine insulin and ovalbumin were performed in FluoStar Optima
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and Omega plate readers. These plate readers are filter-based fluorescence plate
readers. The filters used were a 450 nm excitation and 485 nm emission with a
band width of ± 10 nm.
2.2.1.2 Insulin Assays
Bovine insulin was obtained from Sigma-Aldrich (I5500, lot # 0001434060).
The zinc content was approximately 0.5 % (w/w). The samples in this study
were dissolved in 25 mM HCl (pH 1.6) immediately prior to the experiment.
All solvents and solutions were filtered through a 0.22 µm filter (Millipore).
Concentrations were checked via UV-Vis absorption spectroscopy. ThT was
added to each solution to a final concentration of 20 µM. Experiments were
conducted using Corning NBS 96-well plates (Corning 3641). These plates are
coated with a proprietary PEO-like hydrophilic coating which minimizes the
interaction of protein with the plates. It was found that using these plates
significantly minimized the variability in the kinetics compared to standard
polystyrene microwell plates. Each well of the plate was filled with 100 µL of
solution. Experiments for each protein concentration were replicated across 2-3
whole plates. The plates were sealed with a plastic adhesive and then incubated
at 60◦ C. Fluorescence readings were taken from the bottom optic. Readings were
taken every 10 minutes for all kinetic experiments. In the case of experiments
with agitation, the plate was shaken at 600 rpm for two minutes. It then remained
quiescent for the remaining eight minutes of the cycle. The plate was not shaken
for the entire duration of the cycle so as to minimize the effects of any temperature
gradients within the plate reader (for a discussion on temperature inhomogeneities
within plate readers see Appendix A). The final number of individual experiments
for a given protein concentration ranged from ∼ 140-200.
The experiments involving adding NaCl at regular time points during the
course of fibril formation (Chapter 3.2.5) were performed by preparing a microwell
plate of 1.5 mg/ml insulin samples containing 20 µM of ThT. 6 µL of a 5M stock
NaCl solution was added to three wells at the start of the experiment. The plate
was placed into the plate reader at 60◦C and ThT fluorescence was monitored.
Subsequently, 6 µL of the same concentrated NaCl solution was added to another
three wells every 30 minutes, for a total of 240 minutes. A final reading was
taken at 400 minutes. The final concentration of NaCl in the wells was 0.3M.
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Concentrated NaCl was added in small volumes to minimize any change in volume
which could affect the kinetics of fibril formation.
2.2.1.3 Ovalbumin Assays
Albumin from chicken egg white was obtained from Sigma-Aldrich in two grades
of differing purities: Grade 2 (A5253) and Grade 5 (A5503). Ovalbumin was
incubated in the presence of 10mM dithiothreitol (DTT) and 10 mM Ammonium
Acetate. ThT was added to a final concentration of 55 µM. Samples were initially
incubated at 37◦C for 2 hours. This is following the protocol outlined by [144].
This step is performed in order to reduce intra-protein disulphide bonds which
was found to increase the rate of formation of amyloid-like fibrils. After this
pre-incubation, samples were added to microwell plates at a volume of 100 µL.
Plates were shaken at 600 rpm (double orbital) for 1 minute at a temperature
of 60◦ C. Total time between cycles was 2 minutes. The experiments measuring
the kinetics of fibril formation were performed in a variety of plates: Corning
NBS 96 and 384 well plates, as well as Iwaki 96 and 384 polystyrene microplates.
Microwell plates were sealed with a plastic adhesive. Temperature dependence
studies were performed on a Varian Cary Eclipse Fluorimeter in quartz cuvettes.
Three cuvettes were monitored for each temperature studied.
2.2.2 UV-Vis Spectroscopy
Insulin concentrations were found using a Cary UV-Vis spectrophotometer using
Varian software. Samples were placed in a quartz cuvette and a spectral scan
was taken for wavelengths ranging from 200 to 500 nm at a scan rate of 30
nm/sec. The spectrum was blank corrected using a matching quartz cuvette and
buffer. The extinction coefficient of bovine insulin is 5734 M−1cm−1. For the
experiments determining the amount of insulin left in solution after fibrils have
formed, fibril samples were centrifuged in eppendorf tubes at 18,000 rpm for 30
minutes. The supernatant was carefully pipetted away without disturbing the
pellet. The supernatant was then scanned as described above.
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2.2.3 Bradford Assay: Another Means of Determining
Protein Concentration
Bradford Assays are a means of determining the concentration of a protein in
solution when performing UV-vis absorbance analysis is difficult or not possible.
Unlike UV-vis spectroscopy where an absolute value for the concentration is
found via the intrinsic absorption of the protein, the Bradford assay determines
concentration relative to a known standard concentration curve. The key to
the Bradford Assay is a spectral shift in absorbance of Coomassie Blue dye
when bound to protein. Coomassie Blue, at very acidic conditions, exists as
a stable, doubly-protonated form which shows characteristic absorbance ∼ 470
nm (appears red/brown in color). However, upon binding protein, Coomassie
blue becomes unprotonated and shifts to an absorbance of ∼595 nm (becomes
blue). The Beer-Lambert law is then applicable in determining the concentration
of protein based on the amount of absorbance at 595 nm. Bradford Assays are
most reliable when comparing the absorbance shift of Coomassie Blue with a
known standard. Bovine serum albumin (BSA) is a common protein used as a
Bradford Assay standard. In practice, one makes a serial dilution of BSA and
measures the absorbance at 595 nm in the presence of Coomassie Blue. For
sufficiently low concentrations, one will obtain a linear trend in the absorbance.
These values can be fit by linear regression to form a standard curve. One can
then measure the Coomassie Blue absorbance for an unknown concentration of
protein and utilize the standard BSA curve to determine the concentration.
This technique was used when determining the amount of unaggregated oval-
bumin present after incubating 24 hours in conditions promoting the formation
of amyloid fibrils. This was done because the reducing agent, DTT, has a similar
absorbance band to proteins. Bradford Assays were performed to avoid this
complication. The ovalbumin amyloid fibril samples were spun in centrifuge
tubes at 3200 rpm for 30 minutes and 4◦C. The supernatant was then removed.
A standard curve of BSA was made by making a serial dilution from 1.5 mg/ml
down to 0.125 mg/ml. Bradford reagent was added to the BSA dilution and
then three replicates of each concentration was aliquotted to a 96 well plate.
The absorbance at 595 nm was determined by a BMG FluoStar plate reader.
The absorbance values for each replicate were averaged and a standard curve
was generated by fitting the data by linear regression. Bradford reagent was
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then added to the supernatant and added to a plate reader in triplicate. Again,
absorbance readings were taken at 595 nm which were averaged. The values were
then compared to the standard curve to determine the concentration.
2.2.4 Transmission Electron Microscopy
Transmission electron microscopy (TEM) is a valuable tool for imaging objects
on the nanometer scale. This is because the de Broglie wavelength of an electron
in a typical TEM instrument (accelerating potential ∼ 100 kV) is on the order
of 10−12m. An image is acquired through the interaction of an electron beam
with the sample. In standard ‘bright field’ mode, an image which absorbs more
electrons will stand out as a darker object relative to one that absorbs electrons
less. In many cases, particularly for biological samples, a negative stain such as
uranyl acetate is used to enhance contrast.
2.2.4.1 TEM of Amyloid Fibrils
Insulin and ovalbumin amyloid fibrils were made by incubating samples in the
conditions outlined above. Fibril samples were then diluted to either 1:5, 1:10,
or 1:20, depending on the concentration of the starting sample. This dilution is
carried out because concentrated samples are too dense to image. Aliquots of
3 µL fibril samples were placed on 400 mesh copper grids (Taab, Aldermaston,
U.K.) coated with formvar and carbon and allowed to left for 5 minutes. The
grids were washed with 10 µL MilliQ water followed by application of 4 µL of
2% uranyl acetate (w/v). The uranyl acetate was left on the sample grid for 30
seconds. Excess water and stain were removed with filter paper and the grids
were left to air-dry for 20 minutes. Imaging was performed using a Philips (FEI)
CM120 Biotwin transmission electron microscope with an operating voltage of
-80kV.
Length distributions were obtained using ImageJ image analysis software.
Using a sufficient dilution (1:20), one can obtain samples which contain fibrils that
do not excessively overlap and are easily distinguishable as individuals. Fibrils
were then traced and individual lengths obtained. Fibrils used in the analysis were




2.2.5 Microrheology: Bead Tracking
2.2.5.1 Brownian Motion
Brownian motion, named after Robert Brown who noted the chaotic, non-
directed motion of pollen in water in 1827, is the stochastic movement of particles
suspended in solution. The correct interpretation of Brownian motion was given
by Einstein in 1905-that the random motion is due to thermally driven collisions
between the particle and the constituent solution. Einstein made the insight








where, ρ(x, t) is the density of Brownian particle at position x and time t, and
D is the diffusion constant. The solution to this equation is a Gaussian function







Given this probability distribution function, the mean displacement may be
calculated. It is readily evident from the nature of the Gaussian function that
< x >= 0. The second moment, the mean square displacement, is non-zero
< x2 >= 2Dt. This result can be extended to any dimension, d, such that
< ∆r2 >= 2dD∆t (2.3)
This result shows that the mean square fluctuations of a particle depends
linearly on time. This result is a hallmark of isotropic random-walk processes.
This linear temporal dependence on the mean square displacement is true for the
case of diffusion in a viscous fluid. The existence of an elastic component to the
fluid in which the particles are diffusing results in sub-linear time dependence
[152, 153], i.e., < ∆r2 >= 2dD∆tα, where α < 1, over long time scales. It should
be noted that this sub-linearity of α is theoretically transient and in the long time
limit, α→ 1.
Einstein made a second and important observation: that the forces that drive
the fluctuation of Brownian particles are the same dissipative forces that exert a
viscous drag on the particles. This relation, known generally as the fluctuation-
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dissipation theorem, relates the diffusion constant, D, and the mobility of
particles in solution. He showed that for a spherical particle the diffusion constant





where k is Boltzmann’s constant, T is the temperature, η is the viscosity of the
solution, and a is the radius of a diffusing particle. Therefore, by measuring the
diffusion constant one can determine the viscosity of a substance, temperature of
the system or the size (and shape) of diffusing particles.
2.2.5.2 Video Particle Tracking
From the insights gained above, video particle tracking allows one to monitor
the diffusion of particles within a potentially complex fluid system and thereby
determine important material properties about that system. A typical experiment
consists of recording the motion of tracer particles (typically spherical beads with
radii of 1 µm or less) within a fluid of interest using a microscope that has been
connected to a CCD camera where images may be acquired at a desired frame
rate.
These raw images can then be analyzed using a number of computer programs.
In this thesis, particle tracking was achieved using the very popular algorithm
developed by Crocker and Grier for IDL [154]. The algorithm identifies candidate
particles, locates their position, and then, frame-by-frame, links the particles into
a trajectory. The information obtained provides the x- and y- position of each
particle within the field of view for each frame.
This information can then be used to calculate the mean squared displacement
(MSD) of each particle. For simplicity consider the one-dimensional case. Call xi
the position at ti and the interval between 2 successive frames ∆t. Any subsequent
position xi+1 = x(ti + ∆t) and therefore any displacement ∆xi(∆t) = xi+1 − xi.
Thus, the MSD for that given time interval is obtained by averaging all steps,





This is the MSD for only one frame interval, e.g. 1/100 s for a frame rate
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of 100 fps. One wants to plot the MSD for many time intervals. Therefore, one
must then calculate < (∆xi(n∆t))
2 > for n time intervals. Of course, for longer
time intervals, the number of steps decreases, resulting in increasing statistical
error. Therefore, it is beneficial to calculate a large ensemble average of diffusing
particles to minimize the statistical errors at longer times. Additionally, taking
large ensemble averages can improve the error in the MSD due to polydispersity
in the size or shape of tracer particles.
2.2.5.3 Particle Tracking: Amyloid Fibrils
Insulin amyloid fibril samples, at several concentrations, were formed in NBS 96-
well microwell plates at 60◦C without shaking for 24 hours. The plates were then
removed and allowed to equilibrate to room temperature. A solution of latex
beads, 1 µm in diameter, were diluted to 1:5 in the buffer used in the formation
of the insulin amyloid fibrils. Roughly 1 µL of the latex bead solution was added
to a microwell containing the amyloid fibrils. The beads were initially gently
mixed with the tip of the pipette. The fibril and bead samples were removed by
pipette and ∼ 100 µL was placed onto a glass microscope slide. A glass cover slip
with petroleum jelly applied to its four edges was carefully placed onto the glass
slide containing the sample. The glass cover slide was gently pressed onto the
lower glass slide making an airtight seal. The sample was then imaged using a
Nikon Ti-U inverted microscope with a Nikon 40x ELWD objective. The images
were captured using a Mikrotron EoSens CCD camera at 100 fps over a field
of view of 500x500 pixels. The movies were saved as individual .bmp files. For
each sample, several movies in different regions of the sample were acquired, with
each movie containing at least 50 beads within the field of view. These files
were then converted into tiff stacks using ImageJ software. Once converted to tiff
stacks, background subtraction, image inversion (so that there are white beads on
a black background), and contrast adjustments were performed. This was done
because the IDL tracking routines work best for white, bright ‘Gaussian’ blobs
on a flat black background. Particle identification, tracking, drift removal, and
the calculations of the MSD were performed using IDL routines of [154].
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2.2.5.4 Particle Tracking: Ocr
To determine the physical characteristics of the aggregated ocr variants, microrhe-
ological bead tracking experiments were performed. Experiments using bulk
rheological techniques was not a viable option because of the prohibitively small
quantities of sample available. The protein variants were stored in a -20C freezer
in 50% (by weight) glycerol. The glycerol was removed and protein exchanged into
a 20mM Tris-HCl, pH 8 buffer using NAP-5 desalting columns (GE=Healthcare).
After buffer exchange, sample concentrations were determined using UV-Vis
absorbance (extinction coefficient of 31860M−1cm−1). Due to varying degrees
of dilution during buffer exchange, some samples required concentrating. This
was done using a centrifugation concentrator (Vivaspin-2). A final concentration
for all protein samples was set to be 36µM. Latex, sulphate-free 2 µm beads
were added to the samples to a final volume fraction ∼ 0.01%. Samples were
then placed in microdialysis buttons (Hampton Research) and sealed with an
equilibrated dialysis membrane with a MWCO of 10 kDa. Buttons were then
placed into a range of ammonium sulphate concentrations. A stock ammonium
sulphate solution of 3.5M was made by dissolving ammonium sulphate (Sigma-
Aldrich) into 20 mM Tris-HCl pH 8. Subsequent concentrations were made by
dilution using 20 mM Tris-HCl pH 8. The samples were allowed to dialyze
between 4-6 hours at 4◦C in a cold room. Prior to imaging, the samples were
removed and allowed to equilibrate to the temperature of the room where the
imaging was taking place (30 minutes). The samples were then directly imaged
through the button by placing the button onto a glass cover slip. Images were
acquired using a Nikon Ti-U inverted microscope with a Nikon 40x ELWD
objective. The images were captured using a Mikrotron EoSens CCD camera
at 100 fps over a field of view of 500 x 500 pixels. Analysis of the subsequent
images to obtain MSD data follows as described above.
2.2.6 Circular Dichroism Spectroscopy
Circular dichroism spectroscopy utilizes the effect that optically active chiral
molecules will differentially absorb left- or right-circularly polarized light (LCP
and RCP) [155]. Linearly polarized light can be thought of as a superposition
between LCP and RCP light with equal amplitude and phase. This can be
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visualized by viewing the projection of the two components, orthogonal to the
direction of propagation (see Fig. 2.5A). However, when light passes through a
material that differentially absorbs the two components, the result is a difference
in the amplitudes of these two components. When looking at the projection
again, one finds instead of a line, an ellipse is formed (Fig. 2.5B). This ellipticity
is known as circular dichroism (CD). A useful measure of CD is the degree of
ellipticity which is defined as the tangent of the ratio of the major and minor
axes of the ellipse (θ in Fig. 2.5C). It should be noted that the CD signal in most
samples is extremely small (on the order of milli-degrees), and the ellipticities
shown in Fig. 2.5B are only for illustrative purposes.
Circular dichroism is particularly useful for discerning secondary and tertiary
structure of proteins. For a CD signal to be observed, radiation must be absorbed.
Proteins contain multiple chromophores of interest including the peptide bond
(240 nm) and the aromatic residues (260-320 nm) in addition to co-factors
such as haem groups that show characteristic absorption bands. Moreover,
when many chromophores of a particular type are spatially arranged in close
proximity to one another they may act as a single absorber which can result in a
distinct spectrum. CD is therefore particularly suited in providing complementary
structural information over a range of spectral regions.
In particular, absorption bands in the far-UV(180-240 nm), provide informa-
tion about the secondary structure of a protein. This is primarily due to the
absorbance and spatial arrangement of the peptide bonds within a protein. For
instance, α-helices, β-sheets, β-turns, or random coiled structures have distinct
CD spectra (see Fig. 2.6). Indeed, many computer algorithms have been
developed to analyze CD spectra to determine the percentage of α-helix or β-sheet
within a protein (see for instance [156]). Information about the tertiary structure
of a protein can be obtained by looking at the CD spectra in the near-UV (260-
320 nm). In this case the primary chromophores are the aromatic residues. A
CD spectrum in the near-UV is determined by the number and identity of the
aromatic residues within a protein, as well as their spatial arrangement, proximity,
and mobility [155]. Due to this, the solution or environmental conditions may
have a marked effect on the CD spectrum. The CD spectra obtained in the
near-UV often can not be ascribed to a particular structure like in the far-UV
case. However, near-UV spectra are particularly useful in discerning changes in
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Figure 2.5: Origin of circular dichroism. A Projection of the left- and
right- circularly polarized light perpendicular to the direction of propagation.
Linearly polarized light can be thought of as a superposition of left- and right-
circularly polarized light that have the same amplitude and phase. B However,
if light passes through an optically active medium which differentially absorbs
left- and right- circularly polarized light (e.g. chiral molecule), the component
which is absorbed more will experience a reduction in amplitude; projecting these
components orthogonally to the propagation direction results in tracing out an
ellipse. This ellipticity is known as circular dichroism (CD). When there is circular
dichroism, there always exists a change in the phase between the left- and right-
circularly polarized components. This results in a change in the polarization
plane (the elliptical axes) creating a ‘tipping’ of the ellipse by some angle. C
Circular dichroism experiments often report the amount of circular dichroism in
a sample by measuring the ellipticity, θ, which is the tangent of the ratio of the
minor and major axes of the ellipse (usually measured in milli-degrees).
tertiary structure of a protein, for instance, between a wild-type and mutant
variant. CD spectroscopy is a very useful tool in gaining general information
about the secondary and tertiary structures of peptides and proteins.
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Figure 2.6: Standard far-UV CD spectra for common protein secondary
structure motifs. One can determine the presence and the relative amount of
a particular type of secondary structure due to these motifs having distinct CD
‘finger prints’. Some examples are α-helix (solid line), anti-parallel β-sheet (long
dashed line), type I β-turn (dotted line), extended 310-helix (cross dashed line),
irregular structure (short dashed line). Taken from [5]
2.2.6.1 CD of Insulin Amyloid Fibrils
A range of insulin solutions between 0.25 and 4 mg/ml were incubated at 60◦C
without shaking for 24 hours in NBS 96 microwell plates. CD spectroscopy of
the resulting fibrils was performed on a Jasco J-810 spectropolarimeter. The
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spectropolarimeter was purged with N2 gas for 24 hours prior to the experiment.
75 µL of fibril samples were placed in a quartz cuvette with a path length of
0.1 mm. Spectra were obtained in the far-UV (190-230 nm) by averaging over
5 accumulations. A bandwidth of 1nm and sensitivity of 100mdeg was used in
all experiments. The J-810 gives the ellipticity in millidegree units. The data
was converted to molar ellipticity (deg cm2 dmol−1) which takes into account
differences in concentration between samples.
2.2.7 Neutron Scattering
There are various techniques which can be employed to elucidate the molecular
organization of biopolymers. X-ray diffraction spectroscopy is a powerful tool
in this regard, capable of providing spatial information for every atom within a
molecule. However, this technique suffers from several drawbacks. Firstly, such
high molecular resolution is achieved through single crystal x-ray diffraction.
It is a very non-trivial experimental hurdle to produce high quality single
crystals of many biological molecules. Secondly, the use of ionizing radiation
can cause irreparable damage and eventual destruction of a sample. Indeed,
with the modern high luminosity synchrotron X-ray sources available at many
international laboratories this consideration must be accounted for.
Neutron scattering techniques avoid these issues altogether. Neutron scatter-
ing experiments can be performed in a myriad of conditions (e.g. in complex
solutions and solvents) with effectively little or no damage to the sample. The
origin of these differences lies in the simple fact of how X-ray and neutron
radiation interacts with a sample: x-rays are scattered by electrons, neutrons are
scattered by nuclei. The strength of the interaction between X-rays and a given
atom, described by the ‘scattering length’, is a function of the atomic number.
This is not the case for the neutron-nucleon interaction. Indeed, hydrogen, which
is usually not resolvable in X-ray diffraction experiments, has an (incoherent)
scattering length almost an order of magnitude larger than any other nuclei.
Even more importantly, the scattering lengths of hydrogen and deuterium are
markedly different. Because of this fact, it is typically advantageous to perform
neutron scattering experiments in D2O or mixtures of H2O and D2O to minimize




2.2.7.1 Basics of Neutron Scattering
In this section a very brief overview of scattering, with an emphasis on small
angle neutron scattering, will be provided in order to elucidate some of the results
presented later. The task at hand is to understand how the information obtained
from scattering a neutron from a sample (i.e. changes in wavevector and energy)
relates to structural or dynamical information.
While neutrons are often thought in terms of their particle nature, they of
course possess a wavelength according to the de Broglie formula λ = h/mv
where h is Planck’s constant, m is the mass of the particle and v its speed. It
should be noted, thermal neutrons, that is neutrons with energy kT , where T is
approximately room temperature, have wavelengths on the order of an angstrom.
This is ideal for probing the structures relevant to molecular characteristics of
biopolymers. Scattering events can be cast in terms of neutron wavevectors, k.
The wavevector k has magnitude 2π/λ and points in the direction of motion. In
an elastic scattering event, the wavelength λ is unchanged only the direction of k
is altered. This change can be parameterized by the scattering vector Q = kf−ki
where kf and ki are the final and initial scattering vectors, respectively (Fig. 2.7).





Therefore, Q encodes the spatial information, in real space, of a scattering
sample.
Generally, consider a sample consisting of N nuclei, each of which has some
scattering length bk. Recall, scattering length describes how strongly a particular
form of radiation will interact with some nuclei. More concretely, the scattering
length, b can be interpreted as the amplitude of a scattered wave by some nuclei.







exp(iQ · rk) (2.7)
where rk is the distance of the kth atom from an observer and Q is the
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Figure 2.7: Graphical origin of the Q-vector. An incoming particle with
wave vector ki (magnitude of 2π/λ) scatters by some angle θ and the resulting
wave vector is kf . If the scattering event is elastic, there is no energy exchange
between the particle that’s been scattered and the scattering center (e.g. the
nucleus). In that case, the wavelength is unchanged and the magnitude of ki and
kf are the same; only the direction changes. This change in direction is quantified
by the scattering vector Q whose magnitude is Q = 4π
λ
sin(θ/2).
One can consider a small solid angle dΩ in which the number of neutrons,
per second, are measured. This number will depend on the orientation of dΩ,
the energy, E of the neutrons, and the initial intensity of the incoming neutron






Integrating over the final energies gives the differential cross section ∂σ/∂Ω
which gives the total number of neutrons scattered into dΩ per second. In other
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〈bjbk exp(iQ · (rk − rj))〉 (2.11)
















exp(iQ · (rk − rj))〉 (2.13)
The term 〈b〉2 results due to the fact bj and bk are uncorrelated with rj and




= N∆b2 + 〈b〉2
N∑
j,k
〈exp(iQ · (rk − rj))〉 (2.14)
The differential cross-section has been partitioned into two parts: one which
only depends on the fluctuations in the scattering length, b, and the second
depends on the relative positions of scattering nuclei. Incoherence arises due to
scattering centers with different scattering lengths. This could arise due to the
presence of isotopic impurities in a sample, for instance. Indeed, the second term
gives an angular dependence to the scattering intensity and encodes the structural







exp(iQ · (rk − rj))〉 (2.15)
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We can define the coherent scattering cross section as σcoh = 4π〈b〉2 and the
incoherent scattering cross section, σinc = 4π∆b2. For the case of hydrogen,
one finds experimentally that σcoh=1x10
−24cm2 and σinc=80x10
−24cm2. The
coherent scattering cross-section for hydrogen is nearly an order of magnitude
larger than any other nuclei. Indeed, the coherent cross section of hydrogen
is larger than all other nuclei. This important fact is the foundation for
hydrogen/deuterium contrast. The experimentalist, for instance, may exploit
the difference in scattering between a D2O solvent and a hydrogenated sample
in order to reduce the large incoherent scattering background one would have if
using H2O as a solvent. Another example would be to selectively deuterate a
region of polymer, thus providing scattering contrast between that region and
the rest of the polymer.
In practice, one measures the intensity of neutrons received by a detector
as a function of the scattering vector, Q. At values of low Q one can write an
approximate form of I(Q),
I(Q) = I(0) exp(−(qRg)2/3) (2.16)
where Rg is the radius of gyration. Writing I(Q) in this form is known as the
Guinier approximation. By plotting lnI(Q) vs. Q2 one can obtain Rg by simply
calculating the slope of the linear plot. Clearly, Guinier analysis can be extremely
useful for determining the size of structures within a sample-particularly when
coupled with time-resolved scattering. One must take caution, however, when
calculating Rg in the Guinier regime for it is only valid for values of qRg  1.
At larger Q-values (i.e. smaller length scales), one can consider the scattering
of neutrons from a ‘fractal’ surface. In practice, fractal objects that can
be observed via neutron scattering are gaussian chains with excluded volume,
diffusion limited aggregates, or gel networks. It can be shown that the intensity
scales with fractal dimension as I(Q) ≈ Q−D, where D is the fractal dimension of
the surface. This analysis can be useful, for instance, when studying the formation
and structure of gels; gels may be characterized by the fractal dimension of the
clusters that constitute them. As ever, one must be careful using this type of
analysis. When plotting lnI(Q) vs. lnQ, the linear regime must extend over at
least one decade of Q to obtain any reliable information on the system in question.
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2.2.7.2 ISIS Neutron Source and the Sans2d Detector
Neutron scattering experiments performed in this thesis was carried out at the
ISIS facility which is located at the Rutherford-Appleton Laboratory in Harwell,
England. ISIS produces neutrons by first accelerating H− ions to 70 MeV by a
linear accelerator. These ions are then transported to a synchrotron, where, upon
entry, they are stripped of their electrons. The resulting protons are accelerated
to an energy of 800 MeV. These protons are extracted from the synchrotron and
delivered to two different target stations which produce neutron beams through
the spallation process. Experiments in this thesis were performed at Target
Station 2, which is designed to provide long-wavelength and low energy neutrons.
The neutrons produced are ideal for studying topics in soft matter and biological
physics.
Experiments were performed on the Sans2d detector. The Sans2d instrument
measures over a Q-range of 0.002-3 Å−1. The detector consists of two ORDELA
(Oak Ridge, Tennessee, USA) two-dimensional area detectors filled with 3He-CF4
gas. The active area on each detector is 96.5 cm x 96.5 cm with 5 mm resolution.
The detectors can be moved, in vacuum, so that the detector distance can vary
between 2 to 12m. To further increase the Q-range, for a given detector distance,
the detectors can be laterally offset up to 1200 mm.
2.2.7.3 Neutron Scattering of Insulin Amyloid Fibrils
Insulin samples were prepared using zinc-free bovine insulin purchased from
Sigma-Aldrich (I5500). Insulin samples were freshly prepared prior to every
experiment. Insulin was dissolved in fresh D2O and pH adjusted with HCl to
a final value of pH 1.6. The samples were then filtered using a 0.22µm polyether
sulfone membrane filter. To ensure no pre-formed aggregates were remaining in
the sample, DLS was performed. It was confirmed prior to the experiments no
pre-formed aggregates were present. Both detectors were positioned at a distance
of L1=L2=4m. Samples were placed in quartz ‘banjo’ cells with a thickness of
2mm and diameter of 20mm. The Q-range covered in these experiments was
0.005-0.77 Å−1. Calculations involving molecular weight were found using the
equation Mw = I(0)NA/c(∆ρ)
2ν2, where NA is Avogadro’s number, c is protein
concentration (gm/cm−3), ∆ρ is the contrast difference between solvent and




Figure 2.8: Schematic of ISIS neutron source and the Sans2D detector.
The ISIS neutron source creates high energy protons (800 MeV) via a linear and
synchrotron accelerator. Neutron beams are created by colliding these protons
into tungsten plates (spallation). There are two target stations at ISIS; Target
Station 2 is optimized to deliver longer wavelength and lower energy neutrons
ideal for soft matter and biological experiments. The Sans2d detector is a time-
of-flight, small angle neutron scattering instrument. It contains two detectors
allowing for a typical Q-range coverage of 0.002-3A−1.
The collected data was fitted using SasView software. The data are fit with
two different models. The first is model which assumes the scatterers are of a
cylindrical geometry. The model provides the form factor for a circular cylinder
with uniform scattering length density. The 2-D scattering intensity for oriented




f 2(Q) + b (2.17)
where,












The angle α is the angle between the axis of the cylinder and the Q-vector,
V is the volume of the cylinder, L is the length and r the radius of the cylinder,
∆ρ is the scattering length density difference between the scatterer and solvent
(contrast), b is the background, A is a scale factor and J1 is a first-order Bessel
function. For fitting, the axis of the cylinder is defined by two angles, θ and φ
(see Fig. 2.9 for their definition). The returned fit parameters are A, r, L, ∆ρ,
b, θ, and φ.
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Figure 2.9: Definition of θ and φ used in the fitting of cylinder model to
data. (Image taken from SasView Manual [6].)
The second model used to fit the data is simply a linear combination of two
cylinder models.
The scattering intensity I(Q) is related to the real-space length distribution








where Dmax is the maximum dimension of a scattering unit. In practice, a
finite Q-range with discrete Q-values are explored in an experiment, therefore
the integral above can not be solved exactly. Algorithms have been developed
to indirectly measure P (r) from I(Q). SASview calculates P (r) by using the
method of [157]. In essence, the distribution P (r) is related to a discrete Fourier
sine series. The components of this series are calculated by performing a least-
squares fit to the measured I(Q) signal. The parameters that are free to be
chosen are the number of terms in the Fourier sine expansion, a regularization
term which smooths the resulting P (r) output, and the maximum distance Dmax.
It should be noted that the values of I(0) and Rg as outputs since I(0) is simply




2.2.8 Brief Overview on Stochastic Simulations of Amy-
loid Fibril Formation
In this thesis, in order to interpret the kinetic experimental results we used coarse
grained stochastic simulations that utilize the Gillespie algorithm [158]. The
simulations were coded and executed by K. Eden. Our simulation model consists




kf−→ fj + fi−j (2.21)
Here, fi denotes a fibril of length i and m denotes a protein monomer. We
assume that the shortest possible fibril length is 2 monomer units (i.e. the
“nucleus size” is 2). Reaction (1) represents elongation by monomer addition,
with rate constant k+ (the factor of 2 arises from the fact that monomers can
be added at either end of a fibril). Reaction (2) represents fragmentation of a
fibril into two shorter fibrils: kf is the fragmentation rate, which we assume to be
independent of the position along the fibril at which fragmentation happens.
Note that this reaction also incorporates monomer loss from the fibril ends
(here f1 ≡ m). Nucleation is not explicitly modeled in our system because the
kinetics of insulin fibril assembly are dominated fragmentation (Reaction 2). The
nucleation event becomes important when the system volume is small (pico-liter
scale) [127]. The working experimental volumes are much larger compared to
such system sizes (100 µL). Therefore, fragmentation is the dominant process in
describing the kinetics of assembly and an explicit account of nucleation is not
required to capture the features of the kinetic experimental data.
We find that our simulations best fit our experimental data (in particular for
the scaling of lag time with protein concentration) if all simulations are initiated
with a single dimer present (f2 = 1 at time zero). In our simulations, we track
explicitly the growth and fragmentation of individual fibrils. Each simulation
data point shown represents the average (and standard deviation) of 150 replicate
runs. Typical run-times are on the order of 100,000 seconds. The values of k+
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and kf were obtained by fitting our experimental data to the model of Knowles, et
al. [119], in the low concentration regime (cp ≤ cT ; k+=5x104s−1; kf=1x10−8s−1)
and also for the lowest NaCl concentration (0.1M) (k+=1x10
6s−1; kf=1x10
−8s−1).
These values of the rate constants obtained from fits to the experimental data





Environmental Control of the
Prevalence & Lifetime of
Amyloid Oligomers
3.1 Introduction
A wide variety of peptides and proteins form self-assembled filamentous structures
known as amyloid fibrils. A universal feature of all amyloid aggregates, regardless
of the amino acid sequence or native conformation of the starting peptide or
protein, is the formation of cross-β sheet structure [159, 55, 114, 160]. Amyloid
fibrils are most commonly associated with human diseases such as Alzheimers
Disease and type-2 diabetes [19], however, they are also garnering interest in
biomaterial applications [86, 75, 161, 79, 77, 162, 81, 163].
Understanding the molecular mechanism(s) leading to amyloid fibril assembly
is a key focus of current research. Mechanistic models of amyloid fibril
self-assembly are often tested by monitoring the kinetics of formation using
absorbance or fluorescence spectroscopy. The kinetics of amyloid fibril formation
are typified by a lag phase followed by the onset of rapid growth. This has been
attributed to the formation of a critical nucleus via primary nucleation [49](which
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may be very rapid) followed by growth via fragmentation, heterogeneous
nucleation or branching [115]. This classical picture has been extended to include
subtle effects of protein concentration [164], multi-stage kinetics [165, 166, 167,
168], and models which include competition between multiple pathways [169].
Recent research has focused on the role of fragmentation in fibril formation
kinetics. Xue et al. [170] first noted that fragmentation is central to explaining
the kinetics of β2-microglobulin aggregation, which cannot be described by a
straightforward nucleated assembly model. More recently, analytical results
show that several important features of fibril growth kinetics can be explained
by a model in which fragmentation is the dominant process in fibril assembly
[119, 120, 121, 122]. The classical nucleation picture [116], in which the lag time,
i.e. the duration of the lag phase, is determined by the time it takes to form a
thermodynamically unfavorable critical nucleus, predicts that the lag time should
scale with protein concentration as τlag ∼ c−γcp , where γc = nc+12 [115]. Since the
critical nucleus size nc > 1, in classical models the scaling exponent will always
be greater than unity. In contrast, a model dominated by fragmentation, in
which fibril fragmentation acts as a positive feedback mechanism producing new
ends that can then grow, will exhibit a scaling exponent γfrag ∼ 12 [119]. This
prediction is largely consistent with experimental observation of many known
amyloidogenic protein systems. However, fragmentation-dominated models
predict exponentially decaying fibril length distributions, while the majority
of experimental measurements show distributions peaked at intermediate fibril
length. [171, 172, 173].
Here I resolve this apparent contradiction by presenting a qualitatively new
model for amyloid fibril assembly. Using a series of experiments on bovine
insulin, combined with stochastic simulations, I find evidence to support the
existence of a critical fibril mass concentration (CFC) above which fibrils undergo
a structural transition that suppresses fragmentation. I attribute the onset
of arrested fragmentation to a transition of the amyloid fibril solution from a
viscous fluid to a viscoelastic gel. Our model predicts the formation of distinct
fibril length distributions for protein concentrations above and below a critical
threshold and I confirm these by experiment. Moreover I show that the concept
of a structural transition that arrests the effects of fragmentation enables us
to successfully predict the influence of environmental conditions on the fibril
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assembly pathway. Our results suggest a possible explanation for the observed
variation in amyloid disease progression among apparently similar individuals:
since the lengths of fibril formed depend critically on the protein concentration
and are influenced by environmental conditions, in some individuals the intra-
and/or inter-cellular environment may favor the formation of predominantly short
and possibly toxic fibrillar species, while in other individuals conditions may
result in benign fibril loads. This work has recently been published in Nature
Communications.
3.2 Results
3.2.1 ThT Fluorescence Assays
The kinetics of bovine insulin amyloid fibril formation were monitored using
ThT fluorescence in 96-well microwell plates coated with a hydrophilic polymer
(§2.2.2). At least 136 replicates were performed for each set of conditions,
resulting in highly accurate results. The inset to Fig. 3.1 shows typical results
from a ThT fluorescence assay of a single microwell plate. I am interested in
primarily two kinetic parameters obtainable from the kinetic traces (averaged
over replicates): the growth rate, kgr, and the lag time τlag. The growth rate,kgr,
is found by fitting a linear function to the points of maximal growth. In turn, the
lag time is obtained by extrapolating this fit line to time-axis. This is illustrated in
Fig. 3.1. There are many definitions of the lag time in the literature [168, 39, 123]
but this definition was adopted to compare results with [119].
It should be noted how reproducible the kinetics are between wells during
a given experiment (Fig 3.1, inset). Previous reports have shown the lag times
measured for identical protein samples to vary by as much as hours, and this has
been attributed to the stochastic nature of the nucleation process [123, 10] (see
§1.4.3): in our experiments, due to careful control of experimental conditions, the
variation in the lag time has been reduced to minutes (see Appendix B for lag time
distributions). Our method thus enables us to identify subtle changes in insulin
amyloid fibril growth kinetics upon changing the experimental parameters. While
considerably reduced, itt should be noted that there still exists some variation
between replicate experiments. Such variation is not completely understood,
however, a proportion may be due systematic errors introduced by pipetting
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Figure 3.1: Representative kinetic trace for insulin amyloid fibril
formation as monitored by ThT fluorescence. The plot shows a kinetic
trace that has been normalized to its maximum. A linear function is fit through
the region of maximum growth. The growth rate is defined as the slope of the
fit curve. The lag time is determined by extrapolating the fit curve to the time-
axis. Inset shows well-to-well variation in the kinetics of insulin amyloid fibril
formation. Replicate experimental kinetics curves show the variability typical of
replicate experiments within a microwell plate, for an insulin concentration of 1.5
mg/ml.
errors, or imperfectly homogeneous heating of the samples (see Appendix A).
3.2.1.1 Kinetics of unagitated samples
I performed a set of kinetic measurements without any agitation of the plate
during the time course of fibril assembly. Initial insulin concentrations ranged
from 0.1 mg/ml up to 4 mg/ml. A fluorescence reading was recorded at 10
minute intervals for all experiments. A plot of the mean lag time as a function
of insulin concentration is shown in Fig. 3.2. The red solid line in Fig. 3.2 is a
fit of the data to a power law function of the form y = axb. I find the scaling
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exponent, γ, is -0.37 ± 0.02. Since γ < 1, the data are broadly consistent with a

















Figure 3.2: Lag time vs. insulin concentration for unagitated samples.
Each data point in the plot consists of 140-200 individual experiments carried out
in several microwell plates. The plates were not agitated during the time course
of fibril assembly. Lag times are plotted as a function of insulin concentration on
a log-log plot. The data is fit with a generic power law function y = axb. The
scaling exponent γ, is -0.37 ± 0.02. Data points show mean ± s.d.
I am also interested in how the rate of growth of ThT fluorescence, which I will
call kfluo, varies with insulin concentration. This trend is shown in Fig. 3.3. There
are two interesting features to this plot. Firstly, in a ‘low’ concentration regime
(from 0.1-0.4 mg/ml), kfluo increases linearly with concentration. Secondly,
however, at ∼ 0.75 mg/ml this trend becomes non-linear. One can also look
at how the mean maximal ThT fluorescence varies as a function of insulin
concentration (Fig. 3.4). Comparing Fig. 3.3 with Fig. 3.4 is becomes apparent
they exhibit very similar trends. Indeed, both show marked increases in kfluo and
the mean maximal fluorescence above 0.75 mg/ml. This effect is not caused by a
change in the total fibril mass; pelleting the aggregated material by centrifugation
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and measuring the remaining protein in the supernatant by UV-Vis spectroscopy
confirmed that more than 99% of the total insulin present is in the pellet regardless
of the initial protein concentration ( see §2.2.3).































Figure 3.3: Maximum rate of fluorescence increase vs. insulin
concentration for unagitated samples. The rate of maximum fluorescence
increase, kfluo, was determined as shown in Fig. 3.1. Plot shows kfluo as a
function of insulin concentration. From 0.1-0.75 mg/ml there is a linear trend;
between 0.75 and 1 mg/ml a sharp increase in fluorescence is observed. Data
points show mean ± s.d.
3.2.1.2 Kinetics of agitated samples
Since the model of [119] relies on fragmentation as being the key driving
mechanism in fibril assembly I wished to further test this idea using our
experimental methods. I performed a second set of experiments, identical to
those performed in the previous section, but now with addition of plate agitation
during fibril assembly. The plates were shaken at 600 rpm in a double orbital
motion for two minutes with a total cycle time between fluorescence readings of
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Figure 3.4: Mean maximum fluorescence vs. insulin concentration
for unagitated samples. The maximum fluorescence values show similar
characterstics as in Fig. 3.3: a sharp increase in the maximum fluorescence
value between 0.75 and 1 mg/ml. Data points show mean ± s.d.
10 minutes (see §2.2.2.1 and Appendix A). I performed this additional shaking
step because Xue and co-workers showed that this results in fibril fragmentation
[170]. Again, I can observe at how the lag time scales with protein concentration
(Fig. 3.5). In the presence of agitation I find a scaling exponent of −0.50 ± 0.03.
Indeed, this is in excellent agreement with the prediction of the model of Knowles
et al..
The trends in kfluo and the mean maximal fluorescence as a function of
concentration are plotted in Fig. 3.6 and Fig. 3.7. Comparing the agitated
results to the unagitated ones, I find that the growth rates and fluorescence are
greater, but the overall trends are very similar. One can surmise that agitating
the samples results in a more efficient means of fragmenting the fibrils, but the
underlying mechanisms of fibril assembly, between the two data sets, are the same.



















Figure 3.5: Lag time vs. insulin concentration for agitated samples. The
plates were agitated in a double orbital motion at 600 rpm for 2 minutes for all
experiments. Lag times are plotted as a function of insulin concentration on a
log-log plot. The data is fit with a generic power law function y = axb. The
scaling exponent γ, is -0.50 ± 0.03. Data points show mean ± s.d.
of both agitated and unagitated samples, see Appendix C.
3.2.1.3 Emergence of two concentration regimes
What becomes apparent by looking at the results above is that: 1) a model
of fragmentation dominated fibril assembly provides a fair description of the
kinetics of insulin amyloid fibril formation (particularly in the lag time) and 2)
the emergence of two apparently distinct kinetic regimes as a function of initial
insulin concentration. As is shown in Fig. 3.3 and Fig. 3.6, kfluo is linear in a
concentration range from 0.1-0.4 mg/ml but becomes non-linear at concentrations
above 0.75 mg/ml. Furthermore, since the mean maximal fluorescence trends
similarly to kfluo (i.e. in a non-trivial way) it would be informative to refer to a
growth rate which is independent of the fluorescence growth rate. To decouple
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Figure 3.6: Maximum rate of fluorescence increase vs. insulin
concentration for agitated samples. The rate of maximum fluorescence
increase, kfluo, was determined as shown in Fig. 3.1. Plot shows kfluo as a
function of insulin concentration for agitated samples. I find a non-linear trend
emerges ∼ 0.75 mg/ml. Data points show mean ± s.d.
the growth rate measurements from the changes in maximal fluorescence, the
growth curves were normalized to their maximal values and the maximal growth
rate, kgr, was extracted. To ensure that the fluorescence growth rates that
are measured are not artifacts of some fluorescence anomaly we simultaneously
measured absorbance. Fig. 3.8 shows kfluo plotted against kabs. What is clear is
that the measured fluorescence rate is correlated well to the measured growth rate
from absorbance. This gives confidence that kgris not influenced by fluorescence
artifacts.
The emergence of these two concentration regimes becomes all the more
apparent when kgr is plotted as a function of insulin concentration (Fig. 3.9). It
is clear that for protein concentrations greater than 0.75 mg/ml the growth rate
becomes nearly independent, if not slightly decreasing, with insulin concentration.
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Figure 3.7: Mean maximum fluorescence vs. insulin concentration
for unagitated samples. The maximum fluorescence values show similar
characterstics as in Fig. 3.6: a sharp increase in the maximum fluorescence
value ∼ 0.75 mg/ml. Data points show mean ± s.d.
Perhaps more importantly, Fig. 3.9 also shows the predicted growth rate from
the model of [119] (blue triangles). This plot was obtained by performing
simulations based upon the model of [119] using kinetic parameters obtained
from our experiments at low insulin concentrations. What is strikingly clear
is that at a concentration of 0.75 mg/ml there is a marked deviation between
the experimentally obtained growth rates and those predicted by the model. The
insulin concentration at which we observe this deviation from the model is defined
as ‘threshold’ concentration, or cT .
3.2.2 Circular Dichroism of Insulin Amyloid Fibrils
It is conceivable that the sudden order-of-magnitude increase in fluorescence (Fig.
3.4, Fig. 3.7) is due to structural or morphological differences (presumably
affecting the binding of the fluorophore) between fibrils formed at ‘high’ and
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Figure 3.8: kfluo as a function of kabs. We measured the ThT fluorescence and
absorbance during insulin amyloid fibril formation for 1 mg/ml insulin. We find
that the measured rates in both techniques are well correlated.
‘low’ insulin concentrations. Moreover, the action of agitating the samples may
have a demonstrable affect upon the structural characteristics of fibrils formed
under those conditions since the fluorescence increase is even greater in those
experiments. It is known that the structural characteristics of amyloid fibrils
are important in the binding of ThT [47, 48, 46]. For example, it has been
shown that glucagon fibrils formed at ‘high’ (> 1 mg/ml) and ‘low’ (< 1 mg/ml)
protein concentrations demonstrate markedly different structural characteristics
and ThT fluorescence emission signals [58]. In order to investigate whether
there are measurable structural differences between fibrils formed at different
concentrations in our experiments I measured circular dichroism (CD) spectra
of insulin amyloid fibrils prepared at concentrations between 0.25 mg/ml and 4
mg/ml, i.e., above and below cT (see §2.2.7.1). I find that the spectra of the fibrils
prepared at high (1-4 mg/ml) and low (0.25-0.75 mg/ml) protein concentrations
are qualitatively different(Fig. 3.10). Indeed, there is a striking transition in
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Figure 3.9: Normalized growth rate as a function of insulin
concentration: predicted and experimental Kinetic curves were normalized
to their maxima and the normalized growth rate, kgr were extracted the same
manner as determining kfluo. There is a linear increase in kgr between 0.1 and
0.4 mg/ml; for concentrations greater than 0.4 mg/ml kgr reaches a plateau (red
circles). For comparison, the predicted kgr from a fragmentation dominated model
is shown (blue triangles). Data points show mean ± s.d.
the circular dichroism signal between 0.75 and 1.5 mg/ml, consistent with the
transition seen in our fluorescence measurements. At low concentrations (<0.75
mg/ml) I attribute the gradual decrease in the CD spectra to changes to fibrillar
association, that is, from single filaments to double [7]. Above 1 mg/ml I ascribe
the contrasting increase in signal to a structural transition similar to that observed
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Figure 3.10: CD spectra of insulin amyloid fibrils formed at initial
protein concentrations above and below cT. Plotted are the molar
ellipticities at the minimum (218 nm) of the CD spectra (inset) as a function
of the insulin concentration. The inset shows the CD spectra for insulin amyloid
fibrils formed from 0.25 mg ml−1 (black), 0.5 mg ml−1 (red), 0.75 mg ml−1 (blue),
1 mg ml−1 (pink), 2 mg ml−1 (green), 4 mg ml−1 (orange). There is a striking
cross-over between regimes reflected in the CD signal above and below 1 mg ml−1
insulin coincident with where the kinetic transition occurs. At low concentrations
(<0.75 mg ml−1) I attribute the gradual decrease in the CD spectra to changes in
the filament organization with increasing protein concentration (i.e. from single
filaments to double [7]). Above 1 mg ml−1 I ascribe the contrasting increase
in signal to a structural transition similar to that observed for small aromatic
molecules on changing from the solution to the crystalline state [8]
3.2.3 Microrheology of insulin amyloid fibrils
To better understand this deviation from the predicted growth behavior I
performed bead tracking microrheology on amyloid fibril samples obtained from
a range of insulin concentrations that had been incubated for 24 hours (see
§2.2.6.3). I find a transition from a liquid to a highly viscous fluid state for fibrils
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formed at protein concentrations above 0.75 mg/ml (Fig. 3.11; see §2.2.5). Taken
together, these findings lead us to propose that there exists some critical fibril
mass concentration, or ‘CFC’, above which fibril-fibril assembly, bundling, and/or
gelation dominates [137, 174] and as a consequence fragmentation is suppressed.












































Figure 3.11: 2D MSD of insulin amyloid fibril solutions shows a
transition to a gel-state at 0.75 mg/ml. The mean square displacement
(MSD) of 1 µm beads are shown for a range of insulin concentrations: buffer
control (squares), 0.09 mg/ml (circles), 0.18 mg/ml (triangles), 0.375 mg/ml
(diamonds), 0.75 mg/ml (hexagons), 6 mg/ml (stars). For particles undergoing
Brownian motion, the MSD scales as 〈r2〉 ∼ tα, where α is the scaling exponent.
Black line indicates α=1. For concentrations below 0.75 mg/ml the insulin
amyloid fibril solutions exhibit the characteristics of a viscous fluid. At 0.75
mg/ml, the MSD scaling exponent drops from 1 to ∼0.2 indicating a transition




3.2.4 Stochastic Simulations of Amyloid Fibril Assembly
To investigate the idea that above a critical fibril concentration (CFC) fragmen-
tation becomes arrested we performed stochastic simulations of fibril assembly.
We performed stochastic simulations of a fragmentation-dominated model of fibril
growth (§2.2.9). The kinetic parameters used in the simulation were obtained by
fitting our experimental data at low protein concentrations to analytical results
derived by Knowles et al.[119]. This resulted in elongation and fragmentation
rates of 5x104M−1s−1 and 1x10−8s−1, respectively (for details see §2.2.9). For
low protein concentrations we find that the values of kgr predicted by these
simulations are in good agreement with our experiments. For high protein
concentrations, however, our simulations of the fragmentation-dominated model
fail to match our experimental results (c.f. Fig. 3.9). To test our hypothesis that a
structural transition is involved we modified our simulations so that fragmentation
is arrested when the total fibril mass concentration exceeds a critical value (the
CFC). In our simulations, a value for the CFC of 0.4 mg/ml reproduces our
experimental results for kgr very well over the entire protein concentration range.
We re-plot Fig. 3.9 now with the addition of our simulations with a CFC (Fig.
3.12).
A natural question is how does the CFC value relate to the observed
‘threshold’ concentration, cT ? Intuitively, for the CFC to have an effect on kgr,
the CFC must be reached before kgr. The maximum growth rate usually occurs
at approximately 50% of the total aggregation (c.f. Fig. 3.1). Therefore, the CFC
must always be at most half the total concentration of initial protein. Therefore,
the threshold concentration cT must be twice the CFC value. The observed
transition occurs ∼ 0.75 mg/ml which corresponds to a CFC of ∼0.375 mg/ml.
As stated above, we find a CFC of 0.4 mg/ml best matches our experimental
data; this corresponds well with the anticipated value.
3.2.5 Transmission Electron Microscopy of Insulin Amy-
loid Fibrils & Length Distributions
A strong prediction which comes out of this model is that the final fibril length
distributions in the long time limit should be markedly different at high and
low initial protein concentrations. For initial protein concentrations less than cT ,
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Figure 3.12: kgr as a function of insulin concentration: comparing
experiment and simulation. With the addition of the CFC into the simulation,
we find a close agreement betweens simulation (black squares) and experiment
(red circles). For comparison, the prediction from the model is shown without a
CFC (blue triangles).
fibrils continue to fragment throughout the simulation, and in the long-time limit
the fibril length distribution is exponential and dominated by short fibrils, as
predicted by fragmentation-dominated models (Fig. 3.13(B)). In contrast, when
the initial protein concentration is greater than cT , the mass concentration of
fibrils exceeds the CFC at some time during the exponential growth phase so that
fragmentation ceases. This results in a log-normal fibril length distribution with
a clear peak at intermediate fibril lengths, in agreement with many experimental
observations (Fig. 3.13(A)). Thus, when the protein concentration cp is greater
than cT the length distribution is prevented from collapsing due to a structural
transition that suppresses the action of fragmentation.
To test these predictions I used transmission electron microscopy (TEM)
to obtain length distributions for amyloid fibrils formed at initial protein
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Figure 3.13: Fibril length distributions obtained by simulation Fibril
length distributions obtained by simulation (A) above cT (4 mg/ml) and (B)
below cT (0.2 mg/ml). We express the fibril length in terms of the composite
parameter κ/kf . Our simulations do not make absolute predictions of fibril
length because the choice of values of k+ and kf is not strongly constrained
(§2.2.9), whereas the shape of the length distribution (plotted as a function of
monomer units × kf/κ ) is independent of this choice. The length distribution
in (A) is best described by by a log-normal distribution; (B) is well-fitted by an
exponential distribution (black fit lines).
concentrations above and below our predicted cT of 0.75 mg/ml (4 mg/ml and
0.2 mg/ml, respectively. See §2.2.5.1). A representative image is shown in
Fig. 3.14. Using images acquired from TEM, lengths were determined using
ImageJ software. The resulting length distributions are shown Fig. 3.15. Our
experimental results are in close correspondence with our simulation predictions:
indeed, I observe an exponential distribution of fibril lengths when the protein
concentration is below cT and a peaked distribution for protein concentration
above cT (Figs. 2A,C). Many other studies have reported peaked fibril length
distributions [171, 172, 173]. I hypothesize that a structural transition may also
69
3.2. Results
be operating in these systems, and that these experiments may have been carried
out in the high protein concentration regime where cp > cT .
A B
Figure 3.14: Representative TEM images of insulin amyloid fibrils
formed above and below the CFC. Images of insulin amyloid fibrils formed
from initial insulin concentrations of (A) 0.2 and (B) 4 mg/ml. See Fig. 3.15 for
corresponding length distributions. Scale bar is 1 µm.
3.2.6 Addition of NaCl & Effect on the Kinetics
Our model further allows us to rationalize non-trivial changes in the kinetic
curves when the environmental conditions are altered. It is well known that the
addition of salt screens electrostatic charge, thereby decreasing the Debye length
and influencing protein-protein interactions [175]. As a model environmental
perturbation, I therefore repeated our kinetic experiments in the presence of
increasing concentrations of NaCl.
Fig. 3.17 shows kgr as a function of insulin concentration for a range of
NaCl concentrations. It is clear that adding NaCl results in complicated and
non-monotonic trends in the kinetics of fibril growth. While these trends are
not readily captured by variation of the parameters in fragmentation-dominated
models, our simulations in which a structural transition is included are in excellent
agreement with the data if one makes the simple assumption that salt affects
both the elongation rate (k+) and the CFC, but not the fragmentation rate.
The results of our simulations are shown in Fig. 3.18. Firstly, the increase
in growth rates between 0 M and 0.1 M NaCl is consistent with a ∼ 20 fold
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Figure 3.15: Fibril length distributions extracted from TEM (A) above
cT (4 mg/ml, N=159, bars) and (B) below cT (0.2 mg/ml, N=75, bars). As
predicted by the model, fibrils formed at protein concentrations below the CFC
are significantly shorter (mean length of 231.5 ± 230.4 nm) and the distribution
is exponential (black curve). Length distributions above cT show a log-normal
distribution (black curve) with a mean fibril length of 2441.5 ± 1590.3 nm (mean
± s.d.). Experimental and simulation data points show mean ± s.d.
enhancement of the fibril elongation rate to 1x106s−1. Secondly, we capture
the complex, salt-dependent and non-monotonic trends of the growth rate with
protein concentration in Fig. 3.17 by allowing the CFC to decrease with salt
concentrations above 0.1M. It should be emphasized that the changes in the
simulated curves at 0.25-0.5 M NaCl arise only from a change in the CFC; the
elongation rate is held constant at 1x106s−1. Further increasing the elongation
rate does not account for the complex behavior observed in Fig. 3.17; the
presence of a structural transition in the model is essential in order to explain
the experimental data. Further evidence to support the hypothesis that salt is
shifting the CFC to lower values is found in Fig. 3.16. I find that the non-linearity
in the ThT fluorescence occurs at lower and lower insulin concentrations as the
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NaCl concentration is increased. This is evidence for the fact that the CFC value
decreases with increasing NaCl concentrations.
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Figure 3.16: The trends in maximum ThT fluorescence as a function of
concentration and NaCl. Plotted are the mean maximum ThT fluorescence
values, as a function of insulin concentration, for (A) 0.1 M, (B) 0.24 M, (C)
0.34 M, and (D) 0.49 M NaCl concentrations. I find that the concentration
at which the non-linearity in the ThT fluorescence occurs at decreasing insulin
concentrations as the NaCl concentrations is increased. This observation can be
explained by positing that the CFC is shifting to lower concentrations.
It should be noted that the plateau in the elongation rate with increasing
salt concentration is not the result of reaching the diffusion limit. A simple
calculation yields a diffusion-limited growth rate on the order of 1x109M−1s−1
which is several orders of magnitude below our experimentally obtained growth
rate. The value obtained above can be understood by positing that the addition
of monomer to the growing fibril end becomes limited by the time scale for the
monomer to adopt the correct conformation to allow the next monomer to attach
[176, 177].
Our structural transition model also helps us to understand how the lag time,
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Figure 3.17: Experimental kgr as a function of insulin concentration with
the addition of NaCl. Growth rates obtained from normalized traces plotted as
a function of insulin concentration for NaCl concentrations of 0M (black squares),
0.1M (red circles), 0.24M (blue triangles), 0.34M (dark cyan diamonds), and
0.49M (pink stars).
τlag, varies with salt concentration. The results of both simulation and experiment
(Fig. 3.19, Fig. 3.20) show that as the salt concentration increases, the lag
time becomes more protein concentration-dependent. This makes sense since
our simulations indicate that adding salt has the two-fold effect of increasing
the elongation rate and shifting the CFC to lower values, so that at high salt
concentrations τlag is dominated by the concentration-dependent process of fibril
elongation rather than the concentration-independent process of fragmentation.
However, a curious feature of the data is that the experimental lag times for 0.1
M NaCl scales more weakly than the experiments performed without salt; this
feature is not captured by our simulations. More works needs to be done to better
understand this behavior. It should be noted that the concentration range over
which we explored the scaling of the lag-time may be insufficient to capture the
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Figure 3.18: Simulated kgr obtained by varying the elongation rate
and the CFC. Parameters used in the simulations were CFC = 0.4 mg/ml,
k+=5x10
4M−1s−1 (squares); CFC= 0.4 mg/ml, k+=1x10
6M−1s−1 (circles); CFC
= 0.2 mg/ml, k+=1x10
6M−1s−1 (triangles); CFC = 0.1 mg/ml k+=1x10
6M−1s−1
(diamonds); and CFC = 0.05 mg/ml, k+=1x10
6M−1s−1 (stars). For all
simulations kf was 1x10
−8s−1.
entire kinetic picture. It is not impossible that the observed scaling exponents
are merely ‘apparent’ exponents. As has been shown clearly, fragmentation is
still an active feature in the kinetics and therefore a scaling exponent of -0.5 may
be recovered if a larger concentration range was explored.
3.2.6.1 Adding NaCl During the Time Course of Self-Assembly
If our model correctly represents the molecular mechanism of fibril assembly then
it should be able to predict what happens when the conditions are changed during
the process of fibril assembly. In the absence of a structural transition, one
would expect that adding salt at any time before the point of maximal growth























Figure 3.19: Lag times as a function of insulin concentration in the
presence of NaCl. The data are fit same generic power law function as above.
The resulting scaling exponents are−0.27±0.01 (0.1M NaCl, circles), −0.56±0.05
(0.24M NaCl, triangles), −0.65 ± 0.04 (0.34M NaCl, diamonds), −0.75 ± 0.06
(0.49M NaCl, stars).
because adding salt increases the fibril elongation rate, which plays a major role
in determining the growth rate in fragmentation-dominated models. Plotting the
growth rate as a function of the time salt is added, one would therefore expect to
obtain results that follow the dashed line in Fig. 3.21. However, in a model with
a structural transition, salt should not influence the kinetics if it is added after
the structural transition has happened - i.e. after the fibril mass has exceeded
the CFC. One would therefore expect to obtain the red line in Fig. 3.21. Indeed,
this prediction is realized in our experiments. Based on our simulation results,
the predicted CFC for the 0.3M salt concentration used in these experiments is
0.1 mg/ml, and that the CFC should be reached at approximately 110 minutes.
Indeed, I find that adding NaCl at any time before the predicted CFC is reached






















Figure 3.20: Lag times as a function of insulin concentration obtained
by varying the elongation rate and the CFC. Parameters used in the
simulations were k+=1x10
6M−1s−1 and kf =1x10
−8s−1. The scaling exponents
are −0.43(circles) −0.55 (triangles), −0.59 (diamonds), and −0.65 (stars) when
the CFC is 0.4 mg/ml, 0.2 mg/ml, 0.1 mg/ml and 0.05 mg/ml, respectively.
adding salt has no effect - i.e. our experiments indeed follow the red line rather
than the dashed line in Fig. 3.21.
3.2.6.2 Implication for the existence and prevalence of small, oligomeric
amyloid species
Small molecular weight species, including short fibrils, that are present during the
assembly of amyloid fibrils are of particular interest because they are thought to
be the causative agents of toxicity [178, 179, 180, 181]. Our model makes a strong
prediction that the prevalence of short fibrils should be very different for initial
protein concentrations above and below the critical threshold. Fig. 3.22 shows
the prevalence of short fibril species in our simulations as a function of time. For
cp > cT we predict the transient formation of a small population of short fibrils,
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time NaCl added (min)
CFC
Figure 3.21: The influence of environment on the growth kinetics. A
series of 1.5 mg/ml insulin samples were incubated simultaneously. At specific
time points during the kinetics of self-assembly (every 30 minutes), NaCl was
added to three samples. The mean value of kgr from the resulting kinetic traces of
each group of samples are plotted against the time at which the NaCl was added
(squares). To illustrate where on the kinetic profile the NaCl was added, the
kinetic trace for the control is also shown (triangles). The grey box corresponds
to the mean kgr ± s.d. for this salt-free control. In the absence of any structural
transition, we would expect to observe the behavior shown by the dashed line,
with enhanced growth rates during the early stages of fibril assembly, returning
to control values if salt is added after the point at which kgr is measured (∼160
min). With the existence of a CFC, we would expect instead the trend in kgr as
shown by the solid line; the decrease in kgr now occurs the moment the CFC is
reached. Indeed, we observe that kgr decreases to the control value when salt is
added at any time after 120 minutes, consistent with the sample having reached
the CFC, which for 1.5 mg/ml insulin under these conditions we estimate to occur
at 110 minutes.
peaking approximately half-way through the exponential growth phase before
returning to low levels (Fig. 3.22(B)). When cp < cT , however, the prevalence
of short fibrils is much greater and increases with time (Fig. 3.22(A)). Thus the
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structural transition has a dramatic influence on the prevalence of potentially
cytotoxic species during amyloid fibril assembly.
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Figure 3.22: Oligomer population as a function of time. The number of
short fibrils, of ≤ 1000 monomer units, plotted as a function of time (red squares);
kinetic traces of the total fibril mass (scaled arbitrarily) are also show (black
lines). (A) At cp= 0.2 mg/ml, the protein concentration is below cT and large
number of short fibrillar species persist for long periods of time. (B) At cp=0.55
mg/ml, a maximum in short species occurs at a time of approximately 50%
assembly completion. Once the CFC is reached and the structural transition takes
place, this population diminishes due to the suppression of fragmentation. The
simulations are stochastic and the data points are the average oligomer number
of 150 runs; the error bars are the standard deviation of the mean.
3.3 Discussion
The key finding in this study is the identification of a critical fibril mass concen-
tration above which insulin amyloid fibrils undergo a structural transition that
suppresses fragmentation. By incorporating this feature into our computational
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models we are able to successfully simulate the complex behavior that we observe
in our kinetic experiments under a variety of solution conditions. Indeed, the
length distributions we found from simulation and TEM experiments for fibrils
formed above the critical concentration are similar to those found in previous
experiments [171, 172, 173] while both simulations and our TEM experiments
show very different, exponential-like length distributions at protein concentrations
below the predicted structural transition.
It has become the general consensus that small oligomeric aggregates are
the causative agents of cytotoxicity [178, 179, 180, 181, 41] while the mature,
long fibrils are the inert end product of assembly [182, 183]. Importantly, Xue
and co-workers have demonstrated that it is not just the oligomers formed
during self-assembly that are toxic, but that short fibrils generated through
the fragmentation of mature fibrils also cause cell death [184]. Intriguingly,
multiple studies have shown that there is no direct correlation between fibril
load within tissue (i.e. mass of long fibrillar material) and loss of function
([185, 186, 187, 188, 189, 190, 182, 183]) Indeed, it has been shown that
a significant fraction of members of the Nun study [191] possessed neuritic
β-amyloid plaques and neurofibrillary tangles at the time of death without
exhibiting any cognitive dysfunction. The observation that in some cases fibrils
can be present but not cause measurable functional impairment could be due
to amyloid fibril assembly pathways that favor the rapid formation of longer
inert fibrils as a result of the local intracellular environment. Our observation of
two distinct length distributions that are determined only by the environmental
conditions, one of which is comprised of long, potentially inert fibrils microns in
length while the other is dominated by very short, possibly toxic, fibrillar species,
may have consequences for determining the propensity of intracellular conditions
to bias toward either benign or cytotoxic fibrillar loads.
To this end, we have shown that salt concentration has a strong impact on
the value of the critical fibril mass concentration. Higher salt concentrations
shift the CFC to lower values, stabilizing the length distribution for lower initial
concentrations of protein. In our study we chose salt as a tool to alter protein-
protein and fibril-fibril interactions, but any additive or solution condition that
can affect the charge characteristics or protein structure, such as pH, temperature,
or the presence of hydrophobic surfaces, could affect the value of CFC. This could
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have far-reaching consequences for toxicity in intracellular environments, where
salt gradients, pH differences, the presence of chaperones and other co-factors
could bias toward the formation of toxic or non-toxic fibrillar species.
It should be noted that the trend we nominally observe of kgr as a function of
concentration has been observed for a number of polymerizing fibrillar proteins,
in particular insulin, bovine lactalbumin [192], and yeast prion protein [76]. In
these cases, above a certain concentration of protein, the scaling of the growth
rate becomes effectively zeroth-order. Formally, such behavior can be understood
as an analogue of enzyme reaction kinetics described by a Michaelis-Menten
type model. In this case, the substrate is the reactive monomer species and the
enzyme is the fibril end. A concentration independent reorganization step occurs
after monomer binding to the fibril end resulting in the apparent concentration
independence in the observed growth rate. This observation does not negate
the interpretation of the data as presented but serves as a complement to the
phenomena that is described in this chapter. Indeed, the fact that kgr seems to
decrease with increasing insulin concentration is consonant with our model and
could not be captured by a Michaelis-Menten type model.
Interestingly, Taylor et al. map the level of Aβ(1-40) cytotoxicity to the
kinetic profile of fibril formation [9], reporting a peak in cytotoxicity during the
exponential growth phase of assembly (Fig. 3.23). After this peak is reached,
cytotoxicity decays back to baseline levels at the point in the kinetic profile where
fibril assembly approaches and reaches the final plateau. The results of Taylor
et al. may be interpreted in the context of our structural transition model: a
population of small molecular weight species is generated through fragmentation,
and then depleted by the combined influence of fragmentation inhibition due to
a structural transition and fibril elongation. Applying our model to the data
presented in [9] we would predict the CFC for Aβ(1-40) to be approximately
0.15 mg/ml(∼ 35µM) under these experimental conditions. In our simulations
at high protein concentrations, the prevalence of short, potentially cytotoxic
oligomeric species shows very similar kinetics to the kinetics of cytotoxicity
reported by Taylor et al (Fig. 3.22(A)). For simulations in which the initial
protein concentration is above the CFC we find an analogous peak in small
molecular weight species mid-way through the exponential growth phase which is
followed by a decay back to baseline levels. In contrast, when the concentration
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of protein is below the cT , the residence time of small, potentially toxic species
is significantly longer: indeed they remain present in high abundance even at
very long times (Fig. 3.22(B)). This could have profound consequences for the
propensity for cellular damage or death when intracellular conditions are such
that short fibrils are the more likely species to be present. If this is indeed the
case, then it may be possible to devise therapeutic measures that take advantage
of these insights to alter cellular conditions so as to bias toward the accumulation
of longer inert fibrils and away from the shorter toxic species.
A B
Figure 3.23: A measure of cytotoxicity as a function of time during Aβ(1-
40) fibril formation. (A)Taylor et al. quantified cytotoxicity by measuring
SYTOX green uptake by human epithelial cells (SH-EP1). SYTOX green is only
taken into the cell when the cell membrane becomes permeable. Upon uptake,
SYTOX green binds to nucleic acids and has a marked increase in fluorescence
intensity. (A) shows the level of SYTOX green fluorescence as a function of Aβ(1-
40) fibrillation time. (B) is a plot Aβ(1-40) fibril formation kinetics as monitored
by turbidity at 405 nm. One observes that a peak in cytoxicity in (A) occurs at
approximately the point of maximum aggregation in (B). Taken from [9].
Amyloid and amyloid- like fibrils have also received attention for their
potential use as biomaterials or components in composite materials (see §1.3.5,
[163]). For example, Reches and Gazit have used fibrils to template metal
nanowires [77], Channon et al., has used them as the basis for light harvesting
structures [86], and a number of authors (e.g. Zhang [75, 161] and Gras et al. [66])
have used them as the basis for cell scaffolds. A significant challenge remains in
controlling the length distribution of fibrils, and the viscoelasticity of the resulting
hydrogel. Our current findings suggest mechanisms for manipulating both, and
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for predicting and controlling the homogeneity of the resulting population.
The exact nature of the structural transition has yet to be determined.
Certainly, the CD spectral data is indicative that there is potentially a complex
conversion of fibril architecture taking place. Chapter 4 will begin to attempt
to address this issue by studying fibril formation using small angle neutron
scattering. It remains an experimental and theoretical challenge to understand
the fundamental origin for the observed transition, and the subsequent arrest of
fragmentation, that we see in our experiments.
Figure 3.24: Schematic of amyloid fibril assembly with the presence of
a CFC. Amyloid fibrils grow by monomer addition to the ends of the fibrils.
Fibril fragmentation multiplies the number of free ends by which monomer may
attach. For concentration below the the critical threshold concentration, cT ,
fragmentation is never arrested. The result are short fibrils at long times.
In contrast, when the concentration is above cT , fibril-fibril association arrests




We have shown evidence for a structural transition which occurs at a critical
fibril mass concentration, or ‘CFC’, above which fragmentation of the fibrils
is suppressed. Fig. 3.24 is a schematic of the features of this model. Our
simulations predict the formation of distinct fibril length distributions for protein
concentrations above and below a critical threshold, which we confirm by electron
microscopy. These results point to a new picture of amyloid fibril growth in
which structural transitions that occur during self-assembly have strong effects
on the final population of aggregate species with small, and potentially cytotoxic,
oligomers dominating for long periods of time at protein concentrations below
the critical threshold, but not for protein concentrations above the threshold.
We further show that the CFC can be modulated by environmental conditions,
pointing to possible in vivo strategies for controlling cytotoxicity.
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Chapter 4
Neutron Scattering Studies of
Insulin Amyloid Fibril Formation
4.1 Introduction
In Chapter 3 we observed the existence of a structural transition where the
physical mechanisms that drive amyloid fibril assembly are altered due to a
physical arrest of the system. The exact mechanism of why fragmentation
becomes suppressed has yet to be determined. It could be due to fibril thickening
and/or bundling via fibril-to-fibril interactions [137], the formation of a gel-like
entangled network of fibrils [174], the association of fibrils into larger macro-
fibrillar assemblies such as spherulites [193, 194], or a combination of these
processes. The ultimate goal is to understand, on a mechanistic level, this
structural transition. Small angle neutron scattering (SANS) is well suited to
address these questions because it provides a means to study in situ the evolution
of structural changes in the aggregates in a time-resolved manner over a range of
length scales from angstroms to hundreds of nanometers. A secondary advantage
is that SANS allows one to carry out time-resolved biological experiments without
fear of significant radiation damage to the sample (i.e. as can be a problem
with SAXS). SANS has been used to study the evolution of aggregates of
insulin amyloid fibril assembly [195, 196] and other protein amyloid systems
[111, 197, 198]. In this Chapter I present initial results obtained from experiments
performed on the Sans2D instrument at ISIS, Rutherford-Appleton Laboratory
(see §2.2.7.2 for details on this instrument). We measured the aggregation of
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insulin into amyloid fibrils, in a time-resolved manner, over a wide Q-range (0.005-
0.8 Å−1) so that the structural evolution of the aggregates could be monitored and
characterized over multiple length scales in order to shed light on the mechanisms
of the structural transition we observed in Chapter 3.
4.2 Results
4.2.1 Time-resolved SANS of 4 mg/ml insulin amyloid
fibril samples
We can model the expected neutron scattering signal for insulin under our
experimental conditions (see §2.2.8.3). We expect insulin to predominately be
monomeric [39, 199]. So that a theoretical scattering curve can be obtained, we
can geometrically approximate the insulin monomer can be modeled as a cylinder
with a length L=30 Åand radius r=11 Å(the dimensions of which are obtained
from crystal structure of an insulin monomer (PDB 1GUJ), Fig. 4.1). The
results are shown in Fig. 4.2. Using these dimensions one can obtain the radius









which yields a value of (11.6 Å). This result is in good agreement with both
experiment values (11.9 Å[39]) and simulation (10-13Å) [200, 201]. While it
is a fair approximation to model the system purely as monomers, it must be
acknowledged that in reality a solution of insulin is not entirely monodisperse. It
has been shown that even at t = 0, there exists a distribution of not only oligomers
but also multiple conformations of each species [201]. With this in mind we may
attempt to fit the experimental scattering curves at t=0 to this approximate
cylindrical model (§2.2.7.3) Fig. 4.3 is the neutron scattering signal for a 4 mg/ml
insulin sample at the beginning of a kinetic run. We find a close agreement
between the cylindrical model and the observed signal. Fitting this signal with a
cylindrical model yields Rg = 11.67 ± 0.98Å. Despite the polydispersity at early
stages of the kinetics, this simple cylindrical model of the monomer fits well to
the data.
We monitored the kinetics of fibril assembly over the course of several hours.
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Figure 4.1: Dimensions of the insulin monomer. Shown is a cartoon of the
insulin monomer taken from PDB 1GUJ. The dimensions used for the theoretical
Rg are r=11 Åand L=30 Å. The helices are green, coil are red, turns are blue.
Surrounding the cartoon is the surface representation of the protein where yellow
is the A-chain and white is the B-chain.
The resulting neutron scattering profiles are shown in Fig. 4.5. For the first ∼
150 minutes we find that the scattering profile does not change. For t > 200
minutes we observed increasing scattering intensity at lower Q-values; this trend
increased with time (see Fig. 4.5). We first attempted to fit the data with the
cylindrical model (examples for t=0 and t=225 mins are shown in Fig. 4.8 A and
86
4.2. Results
1 E - 3 0 . 0 1 0 . 1 1
1 E - 3











Q  ( A - 1 )
Figure 4.2: Scattering function for a cylinder with a dimensions
L=30År=11Å In order to obtain a theoretical scattering curve we assume the
shape of the monomeric state of insulin to be approximated by a cylinder. We use
the crystal structure dimensions of an insulin monomer (PDB 1GUJ) as inputs
for the simulation. The results are shown in the figure above for the Q-range
explored in experiment.
B). For times 0 ≤ t ≤ 255 mins, the data could successfully fit to the cylinder
model. The fits to the data for these time points give lengths that are constant
until t=180, at which point there is an increase in the length of the cylinders
(Fig. 4.6). The radius of the cylinders remain constant over this time interval.
However, for t ≥ 270 mins, the cylindrical model fails to fit the data, particularly
at higher Q-values (Q > 0.1 Å−1). This is demonstrated in Fig. 4.4, where the
cylinder model is fit to the data obtained at t = 270 min. One can see that the
model does not fit the data well at higher Q-values (χ2/N =3.2). This feature
persists for scattering data obtained at times greater than 270 min.
In an effort to understand what does explain the data we plotted the real-
space probability distribution of scattering elements P (r). The distribution P (r)
can provide information about the amount of polydispersity in a system. Fig.
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Figure 4.3: Scattering function of 4 mg/ml insulin at t = 0. Plotted is the
scattering curve for 4 mg/ml insulin at at the beginning of the kinetic run. We find
that this scattering curve is well-fitted to a model where the scatterer is cylindrical
in shape. The red-line is the line of best fit which yields Rg=11.67±0.98 Å.
4.7 shows P (r)for several time points in the kinetics. It is apparent that at
early times, the system is quite monodisperse and gives a fitted Rg value of ∼
12 Å. Moreover, the fitted value for I(0)=0.023 Å−1 yields a molecular weight
Mw=5678±50 Da, which is within error of the Mw for monomeric insulin (5733.5
Da), where the protein specific volume, ν= 0.73 cm3g−1 and the contrast of
scattering length density between the protein and the solvent, ∆ρ=3.4x1010cm−2
(see §2.2.7.3). At t=180 and t=225 min, there are additional peaks at larger
r-values indicative of aggregate species present within the sample. However,
despite the development of increasing polydispersity by the formation of larger
aggregates within the system, the cylindrical model still fits reasonably well to
the data at these times, perhaps due to the still extant monomeric peak. We
find that the time at which the cylindrical model fails is when the monomer peak
effectively disappears and is overwhelmed by larger aggregate species. By the
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Figure 4.4: Fit to the cylinder model at t=270 min. Plotted is the scattering
data at 270 min fit with the cylinder model. Clearly, the fit is poor, especially at
high Q-values. This lack of fitting to the cylinder model persists for times greater
than 270 min.
final time point, a very broad distribution of large aggregate species dominates
the scattering signal.
Clearly, it is no surprise that for t ≥ 270 mins, the data can not be modeled by
a simple model. In an effort to extract some quantitative sense of the structure
of the aggregates we approximate the scattering signal by a combination of more
than one cylindrical species. The justification for this is that the signal for t ≥ 270
mins is still growing therefore monomers and their signal must still be present.
This proposition is plausible since many models of insulin fibril assembly involves
elongation via monomer addition [202, 119](§1.3 & §1.4). Obviously, the fit to
larger objects will be effected by polydispersity. Nevertheless, we fit the data
to a simple linear combination of a cylinder and flexible cylinder (§2.2.7.3) and
examples are shown in Fig. 4.8C and D. The results of the fit gives two lengths L1
and L2 and two radii, r1 and r2. For t=270 mins, the large Q-values are fit much
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Figure 4.5: Time-resolved scattering curves for 4 mg/ml insulin. Plotted
are the scattering curves for 4 mg/ml insulin over a time range 0 to 345 minutes.
For t<150 minutes the scattering curves remain constant. For t>200 minutes
an increase in the scattering intensity is observed in the low-Q range of our
experiments corresponding to growth of larger aggregates.
better by this model yielding L1 = 981± 132Å, r1 = 35± 12Åand L2 = 36± 5Å,
r2 = 9 ± 3Åwith a χ2/N=0.77. At the final time point t=345 mins the fit can
be seen to not be as good with a χ2/N=1.77. However, the values obtained are
L1 = 2484 ± 345Å, r1 = 36 ± 15Åand L2 = 51 ± 12Å, r2 = 15 ± 6Å. For these
time points the aggregates appear to become thicker, perhaps due to fibril-fibril
interactions. It should be noted that lengths beyond these will begin to move
outside the Q-window of these experiments; larger species will no longer be able
to be distinguished.
One must make mention that the time scale of fibril assembly in these in
situ experiments are not the same as in Chapter 3. Such differences could be
associated to inefficient heating of the sample within the chamber. Another source
of discrepancy could be due to cuvette geometry and the type of material it is
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Figure 4.6: The length, radius, and Rg as a function of time for times
0 ≤ t ≤ 255 mins. Plotted are the lengths (black squares) and radii (red
circles) obtained from fitting the data up to 255 min by a cylindrical model. The
fitted lengths are constant until t ≥ 180 mins, after which there is an exponential
increase. The radii over the same time remain constant. The inset shows Rg for
a cylinder as a function of time obtained from the fitted values of L and r.
made of; as was discussed in §1.2, the existence of hydrophobic surfaces can
influence the kinetics of aggregation.
Regardless of the efficacy of fitting a model to the data, what is incontrovert-
ible is that at a critical time (t≥ 270 mins) in the aggregation kinetics, there
is a marked increase in the scattering at low Q-values due to the formation of
larger aggregates. It would be extremely interesting to compare the time at
which this happens to the percentage of aggregate formed. According to the
work in Chapter 3, the CFC for insulin under these experimental conditions is
0.4 mg/ml which corresponds to 10% of monomer being converted to aggregated
material. However, it is difficult to determine how much material has become
fibrillar because the experiment unfortunately was interrupted by a major fault
in the LINAC. It is therefore difficult to get an estimate of the percentage of
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Figure 4.7: P (r) distributions for several time points in the kinetics.
Plotted are real-space distributions P (r) for (A) 0 mins, (B) 60 mins, (C) 180
mins, (D) 225 mins, (E) 270 mins, and (F) 345 mins. Note the change in x-axis
between 60 and 180 min. At t=0, the solution is dominated by a population of
monomer-sized scatterers. Over time, larger-sized aggregates form until a critical
time at t=270 mins (which corresponds to a simple cylinder model no longer
fitting the data) when the monomer peak is dominated by larger aggregates. By
the final time point at 345 mins a large distribution of large aggregates are present
and the monomer peak is obscured completely.
fibrillar material in the system at the critical time. However, with a complete
kinetic run the determination of fibril mass percentage should be achievable.
4.2.2 SANS of 0.5 mg/ml insulin amyloid fibrils
We also attempted to look at the scattering of a 0.5 mg/ml insulin sample.
This concentration was chosen because it is below the critical concentration at
which we expect a structural transition from to occur (§3.2.1.3). The results are
shown in Fig. 4.9. We find that, as expected, the signal-to-noise ratio is much
less favourable at this lower concentration. Despite this, a scattering signal is
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Figure 4.8: Examples of the data fit to cylinder or cylinder+cylinder
models. (A) t=0 and (B) t=225 mins scattering curves fit to a single cylinder
model. (C) t=270 and (D) t=345 mins scattering intensities are fit to a linear
combination of two cylinder models.
discernible. We allowed the sample to incubate for over 15 hours. Over that time
we did not observe any evolution in the scattering signal.
Even though we did not observe an evolution of the scattering signal for this
lower concentration we did look at the scattering from a sample that had been
prepared and pre-incubated in a 96-well plate. We prepared two sets of samples:
1) 0.5 mg/ml insulin in standard buffer and 2) 0.5 mg/ml in buffer with the
addition of 100mM NaCl. Salt was added to the sample as it is expected to shift
the CFC to a lower value (§3.2.6). The sample was incubated for 8 hours at 60◦C.
The resultant scattering profiles are taken from samples that have reached the
plateau region (§3.2.1). The results are shown in Figs. 4.10 and 4.11. We fit the
resulting scattering signals with a power law of the form I(Q) = AQ−m where
Åis a scale factor and m is the scaling exponent. The data was fit from 0.05 to
0.5 Å−1 (one decade). The scaling exponent m is related to the fractal dimension
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Figure 4.9: Time-resolved scattering curves for 0.5 mg/ml insulin.
Plotted are the scattering for 0.5 mg/ml insulin at t=15 minutes and t=15 hours,
10 minutes. The signal-to-noise ratio is much less favourable due to the sample
being much more dilute. We still find a scattering curve that is discernible over
the background. However, in the time-scale of these experiments we did not
observe any evolution in the scattering function.
of the scattering object (see §2.2.7.1, [203]). We find the that m = 1.66 ± 0.04
for the sample without NaCl, and m = 2.12± 0.07.
Interestingly, the scaling exponent for the sample without NaCl has an
exponent in good agreement with the scaling exponent that corresponds to a
self-avoiding polymer chain (m = 5/3). Scaling exponents in the range 2 ≤ m
≤ 3 are typically indicative of mass fractal structures such as branched systems
or networks, i.e. gels. This observation fits well with what would be expected
based upon the model outlined in Chapter 3. Specifically, in the absence of NaCl,
the critical concentration, cT ∼ 0.75 mg/ml (§3.2.1.3). It was shown in §3.2.3
that, an initial concentration of 0.5 mg/ml will not result in the formation of a
gel/viscous fluid. However, with the addition of NaCl, it is expected that the
critical concentration, cT will shift to lower values (§3.2.6). Quantitatively, the
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Figure 4.10: Scattering intensity for the end-point of 0.5 mg/ml fibril
kinetics. Plotted is the scattering intensity for 0.5 mg/ml insulin sample that
had been incubated in a 96-well plate at 60◦C for 24 hours. The data is fit to a
power-law with an exponent of -1.66±0.04. Fit gives an adjusted R2=0.96.
results in that section showed that for a concentration of 0.1M NaCl, cT ∼ 0.4
mg/ml. Therefore, it would be expected that for initial insulin concentration
above this value, a gel-like state should be observed. Indeed, the scaling behavior
of the 0.5 mg/ml sample in the presence of 0.1M NaCl is ‘gel-like’ and is in accord
with this prediction.
It should be noted that the scattering intensities at high Q-values for these
incubated samples (Figs. 4.10 & 4.11) is higher than data collected from samples
formed in situ (Fig. 4.5). This is most likely due to exchange of D2O buffer
with H2O from the atmosphere so that simple background subtraction of D2O
buffer does not completely remove higher incoherent background scattering from
H2O. This can be resolved in the future by taking background measurements of
mixtures of different percentages of D2O/H2O buffer.
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Figure 4.11: Scattering intensity for the end-point of 0.5 mg/ml, 0.1 M
NaCl fibril kinetics. Plotted is the scattering intensity for 0.5 mg/ml insulin
sample with the addition of 0.1 M NaCl that had been incubated in a 96-well
plate at 60◦C for 24 hours. The data is fit to a power-law with an exponent of
-2.19 ± 0.07. Fit gives an adjusted R2=0.98.
4.3 Discussion & Conclusion
We have used time-resolved SANS using the Sans2D detector at the ISIS facility
to monitor the aggregation of insulin into amyloid fibrils. We observed, for an
insulin concentration of 4 mg/ml, an initial scattering curve that was indicative
of a population of insulin monomers with a Rg of ∼ 11 Å. The monomeric
insulin scattering curve was well described by assuming cylinders as the scattering
centres. Over time, we observed increased scattering intensity at low-Q values
and decreased scattering at high-Q. We found that at a critical time, the data
was no longer described by a single cylinder model. This time corresponds to a
marked increase in polydispersity and the loss of a discernible monomer signal.
We fit the data for times greater than 270 mins with a modified model which is
simply a linear combination of cylinder models. The fits indicate these aggregates
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have larger diameters when t ≥ 270 mins relative to the aggregates formed when
t< 270 mins.
During the acquisition of this data at ISIS there was a major vacuum fault
in the linear accelerator which prevented further data from being acquired.
Nevertheless, the preliminary data here demonstrates that insights may be gained
concerning the structural evolution of insulin amyloid aggregates using SANS.
The primary objective is to understand the structural transition that we describe
in Chapter 3. It is of great interest to see whether the increase in scattering
observed at 270 mins corresponds to the time when the CFC is reached. In order
to determine accurately the percentage of fibrillar aggregate present, a full kinetic
SANS run needs to be obtained. The subsequent full kinetics could be measured
either in situ or by taking samples that are incubated in 96-well plates. This latter
approach may be more advantageous since it would correspond more directly to
the work done in Chapter 3. One obvious disadvantage of this approach would
be the possibility shear-induced alterations of the fibrils due to pipetting the
samples from plate to cuvette. What this work has demonstrated is that SANS
can effectively monitor structural changes in aggregating protein samples. With
complete kinetic SANS data one may be able to map the alterations in structure
to the model outlined in Chapter 3.
Of course it would be useful to obtain cleaner scattering data for low insulin
concentrations (particularly below the cT ). This will require longer acquisition
times, however, with a cost of decreased kinetic resolution. Alternatively, the
use of thicker sample cells may help ameliorate the issue. If this is achievable
it would be interesting to measure the mass per unit length, as a function of
time, for aggregates above and below cT . In light of the CD results in Fig.
3.10, where we speculate that the shift in the minima at low concentrations
is due to fibril-fibril association, such analysis could go toward confirming this
hypothesis. Nevertheless, it is extremely encouraging that the scaling behavior of
the 0.5 mg/ml samples with and without NaCl are concordant with what would
be expected from the CFC model discussed in Chapter 3.
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Chapter 5
Investigation of the Kinetics of
Loop Forming Fibrils Using
Ovalbumin
5.1 Introduction
Amyloid fibrils display a large diversity of morphologies depending on the
protein or peptide of interest or due to the conditions in which they form
[53, 58, 52, 107, 137]. It was observed that highly flexible amyloid fibrils
formed from Apolipoprotein C-II (apoC-II) assemble into ‘circularized’ closed-
loop amyloid fibrils [56, 57]. In this chapter, I explore the kinetics of loop-
forming fibrils utilizing ovalbumin as a test protein system. Under the correct
conditions ovalbumin forms closed-loop fibrils. I find interesting characteristics
in the kinetics of ovalbumin fibrils formed under our experimental conditions.
The kinetics are typified by the existence of three features: the lack of a lag
time; immediate onset of rapid exponential growth; and very slow growth at long
times. These features in the kinetics are in contrast to the kinetics of insulin fibril
formation that was discussed in Chapter 3: a lag time followed by exponential
growth phase which completes in a final ‘plateau’ in the growth profile. I used
ThT fluorescence assays to monitor the growth kinetics of ovalbumin fibrils and
TEM to observe their subsequent morphological characteristics. I write down
a simple model that, by including a term which takes into account end-to-end
joining of fibrils, the features of the experimentally observed kinetics are captured.
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Finally, I speculate upon the consequences these observations may have on the
cytotoxicity of loop-forming amyloid fibrils in the context of Chapter 3. It should
be noted that it can not be said with certainty that these fibrils are amyloid in
nature. While they are fibrillar and bind ThT strongly, without X-ray diffraction
experiments confirming the presence of cross β-sheet structure, I will refer to
these as ‘amyloid-like’ fibrils and not strictly ‘amyloid’ fibrils.
5.2 Results
5.2.1 Kinetics of Ovalbumin Fibril Formation
Fibrils were formed by reducing ovalbumin in the presence of 10mM dithiothreitol
(DTT) and 10mM ammonium acetate. For initial experiments investigating
the kinetics of amyloidogenesis of ovalbumin, two types of ovalbumin were
used. Grade 2 ovalbumin (Sigma-A5253) is comprised of 62-68% hen egg white
ovalbumin; it is essentially a crude dried egg white powder. Grade 5 ovalbumin
(Sigma-A5503) is of a much higher quality with a purity ≥ 98%. Solutions of
ovalbumin (of both grades) were pre-incubated for 2 hours at 37◦C in the presence
of DTT and ammonium acetate (see §2.2.2.2). After incubation the solutions
were aliquotted (100 µL) into 96 well plates. The kinetics of fibril formation
were measured using ThT fluorescence in a plate reader at 60◦C for 24 hours.
This procedure was performed for a range of initial ovalbumin concentrations
(0.1 mg/ml-12 mg/ml). Representative kinetic curves for a variety of ovalbumin
concentrations are shown in Fig. 5.1.
Fig. 5.1 show marked qualitative differences between ‘typical’ amyloid fibril
kinetic curves (c.f. Fig. 3.1). Firstly, the kinetics of ovalbumin fibril formation
under these conditions do not possess a discernible lag time. However, as can
be seen in the traces above, there is a dip in the fluorescence at the start of the
experiment. This reduction in fluorescence proceeds to a minimum value after
which fluorescence increases exponentially. I define the ‘flick time’ as the time at
which this minimum occurs (see inset to Fig. 5.5). The flick times are plotted
in Fig. 5.2 as a function of concentration, for both grades of ovalbumin. As can
be seen, the flick time becomes shorter with increasing protein concentration.
Furthermore, flick times are effectively the same for both grades of ovalbumin.
The flick time may represent a very short lag time in the kinetics. Alter-
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Figure 5.1: Representative kinetic traces of ovalbumin amyloid fibril
formation. Plotted are representative kinetic traces, monitored using ThT
fluorescence for Grade 5 ovalbumin: 0.1 mg/ml (black), 0.4 mg/ml (red), 0.8
mg/ml (blue ), 1 mg/ml (green diamonds), 2 mg/ml (magenta), 4 mg/ml (purple),
12 mg/ml (orange).
natively, it could be an error in the way in which the fluorescence is measured.
To test whether it is an artifact arising from a temperature dependence on the
fluorescence signal, which may possibly be induced by heating the sample from 37
to 60◦C, the flick time was determined for a constant concentration of 6 mg/ml
of ovalbumin for several temperatures. These experiments were not done in the
plate reader, which can only go to a maximum temperature of 60◦C. I used a
Cary Fluorimeter outfitted with a Peltier controlled cuvette holder. This cuvette
holder allows readings up to 80◦C with a much more precise level of temperature
control than within a plate reader. As is shown in Fig. 5.3A, the flick time
decreases with increasing temperature; by 70◦C, the flick time goes to zero. It
should also be noted that the fluorescence value at the minimum is roughly the
same for each temperature investigated (Fig. 5.3B). I conclude that the the flick
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Figure 5.2: ‘Flick time’ as a function of concentration for two grades of
ovalbumin Plotted are the flick times for Grade 5 ovalbumin (black) and Grade
2 ovalbumin (red). In each case, the flick time decreases with concentration.
time is not in fact a proper lag time but could be the result of a decrease in
the ThT quantum yield as the sample is being heated. More works needs to
be done, in particular performing fluorescence lifetime measurements, in order
to confirm this hypothesis. Indeed, the fact there is a non-zero fluorescence
value at t=0 is indicative there are ThT-binding species already present at the
beginning of the readings. Moreover, the fluorescence at t=0 is proportional
to the initial concentration of ovalbumin (Fig. 5.4). Taken together, I can
conclude that the kinetics show no lag time and thus resembles seeded amyloid
fibril growth (§1.4.1.1; [49]). This seeding could be a result of the preparation
process. The ovalbumin is reduced with DTT, breaking the internal disulphide
bonds rendering the protein much more conformationally flexible and, in turn,
more prone to aggregation. This susceptibility to aggregation , I hypothesize,
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Figure 5.3: Temperature dependence on the ‘flick time’ (A) The ‘flick
time’ is plotted as a function of temperature. We see that with increasing
temperature, the ‘flick time’ decreases and may be eliminated at temperatures
> 70◦C. (B) The fluorescence value at the minimum is plotted as a function
of temperature. I find the fluorescence value is roughly equivalent for each
temperature.
After the flick time has elapsed, the kinetics of fibril assembly move into an
exponential growth phase. This phase is characterized by a maximum fluorescence
growth rate k1. As exponential growth proceeds, the monomer pool begins to
become depleted causing the curve to turn over as in the insulin case. However,
instead of the kinetics reaching a plateau, the fluorescence slowly increases.
Indeed, the data are typically well-fitted by a combination of two exponentials.
We define this slow growth rate as k2. See Fig. 5.5 for a schematic of these
definitions.
A plot of k1 as a function of ovalbumin concentration is shown in Fig. 5.6
for both grades of ovalbumin. Over the range of concentrations investigated, k1
is linear for both grades of ovalbumin. The impure Grade 2 ovalbumin exhibits
fluorescence growth rates much lower than the higher quality ovalbumin samples.
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Figure 5.4: Fluorescence at t=0 is not constant with increasing
concentration. Plot of the fluorescence value at t=0 for the concentrations
investigated (Grade 5). This initial fluorescence value scales with the initial
ovalbumin concentration. I attribute this to the fibril growth process being
effectively seeded.
The long-time growth rate, k2, is plotted as a function of concentration (Fig.
5.7); this trend shows a non-linear relationship between k2 and concentration
with overall lower rates for the lower grade ovalbumin samples. For the remainder
of the Chapter I conducted experiments only on Grade 5 ovalbumin due to its
kinetics being quicker as well as minimizing the error introduced by any additional
substances (such as salts) present in the Grade 2 ovalbumin.
Again, it is useful to contrast this behaviour with the insulin amyloid fibril
system studied in Chapter 3. Recall, for insulin the maximum growth rate showed
a complex and non-linear dependence as a function of concentration. In that
case the growth curves are normalized to remove the explicit dependence on
fluorescence. This was possible due to the fact the assembly process comes to
completion; the monomer pool is essentially exhausted and the kinetic curve
plateaus to a steady-state value. For the case of ovalbumin, this non-linear
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Figure 5.5: An illustrated example of the different phases of growth
observed in ovalbumin amyloid fibril formation. This plot shows the
aggregate growth, as monitored by ThT fluorescence, of a 4 mg/ml ovalbumin
sample. We first observe an initial decrease in the fluorescence which results in
a minimum value. After this minimum is reached the kinetics are characterized
by exponential growth. The minimum in fluorescence at the early times of the
kinetics is defined as the ‘flick time’(inset). The exponential growth rate is called
k1. Instead of the growth kinetics reaching a constant plateau, I observe a slow
growth regime which is parameterized by the growth rate k2.
complex behaviour is not observed. Therefore, the growth rates measured for
ovalbumin need not be converted from units of fluorescence min−1 to simply
min−1. However, another issue arises: since the fluorescence signal continues
to increase during the time frame of the experiment, what percentage of the
monomer pool has been converted to fibril after some time t in this slow growth
phase?
To determine this I took the time t to be the end of the kinetic run, which
for all experiments was 24 hours. Fibril samples were formed from several
different initial ovalbumin concentrations and spun down in a centrifuge. The
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Figure 5.6: Exponential growth rates for two grades of ovalbumin. The
growth rates during the exponential are plotted for Grade 5 (black squares) and
Grade 2 (red triangles) as a function of concentration. The rates for the less pure
Grade 2 ovalbumin are less than the Grade 5 possibly due to inhibiting effects of
additional salt and/or proteins. Furthermore, the actual percentage of ovalbumin
present in Grade 2 is roughly 70% which will render the kinetics to be slower.
supernatant was then analyzed using a Bradford Assay to determine the soluble
protein concentration remaining. The results are shown in Fig. 5.8. What is
immediately apparent is that after 24 hours, the fibril formation process is far
from complete. Even at the ‘high’ concentration of 10 mg/ml, where the kinetics
apparently proceed very rapidly (Fig. 5.1), only about 50% of native ovalbumin
has been converted to fibrils. One consequence of this observation is that one
can not simply normalize the kinetic curves to their maxima, as in the insulin
case. Ultimately, this result shows that there is some mechanism which slows the
depletion of the native ovalbumin population so that the polymerization reaction
does not rapidly go to completion.
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Figure 5.7: The rates of growth in the slow growth regime for two grades
of ovalbumin The growth rate in the slow growth regime of the kinetics is shown
for Grade 5 ovalbumin (black squares) and Grade 2 (red triangles) as a function
of concentration. The rates for the less pure Grade 2 ovalbumin are less than the
Grade 5.
5.2.2 TEM of ovalbumin fibrils
I performed negative stain TEM to study the morphological characteristics of
the fibrils formed from ovalbumin under our experimental conditions (Chapter
2.2.5). As is shown in Fig. 5.9, several attributes of these fibrils are apparent.
First, the fibrils are thin and apparently flexible filaments and show no detectable
underlying substructure such as helical repeats. Second, images often show large
entangled masses of fibrils. Third, imaged fibrils that are free from these tangled
masses appear to be short (for comparison see Fig. 3.14). Finally, closed-loop
fibrils are observed in many of the images (Fig. 5.9, Fig. 5.10). I define a ‘
closed-loop’ in our images as a fibril whose ends appear to be joined to form a
contiguous structure.
In order to quantify the average length and flexibility of the ovalbumin fibrils,
106
5.2. Results

















I n i t i a l  O v a l b u m i n  C o n c e n t r a t i o n  ( m g / m l )
Figure 5.8: Bradford assays show growth kinetics far from completion
in the time-scale of our experiments. We performed a Bradford Assay,
using a BSA calibration standard, to determine the percentage of fibrillar material
produced during the time course of our experiments. We find, even for the highest
concentrations studied, after 24 hours, the fibril formation process is far from
complete.
length distributions were measured and an estimate of the persistence length was
made. For each image, fibrils that were clearly independent of an entangled mass
and whose ends were clearly visible were chosen for measurement. Each fibril’s
contour length, L, was measured as well as the end-to-end distance, R. The
process is shown in Fig. 5.11. I find an average value of L to be 239.8 ± 183.6
nm. The length distribution is shown in Fig. 5.12 and is well-fitted to a log-normal
distribution (N=110). As ever, it can be beneficial to compare these results to
what we know in the insulin amyloid fibril system. The average fibril lengths
for ovalbumin are similar to fibrils formed from ‘low’ insulin concentrations (i.e.
when cp < cT ; Lavg=231.5 ± 230.4 nm, §3.2.5) but have a length distribution
akin to when the insulin concentration is at higher concentrations (cp > cT ). One
conclusion I can suggest from this analysis is that fragmentation is not an active
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Figure 5.9: Representative TEM image of ovalbumin fibrils. This image
is an example of a typical TEM image of fibrils formed from 6.4 mg/ml ovalbumin.
They exhibit a worm-like, highly flexible morphology.
mechanism that is driving ovalbumin fibril assembly. As we saw for insulin, we
would expect an exponential length distribution for a system where fragmentation
is a driving force in the kinetics. The short fibril lengths can be rationalized in
two possible ways. First, as has been shown, the fibril assembly process is still far
from complete. One may expect that at long times fibril lengths would become
longer. Second, the lack of an appreciable lag time indicates that the kinetics are
in a seeded regime. One would obtain a distribution of short fibrils if the system
was highly seeded so that most of the protein material is immediately growth
competent. However, this scenario is less likely due to the fact that the majority
of ovalbumin has not been converted to fibril after 24 hours.
The persistence length was estimated for ovalbumin fibrils by measuring the
conformational parameters L and R. One must consider the effect of transferring
3-d conformation in solution to a 2-d conformation when fibrils are deposited
upon a TEM grid. The conformation of a fibril observed in a TEM image can
be the result of two scenarios: 1) after deposition fibril can conformationally
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Figure 5.10: Ovalbumin fibrils form a population of closed loop
morphologies. This is a more detailed image showing a population of closed-
loop fibrils, formed from 6.4 mg/ml ovalbumin, interspersed with other worm-like
fibril structures. Boxed in fibrils highlight the closed-loop morphologies. Inset
shows detail of a ovalbumin fibril loop. Scale bar is 0.2µm.
A B C
Figure 5.11: The process of determining the contour length and end-
to-end distance from TEM images TEM images were analyzed using
ImageJ software. The distance measurements were calibrated using the scale
bar associated to the image. (A) shows an image of a fibril to be measured.
(B)The contour length was found using the ‘segmented line tool’ in ImageJ; (C)
the end-to-end distance is simply found using the ‘line’ tool. Fibrils were only
measured where the ends were clearly discernible in the image.
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Figure 5.12: Experimentally determined length distribution for
ovalbumin fibrils. The contour lengths of ovalbumin fibrils were found as in
Fig. 5.11. The plot is a histogram of the contour lengths with N=110. The mean
fibril length is 239.8 ± 183.6 nm. We find the distribution is best fit to a log-
normal distribution (black curve). This result is consistent with the observation
that the mean length is short due to the fibril assembly process being far from
complete.
equilibrate or 2) immediately adhere to the grid surface. Furthermore, the
conformations observed are assumed to arise from conformational flexibility and
not inherent structural bending. It has been shown previously [204] for the case
of conformationally equilibrated filaments one can obtain an equation for the
mean-squared end-to-end distance, 〈R2〉2D, of a fibril as a function of the contour














It is assumed that the conformations of ovalbumin fibrils on the TEM grids
are the result of conformational equilibration after deposition. R and L are
110
5.2. Results
measured from our TEM images and plotted 〈R2〉 as a function of L. I then
used the equation above to fit our data to obtain an estimate of the persistence
length. The results are shown in Fig. 5.13. The persistence length is estimated
to be 26 nm. For comparison, the persistence length of DNA obtained from AFM
images under the same assumptions was found to be 53 nm [204]. Even more
importantly, similar analysis performed on fibrils assembled from apo-CII gave
an estimate of the persistence length of 36nm [56]. To compare to another fibrillar
aggregate system, Smith et al. calculated a persistence length of 42 ± 30 µm for
insulin fibrils [205]. Note the three orders magnitude difference between these
two values. It may be concluded that ovalbumin fibrils are highly flexible and
this flexibility helps facilitate end-joining so that closed-loop fibril conformations
may be formed, as in the apo-CII case.
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Figure 5.13: Calculating the persistence length of ovalbumin fibrils. Fibril
contour lengths (L) and end-to-end distances (R) were found as is shown in Fig.
5.11. From this procedure R2 is plotted against L for each fibril (N=110). The




5.2.3 A model of ovalbumin kinetics
I can attempt to reproduce the experimental growth kinetics in the ovalbumin
system by writing down two simple models of fibril assembly, one with end-
joining and one without. In the first iteration I assume a model where downhill
polymerization (§1.4.1) is the dominant mechanism in the growth of the fibrils
and no end-joining occurs. As we have seen from the experiments, we are in a
regime where the kinetics are effectively seeded (i.e., there is no lag time) so this
type of growth mechanism is plausible. We can write the time rate of change of





where k+ is the elongation rate, E
∗ is the number of seeds (‘ends’) present
at t=0, and mtot is the initial mass of monomer. There is no nucleation term
because we are in the seeded regime. The solution to this equation is,
M(t) = mtot + (M0 −mtot)e−k+E
∗t (5.3)
where M0 is the initial seed mass. This solution is plotted in Fig. 5.14 for
several different parameter values. This simple model clearly does not capture
the features we observe in the experimental kinetics. First, the initial rate is
too rapid. Second, there is no second slow growth phase at long times. This of
course is not surprising; once the monomer pool has been exhausted the growth
M(t) → mtot, thus reaching a plateau in the growth kinetics. If fragmentation
were to be included into this simple scenario it would not ameliorate the problems;
indeed, the kinetics should process even faster and still lack a slow growth phase.
There is no physically realistic combination of parameters in this simple model
which will yield the features I observe in our experiment: a gradual turn-over
in the kinetics followed by very slow growth and a system far from coming
to complete polymerization in the time scale of our experiments. Fig. 5.14
shows that the curve representing the slowest growth rate k+ (pink diamonds)
nominally reproduces the shape of the observed kinetics but fails to reproduce
the polymerization time-scale I find in experiments.
As has been shown by the presence of closed loops in TEM images (Fig. 5.10,
end-joining certainly occurs in this system. It would be advantageous to see how
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Figure 5.14: A simple downhill polymerization model does not capture
the experimental kinetics. Plotted are solutions to Equation Fig. 5.2
for several parameters of k+: 1x10
−4s−1(blue triangles), 1x10−5s−1 (red circles),
1x10−6s−1 (black squares), 5x10−7s−1 (pink diamonds). The other parameters
were held constant: M0=1x10
−4 mg/ml, mtot=1 mg/ml, and E
∗=100. For larger
values of k+, fibrils are formed extremely rapidly and the polymerization reaction
quickly comes to completion. Even for small values of k+, the amount of material
converted to fibrils approaches 100% in the time window of a typical experiment.
In experiments we find the percentage of fibrillar mass is far from 100% (Fig.
5.8) during the time scale of the experiments. This simple model does not match
these observations. Moreover, there is an absence of the slow growth phase in
this model.
adding an ending joining rate, kj, will effect the model kinetics. I can again write
down a set of equations, first for the rate of change of fibril mass M,
dM
dt
= k+E(t)(mtot −M(t)) (5.4)






where the squared term accounts for the fact there are two ends to each fibril.













where α = k+
kj
.
This solution is plotted in Fig. 5.15 for several parameter values. Two
features of this solution are the presence of an an initial exponential growth phase
followed by a slow growth regime at longer times. Unlike in the simple downhill
polymerization model where the number of ends is constant, the introduction of
an end-joining rate, kj, results in a depletion of ends over time. The decrease in
the number of ends retards the rate at which monomer is converted into fibril.
The net result in the long-time limit is the appearance of the slow growth phase,
similar to what is observed in the experimental kinetics above. One can see from
Fig. 5.15, the percentage of fibrillar mass that has been produced by the time
the slow growth regime is reached is far from 100% for values of kj < 1x10
−5s−1
(with k+=1x10
−5s−1). As I have shown from the results in Fig. 5.8, the amount
of fibrillar material created in our experiments is in the range of 10-60% in the
time course of our experiment. I find that, for this model, such values can be
nominally reproduced with kj=1x10
−4s−1 (or α=0.1).
As was shown in Chapter 3, fragmentation can act as an important mechanism
for fibril assembly. One can attempt to include the effects of fragmentation into
the model. However, by doing so the solution becomes non-trivial and a closed-
form solution is not possible. Furthermore, the model as outlined in this thesis
violates detailed balance; that is as t → ∞, the number of ends E(t) → 0.
An incorporation of fragmentation, even if the rate is small can restore detailed
balance to the model. Nevertheless, even without explicitly investigating the
effects of fragmentation on an end-joining model one can posit some features of
the kinetics and the resulting fibrils. For loop formation to be active, the fibrils
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Figure 5.15: A model with end-joining reproduces the observed kinetics.
Plotted are solutions to the set of equations Fig. 5.4 and Fig. 5.6 for several
different values of the joining rate kj: (A) 1x10
−2s−1, (B) 1x10−3s−1, (C)
1x10−4s−1, (D) 1x10−5s−1. The other paremeter values were held constant:
k+=1x10
−5s−1, M0=1x10
−5 mg/ml, mtot=1 mg/ml, and E
∗ = 100. The resulting
solutions show an initial exponential growth phase followed by a slow growth
phase at later times. The slow growth phase exists due to the elimination of
available growing ends due to joining; because of this the polymerization reaction
can not come to a rapid completion. For larger values of kj the amount of material
converted to fibril is very small (∼ 1 %) before the slow growth regime is reached.
In our experiment we see fibril mass percentages similar to the parameter values
in C. Note in the limit that kj → 0 the solution becomes a simple downhill
polymerization.
must be flexible with short persistence lengths. Since fragmentation is postulated
to be driven by thermal fluctuations [205], the intrinsic flexibility of the fibrils
may result in fragmentation rates being lower than in systems with more rigid and
inflexible fibrils. Second, assuming fragmentation is present, qualitatively distinct
fibril length distributions would arise in systems with and without an end-joining
rate. In the case where there is no end-joining the length distribution would
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become exponential in the long time limit (as has been discussed in Chapter 3).
Alternatively, end-joining can act as a ‘self-repair’ process when fragmentation is
active; end-joining is not only the ‘self-association’ event where closed-loops are
formed but fibril growth is also achieved via the concatenation of two separate
fibrils into one. In other words, end-joining is the inverse process of fragmentation.
In contrast, the only growth mechanism for insulin fibrils in Chapter 3 was via
monomer addition only.
I hypothesized that since the length distribution is dominated by short fibrils,
the resulting fibril solution should not be gel-like or highly viscous. I tested this
by performing bead tracking microrheology on ovalbumin samples for a range of
concentrations. As can be seen in Fig. 5.16, I found no apparent gel is formed
from ovalbumin fibrils over the range of concentrations studied. The lack of
formation of a highly viscous fluid is consonant with the observation that only
short fibrils have been formed during the time-frame of the experiment. It is
interesting to note, however, that the length distribution found experimentally
is not exponential. I contrast this result to what was found for insulin (Chapter
3.2.3). Therefore, the mechanism which prevents the collapse of the fibril length
distribution in ovalbumin may be distinct from that of insulin (see Chapter 3).
5.3 Discussion & Conclusion
In this chapter I have shown that the kinetics of ovalbumin fibril formation is
typified by ’non-standard’ assembly kinetics. Specifically, the kinetics appear
seeded and lack a lag phase. It would be advantageous in the future to test this
hypothesis by attempting to remove Moreover, there exists a slow growth phase
which occurs after the initial exponential growth phase. The presence of this
slow growth is in contrast to what typically happens in amyloid fibril assembly
where a plateau is reached due to the exhaustion of competent growth species. I
observed worm-like and highly flexible fibrils with a persistence length of 26nm.
Interestingly, I noted the presence of closed-loop fibrils. I attribute the observed
kinetic features, particularly the presence of the slow growth phase, on the ability
for these fibrils to join end-to-end (in contrast to other models that explicitly
assume growth by monomer addition). This end-joining mediates the formation
of closed-loops which gives rise to end depletion. By writing down a simple model
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Figure 5.16: Gels do not form from ovalbumin amyloid fibril samples
as shown by bead tracking experiments 1 µm beads were optically tracked
while diffusing in amyloid fibril solutions made from ovalbumin. A range of
concentrations were explored: buffer control/no fibrils (black squares), 0.375
mg/ml (red circles), 0.75 mg/ml (blue triangles), 1.5 mg/ml (yellow diamonds),
3 mg/ml (magenta stars), 6 mg/ml (purple asterisks), 12 mg/ml (grey crosses).
With increasing concentration the solutions become increasingly viscous, but no
viscoelastic plateau is observed. The hypotenuse of the black triangle has a slope
of 1, and is provided for comparison.
with an end-joining rate, the qualitative features of the kinetics may be captured.
A natural question is how universal is the ability for amyloid fibril systems
to form closed-loop morphologies. The kinetics of such a process has not been
widely studied to date. However, closed-loop amyloid fibrils have been observed
in a number of protein systems besides ovalbumin and apo-CII, for instance αB-
crystallin [206], β2-microglobulin [52], and α-synuclein [207]. If fibril flexibility
is a good indicator for the potential of forming closed loops, many other protein
systems exhibit flexible, worm-like fibrils under the correct conditions (e.g. BSA
[208], Aβ(1-40) [108]). However, fibril flexibility may be a necessary but not
117
5.3. Discussion & Conclusion
sufficient condition to form closed loop fibrils. Other considerations may play a
role such as fibril structure or electrostatic self-interactions.
Of note is that many of these systems may exhibit many different morphologies
depending on the conditions in which they were formed. For instance, Gosal and
co-workers have shown in the β2-microglobulin system, one can obtain a myriad of
structures, from long straight fibrils, to flexible worm-like ones depending on the
pH and ionic strength of the solution [52]. The existence of closed loop amyloid
fibrils is simply an interesting addition to the amyloid fibril morphological ‘zoo’.
The fact that, for a given protein system, morphologies may be tuned simply by
changing the conditions of formation holds interesting possibilities for creating
novel amyloid-fibril based biomaterials. To this end more studies need to be
done in order to better understand the conditions which promote the formation
of closed-loop amyloid fibrils and how this particular morphology is connected to
the other morphological pathways of fibril assembly.
This potential control of morphologies could be of great interest in regards
to the potential cytotoxicity of closed-loop amyloid fibrils. As was discussed
in Chapter 3, oligomeric and flexible protofibrillar amyloid species have been
implicated as being the cytotoxic agents in many diseases (e.g. [186]). Lashuel
et al. showed that mutations which cause Alzheimer’s Disease (Aβ(1-40)) and
Parkinson’s Disease (α-synuclein) promote the formation of annular, pore-like
morphologies of amyloid protofibrils. Other pore-like annular structures have
been observed for other amyloid fibril forming proteins [42]. In the absence of
fragmentation, a closed-loop amyloid fibril is non-reversible. The fact that loops
are a kinetic end point could have implications for the prevalence and toxicity of
these species.
Conversely, if it were the case that larger, non-pore forming closed-loop
amyloid fibrils were not cytotoxic, forming loops may prove to be beneficial. In
a system where fragmentation creates short, oligomeric species, the formation of
loops may act as a kinetic sink, stabilizing the length distributions and preventing
these shorter and potentially toxic species from accumulating. This mechanism
that prevents run-away increase in potentially harmful oligomeric species is in




Investigating ocr aggregation by





In a typical ammonium sulphate precipitation step during protein purification,
less than 2M ammonium sulphate is used to ‘salt out’ protein from solution.
However, it was observed that at high ammonium sulphate concentrations (∼
3M), instead of precipitating, ocr formed a weak gel. Richard Higham published
a PhD thesis elucidating some of the physical and phenomenological aspects of
ocr gelation [4]. Curiously, ocr gelation seems to be salt specific. Gelation of the
wild-type, native protein only occurs in the presence of a critical concentration
of ammonium sulphate. In Higham’s thesis, despite using salts with similar
properties to ammonium sulphate, gelation was never observed. In addition,
AFM results showed that ocr forms fibrils several nanometers thick and with
lengths over 1 µm (Fig. 6.1). Such high charge-screening conditions usually
result in particulate gels or protein precipitates (see Chapter 1.2.1). The fact
that ocr, under these experimental conditions, forms a ‘fine-stranded’ translucent
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gel is, to the best of my knowledge, unprecedented.
Figure 6.1: AFM images of ocr fibrils AFM image of 36 µM ocr in 20 mM
Tris-HCl pH 8 with 3.2M ammonium sulphate. Typical dimensions of fibrils from
AFM measurements show heights ∼ 10 nm with lengths up to 1 µm. Taken from
[4].
There are many open questions about the gelation of ocr. Most pressing
is the mechanism of ocr fibril formation. For instance, unlike the aggregation
of protein into amyloid fibrils, there appears to be no conversion of the native
secondary structure into a significant proportion of β-sheet. Furthermore, ocr
gelation is a reversible process; cycling through aggregation and dis-aggregation
does not appear to have ill effects on the native conformation. In this chapter,
we attempt to gain a better understanding of ocr aggregation by studying the
gelation of ocr mutants. These mutant variants each contain modifications to
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regions containing high surface charge density. I use bead tracking microrheology
to study the structural characteristics of the gels formed from these mutants




Mutant variants of ocr were produced using genetic modification so that negative
charge regions on the surface of the protein were neutralized. More specifically,
acidic aspartates and glutamates were mutated to asparagines and glutamines,
respectively. The details of the genetic modification protocol can be found in
[209]. In this chapter we studied three mutants: ‘ocr-Mutant7’ (Mut7),‘ocr-
Mutant11’ (Mut11), and ‘ocr-pOcr’(pOcr). The amino acid modifications for
each are:
Mut7:
D25C, D26N, D29N, D31N, D32N, D35N, D92N, E95Q, D96N, E98Q, D99N
Mut11:
D25C, D26N, D29N, D31N, D32N, D35N, E59Q, D62N, E64Q, E66Q, D67N
pOcr:
D76N, E87Q, D92N, E95Q, D96N, E98Q, D99N, E103Q, E106Q, E107Q,
E109Q, E110Q, E112Q, E113Q, E114Q, E115Q, E116Q
Note that Mut7 and Mut11 share a region of common modification. The
majority of pOcr modifications take place toward the C-terminal end of the
protein which is comprised of both α-helix and unstructured coil. Diagrams
of these modifications, visualized for a dimeric ocr are shown in Figs. 6.2, 6.3,
and 6.4.
Additionally, I also studied a truncated variant of ocr (ocr99), where the final
17 amino acids (10 of which are acidic residues) were chemically excised.
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Figure 6.2: Diagram of ’ocr-Mutant7’ Regions of genetic modifications of the
ocr dimer are highlighted. Amino acids substitutions are: D25C, D26N, D29N,
D31N, D32N, D35N (magenta); D92N, E95Q, D96N, E98Q, D99N (blue).
6.3 Results
We performed bead-tracking microrheology experiments on wt-ocr and the
mutant variants (see §2.2.6.4 for details on the experimental methods). We first
performed bead-tracking microrheology on wild-type ocr to establish a baseline
for comparison with the modified ocr variants. The mean squared displacements
(MSD) for a range of ammonium sulphate concentrations are shown in Fig. 6.5.
I find that from 0 to 2.4M ammonium sulphate, the samples become increasingly
viscous. I then find a sharp change in the scaling of the MSD at 2.8M. By 3.3M
the scaling exponent has decreased to a value 0.12. This value indicates that a
viscoelastic solid has formed.
Looking first at the raw data from microrheology we can infer different
behaviour for the three mutant proteins. Mut7 begins to display increased
viscosities at 0.8M ammonium sulphate, similar to what was found with wt-ocr
(Fig. 6.6). However unlike wt-ocr, at 1.6M we find an abrupt change in the MSD
scaling behavior. With further increasing ammonium sulphate concentrations,
the MSD scaling relation continues to decrease. Interestingly, the MSDs for
Mut11 are remarkably similar to that of Mut7 (Fig. 6.7). Finally, pOcr exhibits
markedly different behavior from wt-ocr and the other mutant variants. As
can be seen in Fig. 6.8, the slope of the MSD goes to zero with only a 0.8M
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Figure 6.3: Diagram of ‘ocr-Mutant11’ Regions of genetic modifications of the
ocr dimer are highlighted. Amino acids substitutions are: D25C, D26N, D29N,
D31N, D32N, D35N (magenta); E59Q, D62N, E64Q, E66Q, D67N (red). The
bottom image of the ocr dimer is rotated by 90◦ relative to the top view.
ammonium sulphate concentration, indicating a gel state is reached. Further
increasing the ammonium sulphate concentration does not dramatically effect
the MSD scaling. This marked change in the gelation behaviour may begin to
highlight an important region on ocr, namely the final α−helix and unstructured
tail on each monomer of ocr.
To better visualize the changes taking place for each variant of ocr, the
viscosities are plotted as a function of ammonium sulphate concentration.
Viscosities were calculated from the MSDs and an application of the Stokes-
Einstein equation (§2.2.5). As is discussed in §2.2.5, we assume that at in the
long time limit, the scaling exponent for all MSDs goes to one but with a much
reduced diffusion coefficient relative to pure water. For wt-ocr (Fig. 6.9a), we find
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Figure 6.4: Diagram of ocr-POcr Mutant Regions of genetic modifications of
the ocr dimer are highlighted. Amino acids substitutions are: D76N, E87Q,
D92N, E95Q, D96N, E98Q, D99N, E103Q, E106Q, E107Q, E109Q, E110Q,
E112Q, E113Q, E114Q, E115Q, E116Q.
a gradual increase in the viscosities up to 2.4M. At 2.8M we find a sharp increase in
the viscosity. Further increasing the ammonium sulphate concentration to 3.3M
results in a further increase of the viscosity to a value of 541 cP. Mut7 and Mut11
again show a steady increase in viscosity from 0-1.2M (Fig. 6.9b,c). At 1.6M we
find an appreciable increase in the viscosity. Again, increasing the ammonium
sulphate concentration results in an additional increase in the viscosity up to
final values of 524 and 595 cP at 3.3M, respectively. In the case of pOcr, the
sharp increase in viscosity occurs at 0.8M (Fig. 6.9d). Additional increases
of ammonium sulphate concentration do not lead to an appreciably different
viscosity. Furthermore, the average viscosity for pOcr (0.8-2.8M) is 311.7 ±
45.3 cP which is less than wt-ocr and the other mutant variants. An interesting
feature that is found in Fig. 6.9 is that there is an increase in the viscosity at
lower ammonium sulphate concentrations for wt-ocr (1.2M) and the two mutants,
Mut7 and Mut11 (0.8M). This feature may correspond to the formation of higher
order aggregates or the assembly of filaments without complete entanglement.
A final ocr variant was studied, namely, the truncated version of ocr where
the final 17 amino acids have been chemically excised (ocr99). The experiments
involving this truncated ocr variant were performed early in the process of
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Figure 6.5: Mean squared Displacements for wild-type ocr. Plot of the
MSDs for a range of ammonium sulphate concentrations (M): 0 (black squares),
0.8 (red circles), 1.2 (blue triangles), 1.6 (pink diamonds), 2 (green hexagons), 2.4
(navy stars), 2.8 (purple +), 3.3 (orange *). Triangle is a guide for the eye; the
hypotenuse shows a slope of 1 which is equivalent to a liquid with the viscosity
of water.
developing the methods employed in this Chapter. A lower frame capture
rate (10 fps) was used and only two movies were made with only of order
∼ 10 beads per movie. Furthermore only a reduced range of ammonium
sulphate concentrations were investigated however there was insufficient protein
to complete these experiments. However, the data will still be presented for while
it may not allow for reliably quantitative comparisons with the other variants,
qualitative ones may still be made. Between 0.8M and 2M there is an increase
in the viscosity. At 2.4M we find a sharp change in the scaling of the MSD
corresponding to the formation of a visco-elastic gel.
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Figure 6.6: Mean squared Displacements for Mut7 ocr. Plot of the MSDs
for a range of ammonium sulphate concentrations (M): 0 (black squares), 0.4 (red
circles), 0.8 (blue triangles), 1.2 (pink diamonds), 1.6 (green hexagons), 2 (navy
stars), 2.4 (purple +), 2.8 (orange *), 3.3 (yellow spheres). Triangle is a guide for
the eye; the hypotenuse shows a slope of 1.
6.4 Discussion & Conclusion
This chapter has attempted to elucidate the mechanism of ammonium sulphate
induced aggregation of ocr by studying the visco-elastic properties of the variants
(both genetically and chemically modified) using microrheological techniques.
From this work several conclusions may be drawn. First, the modified variants
of ocr exhibit markedly different aggregation behavior from the wild-type as a
function of ammonium sulphate concentration. The concentration of ammonium
sulphate at which the variants will form a gel is less than the wild-type for all
variants studied. This result may be rationalized by the fact that the decreased
charge allows for smaller ammonium sulphate concentrations to effectively shield
the electrostatic interactions and induce aggregation. Indeed, the gel-point
ammonium sulphate concentration does scale well with surface charge (Fig. 6.11).
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Figure 6.7: Mean squared Displacements for Mut11 ocr. Plot of the MSDs
for a range of ammonium sulphate concentrations (M): 0 (black squares), 0.4 (red
circles), 0.8 (blue triangles), 1.2 (pink diamonds), 1.6 (green hexagons), 2 (navy
stars), 2.4 (purple +), 2.8 (orange *), 3.3 (yellow spheres). Triangle is a guide for
the eye; the hypotenuse shows a slope of 1.
Second, it has been shown that the aggregation behavior is very similar for
Mut7 and Mut11. Both variants contain an overlap in modification, namely the
substitutions D25C, D26N, D29N, D31N, D32N, D35N. Mut7 and Mut11 have
further modifications in different regions of the protein (see Figs. 6.2 and 6.3).
One possibility is that the aggregation behavior and structural characteristics of
the resulting gel are so similar because the shared region of charge modification
has a greater impact on the aggregation of ocr than the other regions of
modification of these mutants. Alternatively, the phenomena observed is simply
a result of electrostatics, regardless of which amino acid side chains are changed.
Third, pOcr had the lowest ammonium sulphate concentration gel point of
all the variants. While the ammonium sulphate concentration gel-point may
be interpreted in terms of a loss of surface charge due to amino acid charge
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Figure 6.8: Mean squared Displacements for pOcr ocr. Plot of the MSDs
for a range of ammonium sulphate concentrations (M): 0 (black squares), 0.4
(red circles), 0.8 (blue triangles), 1.2 (pink diamonds), 1.6 (green hexagons), 2
(navy stars), 2.4 (purple +), 2.8 (orange *). Triangle is a guide for the eye; the
hypotenuse shows a slope of 1.
substitutions, the fact the gel is physically weaker than the wild-type and other
genetically mutated variants is of interest. This could be an indication that the
regions of modified charge on pOcr could strongly influence the formation of
aggregates and their structural integrity.
Fourth, ocr99 does not exhibit similar aggregation behavior as pOcr. The
excised portion missing from ocr99 contains 10 of the 17 charge modifications
of pOcr (predominately located in the unstructured C-terminus tail). We find
the gel points of pOcr and ocr99 occur at 0.8M and 2.4M, respectively. One
can conjecture that the excised portion of ocr99 is not a critical region of charge
that influences the aggregation behavior. The fact that the ammonium sulphate
concentration gel-point of ocr99 is lowered does indicate it does play some role; the
loss of the charge in that region results in less non-specific electrostatic repulsion
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Figure 6.9: Viscosities of ocr and its mutant variants as a function of
ammonium sulphate concentration. Plotted are the viscosities determined
from the mean squared displacements and applying the Stokes-Einstein equation:
(A) wt-ocr, (B) mut7, and (C) mut11, and (D) pOcr. pOcr behaves distinctly
from wt-ocr and the Mut7 and Mut11: there is a transition to a gel-like state at
0.8M ammonium sulphate. Moreover the gel formed is apparently weaker than
the other samples tested. Mut7 and Mut11 exhibit very similar viscosities as a
function of ammonium sulphate concentration.
between proteins. However, the regions of charge where the modifications of
ocr99 and pOcr that do not intersect (the amino acids D76, E87, D92, E95,
D96, E98, D99) indicates they have a stronger role in the aggregation behavior
of ocr. The location of these amino acids are primarily located in the last α-helix
prior to the C-terminal (on each monomer unit). The aggregation behavior of
pOcr, which containing this modified region, may indicate that this α-helical
region and the charge present there may be a specific region on the protein
surface which contributes strongly to the gelation behavior of ocr. Moreover,
while the surface charges of ocr99 and the mutants Mut7 and Mut11 are similar,
the ammonium sulphate concentration where the gel point is observed is different
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Figure 6.10: Mean squared displacements for ocr99. Plot of the MSDs for
a range of ammonium sulphate concentrations (M): 0.8 (black squares), 2 (red
circles), 2.4 (blue triangles), 2.8 (pink diamonds), 3.3 (orange stars). Triangle is
a guide for the eye; the hypotenuse shows a slope of 1.
for ocr99 and Mut7/11(2.4M and 1.6M, respectively). This is further indication
that this specific truncated portion of ocr is of less importance than other regions
of surface charge.
The question remains to be answered: what is the mechanism which causes
ocr to form fibrillar aggregates at high ammonium sulphate concentrations?
(Fig. 6.11) follows an archetypal salting-out trend, yet ocr and the variants
studied do not precipitate. It was noted in [4] that at pH values ∼ 4, ocr
will precipitate. Theoretical titration curves predict a surface charge of ∼ -
30e at pH 4. It is interesting to note that pOcr, which forms a weaker gel at
a much lower ammonium sulphate concentration, has a surface charge that is
approaching the surface charge at which wt-ocr will precipitate. Based on this
observation, there must exist some critical amount of surface charge which may
facilitate some specific interaction so that ocr can aggregate into ordered fibrillar
130
6.4. Discussion & Conclusion






















D i m e r i c  O c r  C h a r g e  a t  p H  8
p O c r
M u t 1 1M u t 7
w i l d - t y p e
o c r 9 9
Figure 6.11: The ammonium sulphate concentration at the gel-
point scales with surface charge. Plotted are the ammonium sulphate
concentrations at which a gel is formed as a function of surface charge. One
finds that the gel point ammonium sulphate concentration scales with surface
charge.
structures. The formation of fine-stranded gels occurs when there is sufficient
electrostatic repulsion between partially unfolded species which allows for slower
and more specific association between proteins [22]. The extreme surface charge
of ocr may need the excessive screening provided by such high concentrations
of ammonium sulphate in order to mediate the fine balance between repulsion
and making specific interactions. Of course if the charge of ocr goes below
this critical surface charge, non-specific interactions dominate which results in
amorphous aggregation and coagulation into particulates that can be seen by
eye. However, ocr gelation must not only be related to screening alone. Indeed,
at 3.2M ammonium sulphate where wt-Ocr gels, the Debye screening length is
approximately 1Å; this is less than the size of a water molecule. It is then
unrealistic to speak of a screening length at these salt concentrations. Ammonium
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sulphate is a good salt for salting out proteins because sulphate ions occur early
in the Hofmeister series. Sulphate ions are kosmotropic, that is, they allow for
to better form hydrogen bonds between water molecules. Therefore, a salt not
only can provide screening between other proteins but will effect the solution
environment in which they exist (for instance increasing surface tension) and this
ordering of water is what drives the phenomenon of ‘salting out’. However, salts
and their ions which come before ammonium sulphate in the Hofmeister series do
not cause ocr to gel [4]. Ultimately, charge screening and Hofmeister effects are
not sufficient to completely understand ocr gelation.
Many questions remain, the chief among them, is what exactly are these
specific interactions which occur between ocr dimers that causes ordered fibrillar
aggregates to be formed. Another important question is why is ocr fibrillar
aggregation specific to ammonium sulphate and not other salts. While many
different salts were tested to see whether they would induce gelation in wt-ocr,
the mutants were not screened. It is conceivable that at sufficiently lowered
surface charges, such as in the case of pOcr, other salts may be able to induce
gel formation. Preliminary studies have shown that pOcr does form a gel at a
similar concentration of NaCl to the ammonium sulphate experiments described
above. This would be an interesting avenue of future work. It would also be
advantageous to create additional mutants that have surface charges below this
theoretical critical value. Of course it would be ideal to perform another set of
experiments on ocr99 with better time resolution and statistics. It would also
be useful to characterize the physical dimension of the aggregates formed from
the variants. Attempts to image the aggregates using TEM were unsuccessful.
Perhaps a better approach would be to use solution-state (‘wet’) AFM to image
the aggregates. Solution-state AFM would be preferable to drying aggregates
onto a substrate due to the formation of ammonium sulphate crystals. Indeed,
when TEM was attempted the only visible structures on the TEM grid was
ammonium sulphate. Finally, a rigorous exploration of the viscosity of the gels
by microrheological methods should be performed by using a range of bead sizes
to eliminate potential error introduced by the pore size of the gel. While the
mechanism and organization of ocr into aggregates remains unclear, this chapter
has shed light onto possible regions on the surface of ocr which may play a role




7.1 Insulin Amyloid Fibrils
The kinetics of insulin amyloid fibril formation was studied using ThT fluo-
rescence assays. The experimental protocols used in this thesis allowed for a
drastic reduction in the variability in kinetic experiments (see Appendix B).
Our first observation is that the kinetics match well with predictions made by
a model in which fragmentation plays a dominant role in the kinetics of fibril
assembly. However, we observed a transition in the kinetics at a critical protein
concentration cT . When the experimental kinetic curves are normalized, we
observe a distinct plateau in the growth rates with increasing concentration for
protein concentrations cp > cT . It should be emphasized that the minimization
of variability allowed this observation to be made; the variability in previous
experiments would have completely obscured these kinetics features.
In order to better understand the nature of this transition, the structure of the
resultant fibrils were studied by CD spectroscopy. We found that the structure of
the fibrils formed above and below cT exhibit qualitatively different CD spectra.
Furthermore, bead-tracking experiments demonstrated that for a transition from
a fluid to a highly viscous fluid state occurs precisely at cT . These observations
lead to the postulation of a ‘critical fibril concentration’ (CFC). Once the fibril
concentration in the system crosses this value, we hypothesize that fragmentation
becomes physically arrested.
K. Eden developed computer simulations that employs the fragmentation
model of [119]. This model fails to capture the transition that we observe.
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However, when the simulations are modified to incorporate a CFC, we find that
the model captures the features of the kinetics well. Interestingly, the CFC
model predicts distinct fibril length distributions: for cp > cT we expect a log-
normal distribution populated by long fibrils; when cp > cT fragmentation is
not arrested which results in an exponential distribution of short fibrils. We
measured length distributions obtained from transmission electron microscopy
images. These results matched the qualitative predictions made by the CFC
model.
To further probe the nature of the CFC, kinetic experiments were repeated
with increasing concentrations of NaCl. We observed non-trivial and non-
monotonic trends in the growth rates as a function of protein concentration (and
with NaCl concentration). The features of these trends could be convincingly
reproduced by the CFC model by shifting the CFC value to lower concentrations.
Short fibrils and oligomers have been implicated as being cytotoxic [184, 178,
179, 180, 181, 41]. Since fragmentation is not arrested below cT , a very large
number of small oligomeric aggregates populate the system. We speculate that
the formation of stable, long amyloid fibrils may actually protect against the
accumulation of these harmful species. These results point to a new picture
of amyloid fibril growth in which structural transitions that occur during self-
assembly have strong effects on the final population of aggregate species with
small, and potentially cytotoxic, oligomers dominating for long periods of time
at protein concentrations below the CFC.
In Chapter 4, we used time-resolved SANS to further interrogate the nature
of the transition that we observe in the insulin system. We found that, up to a
critical time, the scattering curves could be well described by a simple cylinder
model, where the radius remained a constant size but the length increased from
t=180 to t=245 mins. For t ≥ 270 mins, this simple model no longer fit the
data. At this critical time we observe a large increase in scattering at low-Q
values indicating the presence of larger aggregates. This was further confirmed
by looking at the length distribution P (r). While polydispersity is an issue,
we modeled the system as a simple linear combination of cylinder models. We
found that the scattering signal at these longer times could be described by two
populations: small, monomer-like scatterers and much longer aggregates. These
longer aggregates had radii larger than the aggregates observed in the 180 mins
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≤ t ≤=255 mins. interval. The fact that this onset of larger aggregates occur
at a distinct time is intriguing and is consonant with the observations made
in Chapter 3. Unfortunately, due to a major fault in the linear accelerator,
we were unable to obtain complete kinetics. It would be very interesting to
determine the percentage of fibril aggregates in the system, relative to initial
protein concentration in these experiments. Doing so would allow a determination
whether the increase in aggregate size at that critical time is coincident with the
system crossing the CFC. It need not be said that further experiments need to
be done in order to test this. Obtaining SANS data for insulin concentrations
below cT has also been shown to be achievable. Observing full kinetic runs for
concentrations in that regime will also be highly informative and help resolve the
exact mechanism which arrests fragmentation at the CFC.
7.2 Ovalbumin Fibrils
We studied the kinetics of fibril formation in reduced ovalbumin using ThT
fluorescence. We found that ovalbumin displays very different kinetics from those
observed in Chapter 3. The kinetics were characterized by several features. First,
there was no lag time which preceded the onset of growth. Second, we observe
almost immediate exponential growth. Third, this exponential growth phase does
not finish in a flat plateau as we observed in insulin amyloid fibril formation in
Chapter 3. Instead, there is a gradual turn-over in the kinetic curve which then
proceeds nearly linearly and at a very slow rate. Furthermore, Bradford Assays
indicate that the aggregation process is far from complete in these systems.
TEM was performed in order to study the morphology of the aggregates that
are subsequently formed. In contrast to the long and straight fibrils we observed
in Chapter 3, ovalbumin fibrils are short and worm-like. We measured a length
distribution which showed that there is a large population of short fibrils (∼
200-300 nm), but was not exponential in character. Furthermore, the persistence
length of the fibrils was found to be very short (∼ 26 nm). One of the most striking
features of the fibrils observed using TEM was the presence of closed-loop fibrils.
We speculate, the fact that the persistence length is so short, facilitates two ends
of a fibril to have a finite probability of meeting and joining.
We develop a simple model where fibril formation is a downhill polymerization
135
7.3. Ocr Aggregation
process. If we do not include a term which takes into account the joining of ends,
the kinetics that we observe can not be well described by such a model. Namely,
the simple downhill polymerization does not capture the slow growth regime and
the time-scale of polymerization that we observe. When an end-joining term is
incorporated into the model such features can capture these features. Therefore
we attribute the kinetics we observe to two features. First, the lack of a lag-
time is due to the system being effectively seeded. Second, the slow-growth at
long times is due to end depletion due to both self-joining and fibril-to-fibril end
joining.
It would be interesting in the future to attempt to isolate the fibril loops,
perhaps by ultra-centrifugation. Can a system be seeded by these species? If so,
what is the resulting morphology of the fibrils? Are there conditions in which
these worm-like fibrils can be converted to longer and straighter fibrils? Another
interesting question is why are the kinetics apparently seeded? Is it because of the
solution conditions or are the fibrils nucleating at interfaces? Finally, a better
characterization of the underlying structure of the fibrils needs to be attained
to determine whether these fibrils are amyloid-like in nature or something else
entirely.
7.3 Ocr Aggregation
Ocr forms a transparent gel at a concentration of 3.2M ammonium sulphate.
The fact that ocr forms a transparent, fine-stranded gel, under such high-charge
screening conditions is highly unusual. In an attempt to better understand the
mechanism which causes this anomalous aggregation behavior, we studied mutant
variants of ocr. These mutants had large surface charge modifications, often
located in different regions of the protein. The structure of the gels formed
from the mutants were interrogated using bead-tracking microrheology. These
experiments revealed the concentration of ammonium sulphate needed to form
a gel decreased with decreasing amounts of surface charge. This type of trend
is typical of a ‘salting-out’ trend; however instead of precipitating ocr and its
mutants form gels.
Preliminary data was taken on a chemically excised variant of ocr. This
variant contained many modifications similar to those in the mutant pOcr. The
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excised portion missing from ocr99 contains 10 of the 17 charge modifications
of pOcr (predominately located in the unstructured C-terminus tail). It is
interesting to find that the ammonium sulphate concentration at which these two
variants gel are markedly different. This may be indicative that the unstructured
tail (which has been removed in ocr99) does not play an important role in driving
the formation of ocr fibrillar aggregates. However, a single region on the surface
of the protein which strongly contributes to the assembly process can not be
pin-pointed from this analysis. However, what does emerge is that charge does
play a critical role in driving the formation of fibrillar aggregates. The general
model that I hypothesize is that there is a critical surface charge which enables
electrostatic repulsion to effectively slow the protein-protein interactions enough
where specific contacts can be made. If there is not enough screening, aggregation
occurs. However, if there is not enough charge on the surface, the electrostatic
repulsions can not mediate the contacts between proteins, allowing for non-
specific aggregation and precipitation. Much more work needs to be done to
understand the nature of these interactions. The production of further mutants
with greater amounts of charge removed and testing whether other salts can
induce aggregation for lower surface charge mutants would be of great interest.
Furthermore, studying the structure of the aggregates could shed light on the
forces which hold the aggregates together.
7.4 Final Conclusion
This thesis has investigated the mechanisms of fibrillar protein aggregation in
three different protein systems. Taken as a whole, these studies have provided
new insights into how and why proteins self-associate into ordered fibrillar
assemblies. This work has the potential to have an impact on our understanding
of diseases related to fibrillar aggregates and their pathology by identifying
the structural characteristics and conditions that influence the accumulation of
harmful aggregates. In general, by establishing a fundamental understanding
of the mechanisms of aggregation, such behavior can be controlled and possibly
exploited. The applications of such knowledge are many-fold and cross many
disciplines, from the improvement of protein-based pharmaceuticals to making
novel and useful materials.
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The approach taken in this thesis has been from a ‘physics’ perspective: I
wished to understand, at a basic mechanistic level, the complicated and often
‘messy’ phenomenon of protein aggregation by employing model systems in which
the parameters of the systems could be well controlled. Modeling can then be
used to understand the essential forces and mechanisms of assembly by reducing
these complicated systems to their minimal ingredients. Not only does modeling
provide insights into the physical phenomenon uncovered in the experiments, but
also offers feedback and informs new ideas for future experimental investigations.
This symbiosis of experiment and modeling allows for maximum insight into
the aggregation mechanisms explored in this thesis. Of course, understanding
the ‘real world’ of in vivo aggregation is never so simple and the biology and
biochemistry involved is highly complex. However, by taking a physics-based
approach, I believe we can begin to deconvolve these highly complex systems into
their essential components which can ultimately inform our understanding of the




Common Plate Readers: A Word
of Warning
A.1 Introduction
In the course of doing a large number of kinetic experiments using a variety
of plate readers, I discovered that for samples that are highly sensitive to
temperature variations, some plate readers are better than others at providing
homogeneous temperatures within the machines. This can have consequences for
reproducibility of experiments and will increase errors and variability in kinetic
data. I present a variety of common plate readers and show some are better than
others at providing homogeneous temperature control. This appendix serves
as a word of warning to individuals using these machines to be vigilant when
performing sensitive experiments using these machines.
A.2 BMG Omega
The Omega series of plate readers made by BMG is the model on which the
majority of ThT fluorescence kinetic data was obtained in this thesis. Correlations
of kinetic parameters as a function of position on the plate were first noticed in
this machine. Clearly, there is a correlation of the lag time from top-to-bottom
in the plate where as going from left-to-right on the plate reveals no correlation
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within error (Figs. A1 and A2). We noticed that the left side of the plate would
sit near the door of the machine (as well as over the optic) between read cycles.
The problem was fixed by programming the plate to sit far away from the door
and optic. In the BMG Omega this meant positioning the plate in the far back
right corner of the machine.





















Figure A.1: BMG Omega Mean Lag Time By Row Displayed are the mean
lag times as a function of row for a 1 mg/ml insulin sample.
A.3 Spectramax M5e
I then tested whether this sort of correlation is found in other plate readers. We
tested our system on the Spectramax M5e, which is the top of the range plate
reader offered by Spectramax. We again used a 1 mg/ml sample of insulin and
measured the lag times. Plotted in Figs. A3 and A4 are the mean lag times
as a function of row and column. The mean lag times are longer on the top
of the plate relative to the bottom. Interestingly, the lag times are shorter on
the left side of the plate relative to the right side. The plate sits in a different
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Figure A.2: BMG Omega Mean Lag Time By Column Displayed are the
mean lag times as a function of column for a 1 mg/ml insulin sample.
orientation inside the Spectramax from the BMG. In the Spectramax, the right
side of the plate sits closest to the door. We hypothesize that the doors on the
BMG and Spectramax are not sealed well allowing for temperature gradients to
be established within the machines.
A.4 Biotek Synergy H4
We tested two plate readers made by Biotek. The Synergy H4 is the top-of-the-
line instrument offered by Biotek. When we tested the Bioteks we used a 1 mg/ml
ovalbumin as our protein test system. As was outlined in Chapter 5, ovalbumin
kinetics lack a lag time. In these tests we used mean maximum ThT fluorescence
as the metric instead of lag time. Fig. A5 shows that the final row, that is the
bottom of the plate, has a markedly decreased maximum fluorescence. This row
sits closest to the door of the machine. Again, there may be sealing issues allowing
for temperature gradients. The salient point gleaned from Fig. A6 is that: first,
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Figure A.3: Spectramax M5e Mean Lag Time By Row Displayed are the
mean lag times as a function of row for a 1 mg/ml insulin sample.
there appears to be some correlation of the maximum fluorescence as a function
of column; secondly, the last two columns have much greater variability in the
mean maximum fluorescence values. These results would be of some concern if
one required high precision in measuring these types of parameters.
A.5 Biotek Synergy 2
We finally tested the Biotek Synergy 2. Fig. A7 shows that there may be a slight
correlation of the fluorescence as a function of the rows. In contrast, Fig. A8
demonstrates that there is no correlation as a function of column.
A.6 Conclusions
What is clear is that one must take care in performing experiments in plate
readers where temperature control is of great importance. One should always
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Figure A.4: Spectramax M5e Mean Lag Time By Column Displayed are
the mean lag times as a function of column for a 1 mg/ml insulin sample.
test their results by performing correlation analyses as shown above.
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Figure A.5: BiotekH4 Mean ThT Fluorescence By Row Displayed is the
mean maximum ThT fluorescence of 1 mg/ml ovalbumin as a function of row.
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Figure A.6: BiotekH4 Mean ThT Fluorescence By Row Displayed is the
mean maximum ThT fluorescence of 1 mg/ml ovalbumin as a function of column.
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Figure A.7: Biotek Synergy 2 Mean ThT Fluorescence By Row Displayed
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Figure A.8: Biotek Synergy2 Mean ThT Fluorescence By Row Displayed




Demonstration of Reduction of
Variability in Polystyrene Plates
Plates vs. NBS Plates
B.1 Polystyrene Plates: Insulin Kinetics
B.2 NBS Plates: Insulin Kinetics
B.3 Lag Time Distributions
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Figure B.1: Insulin Amyloid Kinetics in Polystyrene Plate Insulin amyloid
fibril formation in polystyrene plates results in extreme variations in the kinetics
from well-to-well. Shown are kinetic runs for 1 mg/ml sample.
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Figure B.2: Insulin Amyloid Kinetics in NBS Insulin amyloid fibril formation
in NBS plates results in extremely well controlled kinetics with greatly minimized
variation well-to-well. Shown are kinetic runs 1.5 mg/ml sample.
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Figure B.3: Lag Time Distributions for Insulin Amyloid Fibrils Shown
are lag time distributions for 0.1 mg/ml (red), 0.4 mg/ml (green), 1.5
mg/ml (blue), and 4 mg/ml (magenta) insulin concentrations. Note that the
distributions, especially for higher concentrations are sharply peaked indicating
very reproducible kinetics. This should be contrasted against what has been
previously observed in insulin fibril kinetics where the variability was significantly
larger [10]. Such reproducibility in our experiments has allowed for kinetic
features to be observed which otherwise would be obscured by such variability.
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Appendix C
Table of Kinetic Data for
Agitated and Unagitated Samples
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